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SUMMARY
A structured collection of P. multocida strains, containing isolates from different host 
species, geographic regions and disease categories was assembled from lyophilised 
preserved isolates. Each strain characterized for capsule serotype and for the known 
or putative virulence determinants. In 94% of strains, an indirect haemagglutination 
test allowed unequivocal allocation to a serotype. Capsular antibody raised in rabbits 
with a course of intravenous injection of formalized suspension furnished high 
potency and specificity, though differences were found in their antibody content, 
(serotypes A and D appeared to be less antigenic than B, E and F serotypes). The 
high success-rate in serotyping was attributed to the quality of the antisera prepared.
The virulence determinants investigated were not uniformly present in all serotypes. 
Capsule and neuraminidase were present in all serotypes but the size of the capsule 
zone and the amount of neuraminidase varied between serotypes and within each 
serotype. Protein toxin was detected in 8 strains (5 from serotype A and 3 from D). 
Four of these strains were of ovine origin. Hyaluronidase (which acted also as 
chondroitin sulphatase) was produced only by serotype B. Capsular hyaluronic acid 
was present in only serotype A; a similar, capsular substance in serotype D resisted 
hyaluronidase and was thought to be an acidic polysaccharide differing from 
hyaluronic acid of serotype A. NaCl gradient ion exchange paper chromatography 
proved an effective method for the study of the capsular polysaccharides.
A single mouse model for virulence of P. multocida strains was derived from 
previous work and tested. Statistical analysis revealed significant correlation between 
the high specific neuraminidase activity of serotypes A, D and F and their high 
mouse virulence. The hyaluronidase of serotype B appeared also to have some 
association with high mouse virulence. Mouse avirulent strains of serotype A had 
higher mean capsule zone size and contained more hyaluronic acid than the virulent 
strains. The development of severe hypothermia followed by death of mouse at the 
latter stage of virulent P. multocida infection suggested a possible role of endotoxin 
in disease: the mode of action of the endotoxin in mice may, at least in part, be 
through hypothermia.
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SECTION 1
GENERAL INTRODUCTION AND SUBJECT REVIEW
1
Pasteurella multocida has been recognised as an important pathogen for over a 
century. Diseases such as haemorrhagic septicaemia (HS) and fowl cholera due to P. 
multocida remain among the major infectious diseases affecting the livestock and 
poultry industry in the world, causing significant economic losses. Contributing to the 
persistence of the disease within the livestock and poultry population is the relative 
lack of knowledge regarding pathogenesis, infectivity and virulence factors associated 
with P. multocida. The introductory chapter will be a description of the history and 
characteristics of P. multocida and current views regarding the general virulence 
determinants of this potent disease agent.
1.1 Historical
Pasteurella multocida was first isolated in 1879 by Toussaint (according to Gray, 
1913) in a period which also saw the discovery of similar microorganisms by other 
workers from poultry, cattle, pigs, sheep and other animals suffering from a disease 
characterised by septicaemia with widespread haemorrhages. The organism has had 
many names, beginning with Micrococcus gallicidus and most are listed and 
referenced in Index Bergeyana (1966). The name Pasteurella for the genus was based 
on the suggestion of the Italian Count Trevisan (1887) who wanted to commemorate 
Louis Pasteur’s work on the elucidation of the causative agent of fowl cholera in 
chickens. After many years of nomenclatural changes for the first known Pasteurella 
species, Rosenbusch and Merchant (1939) designated the organism Pasteurella 
multocida. This has now been widely accepted and is listed as the type species of the 
genus (Mannheim and Carter, 1984).
During recent years Pasteurella and allied bacteria have been the subject of 
taxonomic reorganization, and reclassification of these organisms is a subject of 
debate. New taxa and atypical isolates have been described and their affiliation with 
Pasteurella discussed; traditional DNA-DNA hybridization studies employing all 
recognised species and newly described taxa has led to the reclassification of the 
genus itself (Mutters et ah, 1985). More recent genotypic studies have also shown 
that many members of the family Pasteurellaceae have been misclassified (Maclnnes
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and Borr, 1990). The whole question of nomenclature and classification is currently 
being reviewed by a committee of the International Congress for Microbiology.
1.2 Pasteurella multocida
1.2.1 Morphology and Staining
The usual form of P. multocida is a cocco-bacillus or short rod, non-motile, non- 
sporing and staining Gram-negative. Many cultures are quite pleomorphic on initial 
isolation or when grown under unfavourable conditions. Long filamentous forms are 
frequently seen in old laboratory cultures. In tissues, exudates and recently isolated 
cultures, the bacterium shows bipolar staining with Giemsa or Wrights stain. After 
repeated sub-cultivation in the laboratory, this characteristic property of bipolar 
staining may be lost (Bain, 1963). The organism possess a capsule demonstrable by 
Indian ink (Carter, 1967).
1.2.2 Cultural Characteristics
P. multocida is an aerobe and facultative anaerobe which grows best at temperatures 
of 35-37°C in air, or air plus 5 % carbon dioxide. The colonial form of P. multocida 
has been studied extensively. Considerable confusion has arisen because a variety of 
terms have been used to designate the same variants. Carter (1957a) recommended 
adoption of the terminology suggested by Braun (1953) as a standard for the species. 
Braun (1953) suggested that the terms mucoid, smooth and rough be used to designate 
the principal colonial variants of bacteria. P. multocida is generally believed to 
produce all of these variants, though it may be that variant is not the correct word 
since a strain isolated in one form remains so, and seldom if ever dissociates into 
another form.
The gross appearance of serotype B and E on agar media is usually as smooth 
colonies that have a yellowish or bluish green iridescence in obliquely transmitted 
light (Rimler and Rhoades, 1989). The colonies of serotype A and D are mucoid in
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nature. The mucoid characteristics can vary from cultures whose colonies are 
discrete, circular, convex and have a slight mucous like consistency, to cultures 
whose colonies are confluent, markedly moist and viscous. All strains of P. multocida 
that produce colonies of the large watery mucoid variety have been found to belong 
to serotype A (Carter, 1967). Colonies of serotype A and D strains display pearl like 
iridescence, except that watery mucoid colonies of serotype A appear grey (Rimler 
and Rhoades, 1989).
Rough colonies consist of filamentous cells, and have been described as being flat 
with a slight raised central papillae and flattened irregularly serrated edges (Anderson 
et al, 1929) or as discrete, raised, circular, rough and slightly dry (Heddleston et ah, 
1964). Some strains, cultures especially those which have been repeatedly subcultured 
in the laboratory, develop rough cultures which are of a drier consistency and difficult 
to suspend in fluid (Buxton and Fraser, 1977). Rough cultures of P. multocida seem 
rarely to be isolated from natural sources, either diseased or healthy animal material.
1.2.3 Biochemical reactions
The ability of strains of P. multocida to produce indole, their lack of growth on 
MacConkey agar, and their lack of a urease serve as tests to distinguish them from 
other Pasteurella species. All strains of P. multocida produce acid from glucose but 
not gas and are without action on litmus milk and gelatin. Separation of isolates of 
P. multocida into subgroups or "biotypes" based upon variation in biochemical 
characteristics has been attempted (Weaver and Hollis, 1980 ; Oberhofer, 1981) and 
higher incidences of certain fermentation reaction patterns for isolates from a 
particular animal species have been found. For example; Khalifa (1934) found that 
avian strains tended to ferment arabinose but not xylose, whereas mammalian strains 
gave the opposite reactions and acid production from maltose, trehalose and dextrin 
occur more frequently with isolates from dogs, compared to isolates from other 
animals (Smith, 1958 ; Heddleston, 1976).
4
1.2.4 Colonial variation and virulence.
Carter and Bain (1960) summarised the relationship of colonial variation to virulence 
for mice and noted that; a) cultures initiated from mucoid variants vary greatly in 
their virulence for mice; for example, many mucoid cultures from cases of acute fowl 
cholera are highly virulent for mice whereas mucoid cultures that tend to autolyse are 
weakly or moderately virulent; sometimes taking as long as a week to kill mice 
(Carter and Bigland, 1953); b) cultures initiated from smooth (iridescent) variants are 
almost invariably virulent for mice, c) as iridescence is lost, mouse virulence may or 
may not reduce; many laboratory strains that yield smooth (non-iridescent) variants 
are highly virulent for mice (Carter, 1957a) and d) cultures that yield rough variants 
are low in virulence for mice (Anderson et ah, 1929).
1.3 Serological typing of P. multocida
There have been numerous serological studies of P. multocida. The serological 
behaviour is determined by capsular and somatic antigens. Roberts (1947) employed 
passive protection tests in mice to identify several immunotypes of P. multocida, 
including the one that causes most outbreaks of haemorrhagic septicaemia (HS), and 
for this reason, typing by the Robert s system is still sometimes used where the 
disease is enzootic.
Capsular antigens can be detected either by slide agglutination (Namioka and Murata, 
1961a) or by an indirect haemagglutination test, in which the soluble capsular antigen 
is adsorbed (Carter, 1955,1961, 1967; Sawada et al. , 1982). The antibody is provided 
by rabbit antiserum prepared from the inoculation of killed P. multocida. On the basis 
of polysaccharide capsular antigen, Carter (1955, 1961) established 4 capsular types, 
A, B, D and E; A and B being the same as Roberts II and I respectively. A further 
capsular type, designated F was isolated from turkeys in the USA (Rimler and 
Rhoades, 1987). Capsular types B and E have also been identified by an immuno­
diffusion test (Wijewardana et al. , 1982) and counter immuno-electrophoresis (Carter 
and Chengappa, 1981b; Chengappa et #7,1986). A coagglutination procedure has
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been developed for recognition of serotypes B and E (Rimler, 1978). Dawkins et al.
(1990) developed an ELISA test for identification of P. multocida causing HS and 
claimed that it provided a rapid, simple, accurate and inexpensive adjunct to direct 
diagnosis.
Somatic antigens of P. multocida are associated with the cell wall and two systems 
have been commonly used for somatic antigen typing of P. multocida: the Namioka 
system; based upon tube agglutination tests (Namioka and Murata, 1961b ; Namioka, 
1970) and the Heddleston system; based upon gel diffusion precipitin tests 
(Heddleston et a l,  1972). Eleven serotypes (1 to 11) are recognised by the Namioka 
system and 16 serotypes (1 to 16) are recognised by the Heddleston system 
(Heddleston et ah, 1972 ; Brogden et ah, 1978).
The Namioka tube agglutination test utilizes rabbit antiserum absorbed against cross 
reacting serotypes. The antigens consists of hydrochloric acid (HC1) treated bacterial 
suspensions; this treatment removes the capsular antigen. The Heddleston gel 
diffusion precipitin test utilizes antiserum prepared in chickens. The heat stable 
antigens used for the test are extracted from formalized saline suspensions of the 
bacteria. Purified lipopolysaccharides (LPS) can be used to prepare specific somatic 
antiserum in chickens and this antiserum can be used for routine typing (Rimler, 
1984).
The use of a combined somatic-capsular typing scheme (Namioka-Carter) was 
recommended at the Food and Agriculture Organization (FAO-APHCA) workshop 
on HS held in Colombo, Sri Lanka in 1979 (Anonymous, 1979). According to this 
scheme, the two HS serotypes were designated 6:B and 6:E. Later, Carter and 
Chengappa (1981a) suggested an altered system of typing designating serotypes of P. 
multocida, based upon the identification of the capsular substances according to 
Carter’s system and identification of somatic or "O" antigens by the system developed 
by Heddleston and associates (Heddleston et a l,  1972). Thus a serotype is identified 
first by a capital letter representing the capsular type followed by an Arabic number, 
1, 2, 3, 4, etc. representing the somatic antigens. For example, the two HS serotypes
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were designated B:2 and E:2. The B:2 is equivalent to Namioka’s 6:B and the E:2 
to his 6:E.
1.3.1 Problems of serological typing of Pasteurella multocida
One limitation of capsule typing is the difficulty in preparing capsule antiserum of 
high titre. Sometimes host factors influence the preparation of specific typing 
antiserum. For example, low-titre reactions may occur between the sera of normal 
animals and antigens of P. multocida; these may be due to the presence of naturally 
acquired antibodies as a result of Pasteurella species in the normal flora or P. 
multocida epitopes shared in common with other bacterial species which comprise the 
resident flora (Prince and Smith , 1966b; Rimler and Rhoades, 1989). Most workers 
find it relatively easy to make antibodies against capsule antigen of serotypes B and 
E but not the other serotypes. The precise reason for this difficulty is unknown. It 
may be due to an inability of the host immune system to recognise the specific 
capsule antigen because it is a hapten, or because the specific capsule epitopes are 
masked by immunologically-inert material, such as the capsular hyaluronic acid of 
serotype A strains. It is also possible that the more accessible epitopes which are 
immunodominant are preferentially identified (Rimler and Rhoades, 1989).
The immunizing schedule for raising antibody is very important. Hyde (1967) 
reviewed some of the variables that influence the outcome of an immunization attempt 
and noted that there is no universal vaccination procedure that will guarantee 
maximum antibody production. However, according to Rimler and Rhoades (1989) 
the best antiserum can be made in Pasteurella-free rabbits by weekly intravenous 
inoculation with formalin killed bacterial suspensions. Satisfactory results generally 
occurred five to ten weeks after the first inoculation. Preservation of antigen is also 
important in this context. If the antigens are kept in a refrigerator (+4°C) for more 
than two weeks, some parts of the capsular antigens may dissolve in the diluent, 
become haptens and lose their immunogenicity (Namioka, 1978 ; Rimler, personal 
communication); thus the antigen suspensions are best prepared freshly on each 
occasion.
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There appears to be significant problem in typing some P. multocida strains, with 
reports of between 30 and 82% of isolates being "untypable” (Namioka and Bruner, 
1963 ; Manning, 1982 ; Jones et a l ,  1988). Capsular hyaluronic acid in type A 
strains inhibits the reaction between antigen and antibody in the IHA test (Carter, 
1958, 1972; Sawada et a l ,  1982). Namioka and Murata (1961a) noted that cultures 
with prolonged incubation (more than 4 hours) can rarely be typed by the slide 
agglutination test.
The indirect haemagglutination (IHA) test depends on adhesion of soluble antigens to 
erythrocytes surface. Carter (1955) recommended to use group O human red blood 
cells for increase adhesion of RBC but it is difficult to obtain group O human RBC 
for some laboratories. Later, Carter and Rappey (1962) described a modified IHA test 
that uses formalized group O human RBC. Also formalised sensitized RBC have a 
tendency to clump and thus become unsuitable for the assay (Daniel, 1965). Sawada 
et a l (1982) have successfully used glutaraldehyde fixed sheep RBC in the indirect 
haemagglutination test for P. multocida and P. haemolytica.
Problems particular to Roberts’ system are that routine typing tests are expensive and 
isolates must be virulent for mice. There is also the chance of cross-protection due 
to antibodies in a test serum directed against shared common antigens (Rimler and 
Rhoades, 1989). According to Carter and DeAlwis (1989) the potency of the serum 
used and the number of challenge organisms must be carefully standardized and 
adequate controls must be included in this test.
In Namioka’s procedure (Namioka and Murata, 1961b) the antigen involved is LPS 
and may possess, one or more antigenic determinants; for this reason, antisera for the 
agglutination tests have to be adsorbed. Other disadvantages of this technique are the 
frequent autoagglutination and non-specific agglutination of HC1 treated bacterial 
suspensions, which therefore can not be typed (Namioka and Murata, 1961b). In 
Heddleston’s procedure, preparation of all 16 antisera is not practicable for most 
laboratories and the appearance of several precipitin lines is likely to be an expression 
of the heterogenicity of the antigens and antibodies used in the gel diffusion test.
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Brogden and Packer (1979) compared P. multocida typing systems: a single serotype 
in one system often represented more than one serotype in another. Results indicated 
that cultures with one or two serotyping antigens in common may differ in other 
antigens because of the antigenic complexity of P. multocida and the nature of the 
antigens involved in each test.
1.3.2 Nonserogical tests
Several nonserogical tests have been devised in attempts to circumvent the difficulties 
of capsule typing. Carter and Rundell (1975) developed a cross streaking method in 
which serotype A strains are recognised by depolymerization of the capsule during 
growth in proximity to a hyaluronidase producing strain of Staphylococcus aureus. 
They also observed that some type D strains show a slight reduction in colony size 
near the staphylococcal streak, indicating that these strains may possess a small 
amount of peripheral hyaluronic acid, but Dejong et al. (1980) obtained negative 
results for type D isolates using the same test.
Presumptive recognition of mucoid serotype D strains is said to be possible from their 
characteristic floccular agglutination reaction with acriflavin (Carter and Subronto, 
1973). Some serotype F strains also react similarly (Rimler and Rhoades, 1987). 
Confusion is most likely to occur with cultures consisting predominantly of "blue" 
(non-mucoid) variants, which produce a granular precipitate (Carter, 1984).
Recently, nonserological molecular approaches have been used for the identification 
of P. multocida. Johnson et al. (1991) investigated protein profiles of 14 isolates 
from animals with haemorrhagic septicaemia (HS) and found that HS isolates of Asian 
and North American origin of serotype B (American isolates obtained from NADC. 
It may be mentioned here that there have only been few outbreaks of HS occurred 
in 1912 & 1922 in the bison of Yellowstone National Park herd in USA which some 
now believe not to have been HS at all.) had a major protein band with an apparent 
molecular mass of 32 K Da, whereas those of African origin (serotype E) had a major 
protein band with an apparent molecular mass of 37 K Da. Harel et al. (1990) used
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restriction endonuclease analysis (REA) of genomic DNA for distinguishing porcine 
P. multocida isolates with similar capsular and somatic serotyping.
1.4 Association of serotypes of P.multocida with disease
Serotypes of P. multocida tend to be associated with particular animal species and 
forms of disease, and even with geographical regions; although there is a good deal 
of overlap between the varieties of animal species which are susceptible to infection 
with each serotype. Carter (1967, 1984) noted that capsule type A strains cause 
almost all fowl cholera and that most cultures of P. multocida recovered from disease 
processes in farm and other animals in North and South America, are of type A. This 
type had previously been associated with an outbreak of fowl cholera in Britain 
(Curtis, 1981) and, according to Smith et ah (1990), capsular type A and D are world 
wide in distribution. Type D was recovered from a wide range of animal species 
(Carter, 1957a, 1967), but found to be especially characteristic of pigs, and widely 
recovered from enzootic pneumonia and atrophic rhinitis in this species. Capsular 
serotype D also infects avian hosts, for which it exhibits slight to moderate virulence 
(Rhoades and Rimler, 1990).
Capsular type B and E cultures are recovered from cattle, buffaloes and occasionally 
other animals with HS. In Asian countries, the only serotype recovered so far is 
serotype 6:B whereas the serotype prevalent in Africa has been identified as 6:E. A 
few countries, notably Egypt and Sudan have recorded both. Serotype B strains were 
also found to be virulent for turkeys (Rhoades and Rimler, 1988).
In disease conditions other than HS, pasteurellosis in cattle usually occurs as 
pneumonia. The respiratory disease complex in feeder calves in North America is 
known as "shipping fever". However, in the UK and Europe, it is called "transit 
fever". P. haemolytica type A1 is usually involved but P. multocida type A 
occasionally associated (Blood et a l , 1979).
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A new serotype F was isolated from turkeys in the USA (Rimler and Rhoades, 1987). 
In the UK, Jones et ah (1988) isolated a capsular type F strain (somatic serotype 3,4) 
from calves with severe subcutaneous and periocular oedema.
1.5 Economic significance
Infection with Pasteurella multocida is of great economic importance in animals and 
birds and is thought to be increasing in some countries. In tropical Asia, HS causes 
high mortality in clinical cases. Some countries in the region have actually estimated 
the economic losses. According to the report of DeAlwis (1980) Indonesia lost 
approximately 5.4 billion rupiah in 1973, while Malaysia’s estimated loss was M$ =
200,000 in 1976. Bangladesh records an annual loss of about 1000 heads of animals 
(species not mentioned) while Pakistan claims that about one third of the losses in 
cattle and buffaloes is believed to be due to HS. Since the disease is prevalent in 
region where husbandry is primitive, many deaths may go unreported. In addition to 
death losses, there is undoubtedly a serious loss of production from poor growth, 
decreased milk production, the treatment of sick animals and vaccination of 
susceptible animals. The economic impact is particularly marked where water 
buffaloes and bullock are used for draft purposes. HS is also widespread in Africa. 
Wang et al. (1969) reported that 10% of cattle of the Government farms in Ethiopia 
were killed by HS. Francis et al. (1980) mentioned an outbreak of HS in Zambia that 
resulted in the deaths of more than 10,000 cattle.
A report from Animal Health Year Book (1986) indicated wide spread outbreaks of 
fowl cholera in Africa, Asia, Americas and Europe. In a retrospective study the costs 
estimated in fowl cholera in turkeys in USA was nearly $ 0.40 per bird ($ 18750 per 
flock)of a outbreaks of 50,000 birds (Carpenter et ah, 1988).
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1.6 Diseases due to P.multocida
P. multocida associated with a variety of infections. The principal diseases and 
infections due to P. multocida are: haemorrhagic septicaemia in cattle and buffaloes 
and avian cholera. The organism is also involved in primary and secondary 
pneumonias in cattle, sheep, pigs and rabbits and atrophic rhinitis in pigs.
HS is a peracute disease characterized by a rapid course, high fever, nasal discharge, 
respiratory distress, oedematous swelling in the head-throat and brisket region and 
wide spread haemorrhages in internal organs. HS is widely believed to be more 
common in buffaloes than in cattle. There are reports on the association of HS 
serotypes with disease in other species (Carter and DeAlwis, 1989). The disease is 
endemic to most parts of the tropical Asia, Africa and is also known in southern 
Europe (DeAlwis, 1984).
Avian cholera is an acute to peracute septicaemia with world wide incidence. Poultry 
particularly chickens, turkeys, ducks and geese are commonly affected. Depression, 
ruffled feathers, fever, diarrhoea and respiratory distress are commonly observed 
symptoms in birds affected with acute avian cholera. In some cases such signs are 
present only in few hours before death, so the first observed evidence of disease is 
often dead birds (Rhoades and Rimler, 1989).
Atrophic rhinitis is a complex disease characterized by sneezing, nose bleeding, 
shortening or twisting of the snouts, atrophy of nasal turbinate bones and in severe 
cases, by impaired growth. The disease occurs throughout the world in areas with an 
intensive swine rearing industry. Toxigenic strains of P. multocida (serotypes A and 
D) together with toxin producing Bordetella bronchiseptica are recognised as the 
major aetiological agent (Rutter and Mackenzie, 1984; Chanter and Rutter, 1989). 
The role of protein toxin of P. multocida in the pathogenesis of atrophic rhinitis was 
established by inoculation of pigs either with cell extracts of toxin producing P. 
multocida alone or with purified toxin caused characterized lesions of severe turbinate
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atrophy (Il’ina and Zasukhin, 1975; Rutter and Rojas, 1982 and Chanter et ah, 
1986b).
1.7 Virulence determinants
Virulence determinants can be defined as the components and products of the bacterial 
cell which confer on the bacterium the potential to harm the host. With few 
exceptions virulence is rarely the property of a single determinant of the pathogen 
(Smith, 1977). In most cases the damage suffered by the host is multifactorial, the 
factors involved including those of host origin (e.g. immuno pathological reactions 
such as anaphylactic, immune complex and cell mediated production of interleukin 
1, cytokines) as well as bacterial factors.
The following is a review of potential virulence factors that may be possessed by P. 
multocida.
1.7.1 Bacterial capsule and virulence
The capsule adheres to the bacterial surface and form a continuous layer around the 
outer surface of the cell wall of a bacterium. One common method of demonstrating 
bacterial capsules is to suspend the bacteria in Indian ink. The high optical density 
of the ink particles reduces drastically the light transmission in the area around the 
cell and under the microscope capsules appears as a bright area, sharply offset against 
a dark background.
The main role of the capsule in virulence is protection of the organism from the host 
defence system. The classic work on the pneumococcus (Griffith, 1928) showed that 
capsules prevent bacteria from being engulfed by phagocytes. There are several 
possible reasons for this. Capsulated bacteria usually grow in micro colonies in vivo 
and engulfment by the phagocytic cells is difficult on purely steric considerations 
(Poxton and Arbuthnott, 1990). Furthermore, complement and opsonic antibodies 
cannot get access to the cell envelop. Many capsules also confer resistance to the
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bactericidal effect of serum (Glynn and Howard, 1970). Another general observation 
is that the hydrophilic property conferred on the surface of the bacterium by 
polysaccharide may render the cell less susceptible to phagocytosis (Poxton and 
Arbuthnott, 1990). Also, capsule polysaccharide may be anti-phagocytic (Ryu et a l , 
1984).
Several species of bacteria produce a capsule with a chemical structure that mimics 
host tissue. This camouflages the organism from the immune system by appearing to 
the host as self (Jann and Jann, 1990). The best examples are the K1 capsule of 
Escherichia coli and the capsule of Neisseria meningitidis group B. These organism 
have capsules of Af-acetylneuraminic acid polymers. Capsules of similar composition 
are found in the important sheep pathogen P. haemolytica type A2 (Adlam et ah , 
1987). Another example of a capsule mimicking host tissue is provided by the 
hyaluronic acid capsule of Streptococcus pyogenes and of P. multocida (Poxton and 
Arbuthnott, 1990).
The size and form of capsule produced may vary according to species, strain, the 
physiological state of the cell and its growth conditions (Hammond et a l ,  1984). The 
quantity of capsular polysaccharide is apparently important in a variety of pathogens. 
Klebsiella pneumoniae, Salmonella typhi, S. typhimurium, E. coli, Streptococcus 
pneumoniae and Staphylococcus aureus all show a relationship between the amount 
of capsular material and virulence, resistance to phagocytosis or resistance to humoral 
host defences (Hammond et a l, 1984). In Actinobacillus pleuropneumoniae, the 
thickness or amount of cell-associated capsule has also been proposed to account for 
differences in virulence between non-isogenic strains (Jensen and Bertram, 1986 ; 
Jacques et a l,  1988). Vermeulen et a l (1988) found that the amount of E. coli K1 
cell-associated capsule was greatest during very early phases of growth and this 
correlated with increased virulence.
Bacterial capsules also affect the cellular immune system by affecting the response 
of lymphocytes or macrophages. For example, the capsular material of Haemophilus 
actinomycetemcomitans, a pathogen associated with periodontal disease, was shown
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to have many of the biological activities of interleukin (IL) 1, [bone-resorbing activity 
and prostaglandin E2 activity] (Harvey et a l, 1987). Hyaluronic acid, which is part 
of the capsule of Streptococcus pyogenes, has also been shown to induce IL- 
production (Him et a l, 1986). Other capsules may eventually be shown to mimic or 
induce cytokine mediators. Alternatively, capsules may mask the ability of cell wall 
constituents to induce inflammatory responses that may come to the aid of the host, 
as suggested for pneumococci (Tuomanen et al., 1985).
1.7.1.1 Capsule of P. multocida
Although purified capsular polysaccharides of P. multocida are devoid of toxicity, the 
presence of a capsule has frequently been reported to be associated with virulence. 
Manninger (1919) found that encapsulated strains of P. multocida were virulent for 
mice, chickens and pigeons and not phagocytosed. An association between capsulation 
and virulence was accepted by Yaw et a l (1956), Heddleston et a l  (1964), 
Hungerford (1968) and Rebers and Heddleston (1974). The loss of ability of an avian 
strain of P.multocida to form capsular material resulted in the loss of virulence 
(Heddleston et a l,  1964). Heddleston and Watko (1965) considered virulence to be 
associated with a specific component of the capsule rather than its physical presence, 
as an encapsulated isolate from swine was shown to be avirulent for poultry. The 
capsules, besides inhibiting phagocytosis, inhibit complement mediated killing (Snipes 
and Hirsh, 1986).
Not all researchers are convinced that the capsule of P. multocida is regularly 
associated with virulence and, as Collins (1977) notes, virulent strains lacking a 
microscopically demonstrable capsule do occur. Curtis (1981) and Curtis and 
Ollerhead (1980) considered that encapsulation was not related to virulence, an 
observation based on examination of isolates obtained during surveys of chicken 
flocks affected by fowl cholera in Britain. Rather, these researchers felt that virulence 
was associated with invasiveness, i.e. the ability of the organism to disseminate from 
its site of infection; capsule may be one of the features associated with invasiveness 
but is unlikely to be the only one.
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1.7.2 Phagocytosis and bacterial virulence
Internal host defences against invading pathogens can be divided into humoral and 
cellular components. Non-specific soluble antibacterial factors include complement 
proteins, plasma lysozyme and iron binding proteins (transferrin, conalbumin); 
specific humoral defence is provided by antibody and complement (Frank, 1980). 
Circulating organisms not cleared by the humoral component alone, must be dealt 
with by the combined efforts of the humoral and cellular branches of the immune 
response. The main effector of the cellular component are neutrophils (PMNs) and 
monocytes or macrophages, which when the invader is appropriately opsonized, will 
engulf, and if possible, destroy the bacterium. The course of infection depends on the 
success with which this is carried out. Once ingested and sequestered within a 
phagosome, the bacterium is then subjected to a variety of bactericidal enzymes and 
molecules (Goren, 1977 ; Densen and Mandell, 1980). Certain pathogenic bacteria 
have developed strategies to evade this intracellular attack and tend to remain viable 
within the phagolysosome. Densen and Mandell (1980) reviewed several tactics of 
microorganisms against the strategies of phagocytic cells but little is known about 
resistance to killing and digestion in phagocytes.
1.7.2.1 Phagocytosis of Pasteurella multocida
Maheswaren and Thies (1979b)investigated the uptake of radio labelled bovine strains 
of P. multocida by bovine neutrophils in suspension culture. They found that an 
uncapsulated strain was completely phagocytosed within 15 minutes when suspended 
in normal bovine serum compared with 60% uptake of an capsulated serotype B 
strain. When the type B strain was opsonized with specific immune serum, 100% 
phagocytosis was obtained. These results were then compared with phagocytosis of 
a capsular serotype A strain which has a thick hyaluronic acid containing capsule. 
Less than 5 % uptake was observed when the organisms were suspended in normal 
serum and only 7.5% uptake in the presence of specific antiserum. When the capsule 
was removed from the strain by hyaluronidase, phagocytosis increased to 90%. These 
experiments demonstrated the importance of the hyaluronic acid capsule in preventing
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either opsonization or actual phagocytosis by bovine PMNs. Anderson et al. (1984) 
demonstrated that the inhibition of phagocytosis of a rabbit strain of P. multocida type 
A by rabbit PMNs was due to hyaluronic acid containing capsule. They also 
mentioned that type D are resistant to killing by rabbit PMNs even after ingestion. 
Ryu et a l  (1984) investigated the effect of different cellular fractions extracted from 
P. multocida type A on bovine peripheral blood PMNs. They found that a heat labile 
saline extractable capsular material inhibited phagocytic ability but the effect did not 
appear to be due to hyaluronic acid. An anti-phagocytic outer membrane protein has 
been reported on P. multocida type A (Truscott and Hirch, 1988).
Collins (1973) examined the intraperitoneal (IP) growth of P. multocida in normal 
and vaccinated mice. In non-immune mice, 10% of the IP introduced challenge 
organisms became cell associated (phagocytosed) and mice died 9 to 10 hour after 
infection. IP inoculation of the immune serum with the challenge organism did not 
affect early growth within the peritoneum nor inhibit the spread to the liver and 
spleen, but did inhibit later exponential growth. In vaccinated mice the growth of the 
challenge organism within the peritoneal cavity was inhibited. Viable organisms 
reached the blood, liver and spleen within an hour but systemic infection failed to 
develop. Collins and Woolcock (1976) later reported that if specific immune serum 
was injected IP one hour prior to the administration of P. multocida, close to 100% 
of the challenge bacteria were phagocytosed. Passive antibodies did not prevent early 
growth in the liver and spleen, although eventually organisms were eliminated from 
these tissues.
In a review on resistance of mice to P. multocida infection, Collins (1977) stated that 
virulence correlated with ability of P. multocida to resist phagocytosis, and without 
specific opsonins, host white blood cells are unable to phagocytose virulent strain to 
any extent. Normal cellular defences of a mouse are incapable of controlling rapid 
extracellular multiplication; control results from an interaction of specific opsonins 
plus PMNs, limiting the infecting population to the initial site of deposition. In an 
in vitro study with mouse macrophages and P. multocida, Collins et al. (1983) 
reported that uptake by both peritoneal and alveolar macrophages was only 1% when
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organisms were suspended in normal mouse serum, whereas it was 10% when 
opsonized with hyperimmune serum. In this study, the virulence of the turkey strain 
tested correlated with a capsular layer present which inhibited phagocytosis.
The results from the experiments of Pabs-Gamon and Soltys (1971) and Snipes et ah 
(1987) suggests that the virulent strain (type 5A) used was refractory to the 
bactericidal power of hepatic and splenic phagocytes of non-immune turkeys. Further 
evidence that virulent strains are disseminated to the liver and spleen of fowl, where 
they persist and propagate prior to bacteraemia, comes from Maheswaran et al. 
(1973a). These researchers found that an avirulent mutant lacked the disseminative 
power of the virulent parent strain and was cleared from the circulation when 
administered in the drinking water or endotracheally. The virulent parent strain was 
able to infect the liver and spleen. However, Sulong and Maheswaran (1976) 
discovered that two avirulent live mutant (CU vaccine strain and strain M 2283) did 
disseminate to the lungs and spleen of turkeys when administered in the drinking 
water. The less virulent M 2283 strain persisted in the lungs for one week post 
vaccination, compared with the CU strain which persisted 4 for weeks post 
vaccination in both the lungs and spleen. Both of these strains produced local 
respiratory immunity as well as systemic immunity. These results imply that there is 
more to virulence than the qualitative ability to survive within the reticulo-endothelial 
system of the turkey (i.e. in the spleen, liver and lungs).
1.7.3 Protein toxin and virulence
Early findings, which described protein toxin production by P. multocida, attracted 
little interest and were largely dismissed. A study by Dhanda (1960) described 
isolation of protein toxin from a serotype B P. multocida from HS. Bain (1963) was 
unable to isolate a protein toxin from the same strain, but later (Bain, 1964) cited 
unpublished work with a protein (lipopolysaccharide free), isolated from serotype B 
(Insein strain) that was lethal to mice and rabbits. It is not possible to say whether 
these substances were of the same kind as the highly potent toxin of type A and D 
strains. There are no reportsof investigation of serotypes E and F for protein toxin
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production. Most probably, failure to corroborate those findings with different isolates 
and serotypes examined in other laboratories resulted in their dismissal.
Protein toxin production is now well recognised as a virulence attribute of P. 
multocida types A and D. There have been differences in reports of toxin distribution 
between cells and culture medium during the different phases of growth of type A and 
D strains. Rutter and Luther (1984) described toxin produced in the late logarithmic 
and stationary phases of the bacterial culture and found it both in culture supernatants 
and as cell associated toxin released from bacterial sonic extracts, whereas Nakai et 
al. (1985) did not find toxin in the culture media. Such discrepancies could be 
explained by differences in the efficiency of methods used for cell lysis and the 
detection of toxin. However, there is little dispute that the greatest amounts of toxin 
are found in older culture supernatants (Chanter and Rutter, 1989). Nakai et al. 
(1985) also noted that osmotic shock, a common procedure that releases proteins from 
the periplasmic space, did not yield toxin from washed cells and that similar amounts 
of toxin were recovered from the supernatant fraction of lysed whole cells or 
spheroplasts, indicating an intracellular location of the toxin. Recently Dali et al.
(1991) carried out immuno-cytochemistry on fixed ultra-cryocut P. multocida using 
a pool of monoclonal antibodies, and showed that the toxin was located in the 
cytoplasm of the bacterium.
Toxic activities were destroyed by heat, proteolytic enzymes, formalin, trypsin and 
glutaraldehyde (Rutter, 1983 ; Vander Heijden et a l ,  1983 ; Nakai et a l ,  1984 ; 
Chanter et a l ,  1986b and Kamp et a l,  1987), further confirming its identity as a 
protein. Toxin has been purified from supernatant fractions of liquid cultures (Foged 
et al. , 1986 ; Kamp et a l , 1987) and sonicated cells (ChanterW a l,  1986b) and 
greatest yields of toxin are apparently achieved using chemical lysis of cells grown 
on blood agar (Rimler and Brogden, 1986 ; Chanter and Rutter, 1989). The chemical 
composition of purified toxin has been determined as 92% protein and 8% 
carbohydrate (Chanter et a l,  1986b) or 98% protein (nucleic acid free) and 2% 
carbohydrate and nucleic acid free (Rimler and Brogden, 1986). Amino acid analysis 
showed the toxin protein to be characteristically rich in glutamic acid, aspartic acid,
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glycine, proline, alanine and leucine (Nakai ef a l,  1984). Recently, the toxin has 
been cloned (Petersen and Foged, 1989 ; Lax and Chanter, 1990 ; Kamps et a l,
1990) ; sequenced (Lax et a l ,  1990 ; Petersen, 1990) and expressed in E. coli 
(Petersen and Foged, 1989 ; Lax and Chanter, 1990). The deduced amino acid 
sequence of P. multocida toxin did not reveal any significant homologies with other 
toxins or proteins (Lax et a l ,  1990 ; Petersen, 1990). Both native and recombinant 
P. multocida toxin are extremely potent and effective mitogens to Swiss 3T3 cells, 
other established cell lines and early passage cultures (Rozengurt et a l ,  1990 ; 
Staddon era/., 1991).
Toxigenic isolates of P. multocida were first differentiated from non-toxigenic 
bacteria by the lethality of cell-free culture supernatants for mice injected IP (Il’ina 
and Zasukhin, 1975 ; Rutter, 1983) or production of dermonecrosis in guinea pigs 
(Dejong et a l ,  1980). Culture supernatants also produced an easily recognizable 
change in laboratory culture of embryonic bovine lung (EBL) (Rutter and Luther,
1984) and Vero cells (Pennings and Storm, 1984 ; Chrisp and Foged, 1991). It is 
now known that purified toxin, which can be used to reproduce atrophic rhinitis, is 
also cytopathic for EBL cells (Chanter, 1986b ; Foged et a l ,  1986 ; Rimler and 
Brogden, 1986 ; Kamp et a l,  1987) and dermonecrotic for guinea pigs (Nakai et a l,  
1984 ; Foged et a l, 1986 ; Kamp et a l ,  1987). Other in vitro techniques, such as 
the agar overlay method (Chanter et a l ,  1986a), an enzyme linked immunosorbent 
assay with toxin specific monoclonal antibodies ( Foged et a l ,  1988), peroxidase- 
labelled monoclonal antibodies by a membrane assay (Magyar and Rimler, 1991), 
Western blotting with monoclonal antibodies (Chrisp and Foged, 1991) and a DNA 
probe which included the tox A gene coding for P. multocida toxin (Frandsen et a l ,
1991) have all been used for the detection of toxigenic strains.
The mechanism of action of the toxin on pig turbinates is not known. In pigs given 
toxin intranasally (Dominick and Rimler, 1986), or infected with large numbers of 
toxigenic P. multocida in the absence of Bordetella bronchiseptica (Pedersen and 
Filing, 1984), at three days post infection, osteoblasts showing degenerative signs 
and abundant active osteoclasts were most obvious in the rostral end of the ventral
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turbinates. It is not known if the toxin acts directly on osteoblasts, which are 
required to initiate and control osteoclastic bone resorption for remodelling purposes 
(Chambers, 1985), or indirectly, through initiating epithelial hyperplasia in the 
overlying mucosa (Rutter and Mackenzie, 1984) which also occurs first at the rostral 
end of the turbinate (Pedersen and Elling, 1984). Hyperplastic epithelial cells may 
release mediators of bone resorption just as tumour cells are known to do (Chambers,
1985). No effects of toxin on long bones have been detected (Rutter and Mackenzie, 
1984 ; Pedersen and Elling, 1984). Liver and kidney damage was seen in pigs 
injected with toxin parenterally (Chanter et ah, 1986b) or intranasally (Dominickand 
Rimler, 1986) and endothelial damage to the venous system was the common effect 
of toxin on the liver of pigs (Cheville et a l,  1988). Acutely toxic doses caused 
mucoid diarrhoea in mice (Rimler and Brogden, 1986) and smaller doses caused 
splenic atrophy (Nakai et al. , 1984) but the reason for the lethality of the toxin for 
mice is unclear.
1.7.4 Neuraminic (sialic) acid and virulence
The early history of the discovery of sialic acids was reviewed by Gottschalk (1960); 
later the chemistry and biological roles of these amino sugars were discussed by Blix 
and Jeanloz (1969), Tuppy and Gottschalk (1972), Corfield and Schauer (1982) and 
Schau er (1982). The term neuraminic acid is reserved for the unsubstituted parent 
compound. The naturally occurring Af-acylated and Oacylated derivatives are known _ 
collectively as sialic acids. The commonest form is A-acetylneuraminic acid (NANA); 
this is the precursor from which other sialic acids are synthesised. In bacteria, N- 
acetylneuraminic acid is the most common sialic acid (Robbins et a l,  1980).
No unified view of the biological role of sialic acids has emerged although it seems 
reasonable to assume that they are important in the regulation of a variety of 
biological transport processes because of their peripheral position in many 
glycoconjugates and their frequent external location in cell membranes (Gottschalk, 
1960 ; Rosenberg and Schengrund,1976 ; Schauer, 1982). Sialic acid contributes to 
the viscosity of glycoproteins in mucous secretions, which have a protective and
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lubricating role at mucous surfaces (Ahmed and McPhie, 1980). In all these cases, 
neuraminidase treatment interferes either with binding or with later stages in the 
transfer of molecules across the cell membrane.
Assay methods: In order to determine bound sialic acid, it is necessary to release it 
from glucosidic linkages either by dilute acids or sialidases. Almost total release of 
sialic acids can be achieved by heating the material in 0.05 M sulphuric acid or 0.1 
M HC1 for 50 minutes at 80°C. After hydrolysis, the sialic acids liberated from the 
sample are purified from the sample by dialysis or ultrafiltration (Schauer, 1982).
Various methods for colorimetric analysis of sialic acids exist, and have been 
reviewed by (Gottschalk, 1960 ; Schauer, 1978). Some of the procedures are suitable 
for the determination of both free and glycosidically bound sialic acids ; these include 
the direct Ehrlich reaction (Werner and Odin, 1952) and the resorcinol or orcinol 
reaction (Svennerholm, 1957a, b). The periodic and thiobarbituric acid reaction, 
according to Warren (1959) or Aminoff (1959, 1961) is applicable only to free sialic 
acids. Of the various colour reactions for sialic acids the direct Ehrlich reaction is the 
most specific (Gottschalk, 1960) and Warren (1963) noted that examination of 
purified material by direct Ehrlich assays is necessary for a positive identification.
In mammalian tissue, the sialic acids occur predominantly in the carbohydrate portion 
of glycoproteins or glycolipids and in various oligo and polysaccharides ; only small 
quantities are found in the free state. There is conclusive evidence that sialic acids are 
present in a few bacteria. Colominic acid, a polymer of linked NANA, is produced 
by strains of E. coli type K1 (Barry and Goebel, 1957 ; Barry, 1958 ; Barry et ah, 
1962). Other E. coli strains also yield polysialyl exopolysaccharides (Egan et a l,  
1977 ; Rohr and Troy, 1980), as apparently do some serotypes of Salmonella 
(Kedzierska, 1978). The other major groups of bacteria synthesizing polysialic acid 
polymers are various serogroups of Neisseria meningitidis (Bhattachaijee et al., 1975, 
1976 ; Glode et a l, 1977) and group B streptococci (Edwards et a l ,  1982). Sialic 
acid polymers similar to those of E. coli K1 have been found in P. haemolytica A2 
(Adlam et a l,  1987).
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There is much evidence for the importance of the K1 polysaccharide for virulence of 
invasive E. coli strains which possess it. The mechanism of virulence of the K1 
capsule is related to its chemical composition. The K1 polysaccharide is an -2-8- 
linked linear homo-polymer of iV-acetylneuraminic acid and is identical to group B 
meningococcal polysaccharide (Kasper et al., 1973). The poor immunogenicity has 
been explained by the structural similarity of the antigen with compounds found in 
host tissues (Finne et a l,  1983). The virulence of the E. coli K1 is also related to its 
ability to inhibit phagocytosis (Bortolussi et a l ,  1979 ; Cross et a l ,  1984). Capsular 
polysaccharides containing sialic acids are also thought to be associated with 
invasiveness (Pangburn and Muller-Eberhard, 1978; Robbins et a l,  1980 ; Pluschke 
and Achtman, 1984), however there is compelling evidence that the presence of the 
K1 capsule on the bacterial cell, while necessary, is not sufficient of itself to confer 
invasiveness on E.coli (Silver and Vimr, 1990). Additional evidence that the K1 
polysaccharide, while critical to the invasive capacity of E. coli, is not the only factor 
involved comes from the observation that not all naturally occurring K1 strains exhibit 
equal pathogenic potential (Pluschke et a l ,  1983). Additional virulence traits are 
clearly required for the invasiveness of pathogenic E. coli clones. These may include 
specific O antigens within the cell wall lipopolysaccharide and the ability of K1 
organisms to obtain sufficient iron for growth in host tissue. E. coli K1 strains 
synthesize low molecular weight, soluble, iron-binding compounds (aerobactin 
siderophores) together with membrane-associated transport systems that enable the 
organism to obtain the iron it requires for growth (Valvano and Crosa, 1984 ; 
Valvano et a l, 1986).
1.7.5 Neuraminidase and virulence
The enzyme neuraminidase is widely distributed in nature, being found in bacteria, 
viruses, protozoa and vertebrate tissues (Drzeniek, 1972 ; Gottschalk and Drzeniek,
1972). The enzyme acts to release sialic acids (neuraminic acid derivatives) from 
combination in carbohydrates, glycoproteins and glycolipids that have a variety of 
important roles in various animal tissues. In mammalian cells, neuraminidase appears 
to be a lysosomal enzyme (Taha and Carubelli, 1967). The biological role of bacterial
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neuraminidase is not fully understood. It is unlikely that it has a primary intracellular 
role in bacterial metabolism as the enzyme occurs much more widely than do sialic 
acids, which are relatively uncommon in bacterial species.
Bacterial neuraminidase was first demonstrated in culture supemates of Clostridium 
perfringens and Vibrio cholerae (McCrea, 1947 ; Burnet and Stone, 1947). The 
production of enzyme by various other microorganisms was reviewed by Drzeniek 
(1972) and Muller (1974). Neuraminidase remains cell-associated in some bacterial 
species, e. g. Corynebacterium diphtheriae (Moriyama and Barksdale, 1967) and P. 
multocida (Drzeniek et a l,  1972), but there may be variable release into the culture 
medium with other bacteria. Enzyme production depends on the culture medium and 
in a number of cases has been found to be inducible when various substrate 
preparations or sialic acid derivatives are added to a basal medium (Pardoe, 1974).
The enzyme activity of neuraminidase is measured by following the rate of hydrolysis 
of an appropriate substrate. The determination of free sialic acid in the presence of 
bound sialic acid by the thiobarbituric acid method by Aminoff (1959, 1961) or 
Warren (1959) is the predominant method used as a tool for measuring neuraminidase 
activity. According to rules recommended by the International Union of Biochemistry 
(Enzyme Nomenclature, 1965) neuraminidase activity should be expressed in enzyme 
units. One unit (U) liberates 1 p mole neuraminic acid within 1 minute under stated 
conditions. For low activities, the usage of milliunits (mU) is proposed. The specific 
enzymatic activity is expressed in "units per milligram (mg) protein".
The pH optimum of particular neuraminidases may vary considerably according to the 
test substrate (Gottschalk and Drzeniek, 1972 ; Schauer, 1982) with different buffer 
ions (Cassidy et al., 1966). Optimal pH values quoted for bacterial neuraminidase are 
usually in the range 4.5-6.5 (Drzeniek, 1972).
For a correct estimation of the neuraminidase activity, the tested sample should be 
free of substances that interfere with the test procedure especially A-acetylneuraminate 
lyase (NAN-lyase) which hydrolyses A-acetylneuraminic acid to pyruvate and N-
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acetylmannosamine; the latter may act to induce neuraminidase production in some 
bacterial species so that production of the two enzymes is coordinated (Pardoe, 1974 
; Rosenberg and Schengrund, 1976). NAN-lyase enzyme has been detected in many 
neuraminidase producing organisms (Arden et a l , 1972 ; Drzeniek et a l ,  1972 ; 
Muller, 1974). NAN-lyase activity is also found in various mammalian tissues, where 
it may have a regulatory role in sialic acid metabolism; the reaction it promotes is 
reversible (Corfield and Schauer, 1982). The combination of neuraminidase and 
NAN-lyase is thought to enable bacteria not only to degrade sialoglycoconjugates but 
also to take up the released NANA and use its constituents as a minor source of 
energy (Schau er, 1982).
Neuraminidase is produced in vitro by a number of important pathogenic bacteria, 
such as:
Clostridium chauvoei (Fraser, 1978).
(McCrea, 1947; Fraser and 
Collee, 1975 ;
Cassidy et a l ,  1966).
(Gadalla et a l ,  1968).
(White and Mellanby, 1969). 
(Poulik, 1961).
(Arden et a l ,  1972).
(Scharmann et a l ,  1970; Muller, 
1971; Drzeniek et a l ,  1972; 
Scharmann, 1974).
(Frank and Tabatabai, 1981). 
(Laurell, 1959).
(Shilo, 1957).
(Kelly et a l ,  1966, 1967; Kelly 
and Greiff, 1970).
(Burnet and Stone, 1947).
Clostridium perfringens
Clostridium septicum 
Clostridium sordelli
Corynebacterium diphtheriae
Corynebacterium ovis 
Pasteurella multocida
Pasteurella haemolytica 
Pasteurella pseudotuberculosis 
Pseudomonas aeruginosa 
Streptococcus pneumoniae
Vibrio cholerae
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and it might be postulated that it plays a role in degradation of tissue 
sialoglycoconjugates if it is also produced in vivo during infection. Pardoe (1974) 
showed that the enzyme can be induced in vitro by a wide range of sialic acids 
containing substances present in mammalian secretions and tissues, and argued that 
this must also occur in vivo. The presence of bacterial neuraminidase in blood or 
tissues during or experimental infection has been demonstrated directly on a number 
of occasions (Gadalla et a l ,  1968 ; Seger et a l ,  1980 ; Schauer, 1982) although it 
must be borne in mind that there is no direct way of distinguishing bacterial and 
mammalian neuraminidase. Production of the enzyme in vivo has also been deduced 
by the demonstration of alterations attributable to neuraminidase in serum or exudate 
proteins during infection (Muller, 1970, 1974) or by demonstration of exposed T 
antigen on red blood cells (RBC) or in other tissues (Seger et a l ,  1980).
The original evidence for the importance of neuraminidase in infection came from 
analysis of its role in myxovirus (Influenza virus) infection (Drzeniek, 1972). When 
the production of both haemagglutinins and neuraminidases was discovered in some 
bacterial species it was initially thought that it might indicate similarities with the 
process of influenza virus infection. The occurrence of bacterial haemagglutinins was 
reviewed by Neter (1956). In general however there is little correlation between the 
production of soluble haemagglutinins and neuraminidase by bacteria (Muller, 1974).
The general proposition that neuraminidase plays a role in bacterial pathogenesis has 
been supported by two main lines of argument. Muller (1974) claimed that there is 
a strong correlation between pathogenicity and neuraminidase production in several 
groups of bacteria and argued that the enzyme was produced by the more virulent 
strains and species, whereas less virulent commensals produced much lower levels or 
failed to produce it at all. He suggested that the enzyme was commonly inducible in 
pathogenic bacteria but less so in commensal strains; the ability to boost production 
of neuraminidase to high levels in vivo would be a virulence determinant for such 
strains. Furthermore, he argued that the enzyme produced by pathogenic bacteria was 
more active, with a wide range of substrate specificity, and that this explained the 
greater virulence of these strains.
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The other line of argument has rested upon the enumeration of biological effects of 
the enzyme in various test systems. Rosenburg and Schengrund (1976) listed reports 
of the effects of neuraminidase on a wide range of glycoconjugates, circulating blood 
cells and normal and abnormal tissue cells and argued that such findings, though 
incomplete, "are suggestive of a role for bacterial sialidase in the aggressive survival 
of bacterial pathogens". The possible role of the enzyme in the pathogenicity of 
Pasteurella is considered in more detail in the following section.
Muller (1974) noted changes in the electrophoretic pattern of guinea pig serum 
glycoproteins that indicated neuraminidase production during fatal infection of P. 
multocida. Drzeniek et a l (1972) compared the virulence of different P. multocida 
strains in mice with their measured neuraminidase activity but failed to find a 
correlation. Further evidence that neuraminidase is probably not a virulence factor of 
P. multocida was that a neuraminidase free strain showed the same virulence in mice 
as the neuraminidase rich strain (Drzeniek et a l ,  1972). Krasemann and Muller 
(1974) studied the virulence of 25 P. multocida strains and one P. haemolytica in 
mice in relation to their neuraminidase production. The lethal dose (LD) varied 
between 101 and more than 108 bacteria per mouse. They found an imperfect 
correlation between neuraminidase production in vitro and mouse virulence, although 
some of the more virulent strains produced higher levels of the enzyme; it was 
concluded that other factors were important. Frank and Tabatabai (1981) 
demonstrated neuraminidase production in the majority of P. haemolytica strains from 
sheep and cattle, and discussed its possible role in pathogenicity but were unable to 
find a convincing correlation.
1.7.6 Hyaluronic acid and virulence
Hyaluronic acid (HA) is a sulphate free mucopolysaccharide containing equimolar 
proportions of Af-acetyl D-glucosamine and D-glucuronic acid residues. It is one of 
the negatively charged, high molecular weight (2 x 105 to 9 x 106) polymers known 
as glycosaminoglycans (Balazs et a l,  1986). HA was first isolated from bovine 
vitreous humour (Meyer and Palmer, 1934). It has since been recovered from variety
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of sources including connective tissue, umbilical cord, joint fluids, skin, cornea, 
bone, heart valve and arterial wall (Jeanloz, 1970). HA is also a normal constituents 
of lung tissue (Horwitz and Crystal, 1975). HA isolated from different sources has 
been found to vary in viscosity and in the degree of polydispersity, but no chemical 
or enzymatic differences have been found (Meyer et ah, 1956).
Bacteria such as P. multocida type A (Carter and Annau, 1953), Aerobacter 
aerogenes (Warren, 1950), Streptococcus pyogenes (Pierce and White, 1954), 
Pseudomonas aeruginosa (Warren and Gray, 1954) and some encapsulated strains of 
group A and C streptococci (Kendall et al., 1937) elaborate hyaluronic acid capsule. 
Carter and Rundell (1975) using cross streaking against a hyaluronidase producing 
Staphylococcus aureus concluded that small amounts of HA were present in P. 
multocida type D but Dejong et al. (1980) obtained negative results for type D 
isolates using the same test. Serotypes B, E and F strains of P. multocida do not 
produce HA (Bain et al., 1982 ; Rimler and Rhoades, 1987).
HA occurs normally either in a dissolved form, as, for example, in vitreous humour 
and synovial fluids, or, in the form of gels such as exist in umbilical cord and certain 
mesodermal tissues (Meyer, 1947). Several roles have been attributed to hyaluronic 
acid. Hyaluronic acid as one of the constituents of ground substances, Meyer (1947) 
has ascribed to HA the functions of binding water in interstitial spaces, holding cells 
together in a jelly-like matrix and resistance of the tissues toward infections may 
depend partly on this property (Jeanloz, 1970).
Since HA is widely distributed is various tissues, its presence is associated with 
increased hydration and swelling (Toole, 1982). It was first implicated in human lung 
disorders when Meyer and Chaffee (1939) demonstrated its presence in pleural fluid 
from a case of mesothelioma. Recent work shown that in intact lungs of rabbits, the 
HA content correlated significantly with variation in extravascular lung water. 
Further, intravenous infusion of hyaluronidase reduced both HA content and 
extravascular lung water (Bhattacharya et a l , 1989). Recently, an increase in HA in 
bronchoalveolar lavage fluid from human lungs has been shown in a number of
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diverse pathologie conditions including cystic fibrosis (Sahu, 1980), asthma (Sahu and 
Lynn, 1978), alveolar proteinosis (Sahu and Lynn, 1978), adult respiratory distress 
syndrome (Hallgren et ah, 1989) and idiopathic pulmonary fibrosis (Bjermer et ah,
1989). Recently, Bray et al. (1991) reported that HA may be an important initiating 
factor for pathologic changes in lung extracellular matrix components. The increase 
in HA is not merely incidental to the disease process but correlates with loss of 
function and a poor prognosis.
Isolation of HA from bacteria was first reported by Kendall et al. (1937), who used 
acetate and ethanolic precipitation on culture supernatants of group A haemolytic 
streptococci. Similar methods and results were reported by Seastone (1939) and 
Topper and Lipton (1953) with group A streptococci strains in broth media. 
Turbidometric method is widely used for the determination of HA. In this method 
undegraded HA at acidic pH gives a fairly stable, colloidal suspension with diluted 
serum which can be determined turbidometrically (Seastone, 1943). The turbidity read 
at 600 nm is proportional to the HA concentration (Dorfman and Ott, 1948). The 
method was modified by Smith (1958) for P. multocida . DEAE (diethyl aminoethyl) 
and cellulose acetate electrophoresis were also used for the determination of P. 
multocida type A capsular HA (Cifonelli et a l ,  1970 ; Maheswaran et a l ,  1973b). 
Chemical methods depend on the determination of the hexosamine present in 
hyaluronic acid and may be applied only to fluids which are relatively free from other 
hexosamine-containing polysaccharides and where the protein content is low 
(Brimacombe and Webber, 1964).
- Enzymatic hydrolysis is also used for HA identification. HA is degraded by testicular 
(Weissmann et a l , 1954), bacterial (Linker et a l ,  1956) and leech (Linker et a l ,  
1956) hyaluronidase. Leech hyaluronidase is very specific for HA and does not 
degrade other mucopolysaccharides (Linker et a l ,  1956). Enzymes isolated from the 
venom of snakes, spiders, scorpions and bees gave degradation products similar to 
those produced by the testicular enzyme (Linker et a l,  1956).
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The correlation between capsule formation and HA production has been studied by 
Seastone (1939) in a group C streptococcus and found that the invasiveness of group 
C streptococcus was related to the amount of HA they contained. The evidence there 
given for the role of the hyaluronic acid capsule in the virulence of the infecting 
organism has been corroborated by Hirst (1941), who protected mice by the IP 
injection of leech extracts against fatal infection with a strain of group C 
streptococcus; while against a group A strain only feeble protection resulted. Kass and 
Seastone (1944) protected mice against 10 to 100 minimum lethal dose of groups A 
and C organisms by repeated injections of testicular Hase. No protection resulted 
from injection of inactivated hyaluronidase.
The role of HA capsule in type A P. multocida in resistance to phagocytosis has 
been demonstrated by Maheswaren and Thies (1979b); Anderson et a l (1984) and 
Harmon et a l (1991) and considered to be a virulence factor in pasteurellosis. 
Another important aspect of capsular HA is camouflage effect, which may be 
considered as a bacterial virulence (Poxton and Arbuthnott, 1990). On the other hand, 
according to Tsuji and Matsumoto (1989), the role of capsular HA of P. multocida 
was still unclear, because the decapsulation of strain P-1059 by hyaluronidase did not 
cause a decrease in mortality in turkeys at an inoculation dose of about 102 cfu.
1.7.7 Hyaluronidase and virulence
Enzymes that hydrolyse hyaluronic acid have been termed hyaluronidase (Hase) 
(Meyer and Rapport, 1952). Investigations of the enzyme have followed from two 
independent lines: one chemical, with the isolation and characterization of hyaluronic 
acid; and its hydrolysis products; the other biological, starting with the description 
of the spreading reaction by Duran-Reynals (1929). The term "spreading factor" was 
initially employed to indicate the ability of Hase to increase the spread of Indian ink 
when injected into the skin of laboratory animals but soon came to be used to indicate 
its supposed effect in promoting "spreading" infections of the subcutis, such as 
bacterial cellulitis. Shortly after the isolation of hyaluronic acid and its 
characterization as a molecular entity with reproducible chemical and physical
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properties, the enzymic hydrolysis of this compound was demonstrated by the 
liberation of reducing sugar by extracts of a type 2 pneumococcus (Meyer et a l,  
1937). After that, similar enzymes were found in the strains of following organisms:
Clostridium septicum 
Clostridium perfringens 
Clostridium difficile 
Pasteurella multocida type B
Staphylococcus aureus 
Streptococci of groups A, B and C 
Streptomyces hyalurolyticus 
Treponema pallidum
(Princewill and Oakley, 1972). 
(McClean et al., 1943).
(Seddan et «7., 1990).
(Carter and Chengappa, 1980,
1991).
(Duran-Reynals, 1933). 
(McClean, 1941 ; Sellers, 1949). 
(Ohya and Kaneko, 1970).
(Scott, 1949; Fitzegerald and 
Johnson, 1979).
Apart from microbial Hase, other sources includes mammalian tissues and secreta of 
lower animals such as insect and snake venoms. The occurrence of Hase in 
mammalian tissues other than testis (extracts of spleen, and of ciliary body and iris) 
has also been reported (Meyer et al., 1940). Spermatozoa contain and probably 
produce quantities of Hase apparently greater than any other body cells and it appears 
safe to attribute to the enzyme an important role in the penetration by the spermatozoa 
of cumulus cells and the corona of the ovum (Meyer and Rapport, 1952).
Methods for the detection and quantitative estimation of Hase are based on the 
detection of breakdown of its substrate hyaluronic acid. The advantages and 
disadvantages of these methods have been reviewed by Meyer (1947). A direct 
localization and visualization technique for Hase using agar gel electrophoresis has 
been described (Abramson and Friedman, 1967). This technique was modified as a 
screening plate culture method for bacteria (Smith and Willett, 1968). Princewill and 
Oakley (1972) devised a punch plate method for the detection and quantitative 
estimation of Hase produced by Clostridium septicum and Clostridium chauvoei. 
Carter and Chengappa (1980, 1991) detected P. multocida type B hyaluronidase by
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the ability of strains to affect the mucoid growth nature of a hyaluronic acid 
producing P. multocida type A and a streptococcus, using a cross streaking method.
The possible role of P. multocida type B hyaluronidase in the pathogenesis of disease 
is not known. However, the importance of bacterial Hase in determining the virulence 
has been pointed out by several authors. Duran-Reynals (1942) and McClean (1943) 
visualised the sequence in tissue infection as follows: the hydrolysis of the mucoid 
ground substance of the connective tissue removes the physical obstacle and this leads 
to the spread of the invading organism. Further multiplication will result in increased 
secretion of Hase since the presence of the substrate stimulates its production, and 
this in turn will lead to further spread. Similar effects occurring in the walls of local 
blood and lymph vessels lead to further dissemination of the infection and secondary 
localization. Lastly, other substances produced by the multiplication of bacteria attack 
the barriers called forth by inflammation.
Mammalian testicular hyaluronidase has been used in the treatment of a variety of 
clinical conditions e.g. myocardial infarction, myocardial ischaemia, coronary artery 
occlusion and severe peripheral arterial disease usually with thrombosis of the 
femoral/popliteal arteries (Elder et a l,  1980; Flint et a l ,  1982; Saltissi et a l ,  1982). 
Efficacy remains to be established although there have been clinical improvements in 
some of the patients with myocardial infarction and a reduction in cumulative 
mortality (Henderson et a l ,  1982); however results from other studies are less clear 
(Julian et a l,  1985).
1.8 Other virulence determinants associated with Pasteurella multocida
1.8.1 Pasteurella multocida and complement resistance
The complement system plays a key role in non-specific resistance to bacterial 
infection, interacting with microorganisms and phagocytic cells to promote 
phagocytosis via opsonization and direct killing of Gram-negative bacteria by 
disruption of the cell wall (Frank, 1980 ; Brown et a l ,  1983). Gram-negative bacteria
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activate the alternate or classical complement pathways in the absence of antibody 
(Joiner et ah, 1984). Direct killing of Gram-negative bacteria by complement is 
brought about by successive deposition of complement fragments on the surface of 
the bacterium, with the final membrane attack complex (MAC) damaging the bacterial 
outer membrane and initiating lysis (Joiner et a l,  1984).
Obviously, if an invading pathogen is to persist and produce infection, it must 
minimize the deleterious effects of its encounter with complement components. 
Bacterial factors associated with the cell surface or membrane involved with serum 
resistance include lipopolysaccharide (LPS), capsular and acidic polysaccharides and 
outer membrane protein (Frank, 1980 ; Joiner et a l ,  1984). It has been suggested 
that capsules may provide non-specific shielding of the bacterium from antibodies and 
complement, as mentioned in Section 1.7.1.
It is not surprising, considering the virulence of P. multocida , that normal mouse 
serum is not bactericidal for P. multocida even with extrinsic complement added 
(Collins, 1973). Rush et a l (1981) found that two strains of P. multocida capable 
of producing disease in rabbits were not killed in vitro by normal or immune rabbit 
serum, whereas a non rabbit-virulent bovine strain was inactivated by normal rabbit 
serum. Recently, Lee et a l  (1991) found that complement resistant isolates of P. 
multocida contained plasmids and obtained evidence of a positive correlation between 
the level of resistance to complement and the number of plasmids.
1.8.2 Pasteurella multocida and iron and virulence
Iron is an essential element for most forms of life (May and Wiliams, 1980). Nearly 
all bacteria require this element for normal growth and metabolism. Pathogenic 
bacteria must be able to obtain their iron requirement from their host if an infection 
is to be established. The forms and abundance of iron compounds varies greatly with 
in a mammalian host, but free iron is rarely available. Most iron in mammals is 
intracellular, predominantly as heme but also as a component on nonheme protein or 
stored as ferritin. Iron in the extracellular environment is generally held by the high
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affinity, iron binding glycoproteins, transferrin and lactoferrin (Aisen and Leibman,
1972).
Bullen et al. (1974) noted that in mice given iron along with challenge P. multocida 
specific antiserum completely failed to control the growth of challenge bacteria. 
Corbett et al. (1985) established that P. multocida possess an efficient iron transport 
system necessary for the accumulation of iron for growth. Under iron limited 
conditions, P. multocida was found to synthesize a compound for acquiring iron 
(Flossman et al., 1985 ; Hu et al., 1986). The compound had siderophore-like 
properties but it was neither a phenolate nor a hydroxamate. The compound, named 
"multocidin" was partially purified and found to be highly polar, nonaromatic and 
dialysable compound (Hu et a l, 1986). More recently, Lee et al. (1991) 
demonstrated siderophore activity in nearly all of the P. multocida examined. Some 
isolates showed a "double zone" phenomenon suggesting that more than one iron 
chelating compound may be produced. A similar phenomenon has been observed in 
E. coli where at least three iron binding compounds may be elaborated (Rogers,
1973).
Elevated body temperature such as those occurring during an infection, have been 
reported to decrease siderophore production, and this suggests a two-pronged effect 
on bacterial iron starvation (i.e. drop in serum iron and decreased siderophore 
production) (Ogata, 1983). Studies showed that rabbits infected with P. multocida 
responded with a fever and that the concentration of iron in the plasma decreased 
(Kluger and Rothenburg, 1979). Since it had been shown that the ability to produce 
a siderophore was diminished by small elevations in temperature in other organisms 
(Garibaaldi, 1972), Kluger and Rothenburg (1979) suggested that fever, coupled 
with a reduction in plasma iron concentration, might be part of a coordinated host 
defence against pasteurellosis. The implication of the above findings are 1) that iron 
may play an important role in the pathogenesis of pasteurellosis, and 2) that virulence 
of P. multocida can be affected by the availability of iron in its environment.
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1.8.3 Adherence of Pasteurella multocida to host mucosal epithelium and 
virulence
In order for an invading pathogen to persist in a host and produce disease, it must 
initially colonize a particular body surface to the extent that normal host defences can 
not eliminate it (Ofek and Beachey, 1980 ; Sparling, 1983). After adhering, the 
organism must proliferate (either on the surface of the epithelial cell or after 
penetration) to the extent that a local proliferation is built up that can persist in spite 
of loss due to mucus flow and/or epithelial sloughing (Ofek and Beachey, 1980).
Colonisation of mucosal surfaces may also occur in the absence of disease. The 
carriage of P. multocida in the nasopharynx of apparently healthy animals is widely 
documented. For example, both domestic and wild fowls are considered to be capable 
of carrying the organism without overt disease production (Biberstein, 1978). Again, 
25-70% of clinically normal adult rabbits older than 8 weeks in conventionally housed 
colonies have been shown to harbour P. multocida in nares and upper respiratory tract 
(Digiacomo et a l,  1983).
Pathogenic bacteria have evolved surface structures which facilitated their adherence 
to host mucosal surfaces. These are termed adhesins and may be fimbriae (pili) ; 
outer membrane proteins (OMP) or capsules (Ofek and Beachey, 1980 ; Swanson, 
1980 ; Freter and Jones, 1983 ; Pijoan and Trigo, 1990). If the capsules are markedly 
hydrophobic, this would enhance adhesion (Ofek and Beachey, 1980). Indeed, 
examples of adherence of enteropathogenic E. coli (08:K30+:K99 ) without pili to 
intestinal epithelium has been shown to be mediated by capsular material 
(glycocalyces) (Costerton et a l ,  1981). A strain of P. multocida from the middle 
ear of a human being possessed fimbriae (pili) when examined by negative staining 
procedures and transmission electron microscopy (Henriksen and Froholm, 1975). 
Glorioso et a l (1982) detected fimbriae (pili) on one strain of P. multocida which 
adhered to rabbit pharyngeal epithelium, but none on nonadhering strains. Ryu et a l  
(1984) and Trigo and Pijoan (1988) found that more toxigenic than non-toxigenic P. 
multocida isolates produced fimbriae but there was poor correlation between fimbriae
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and experimental reproduction of turbinate atrophy using different isolates (Ryu et 
ah, 1984). Attempts to demonstrate adhesion of toxigenic P. multocida to turbinate 
mucosa have also failed (Frymus et al., 1986). However, Pijoan and Trigo (1990) 
using turbinate explants from new bom pigs found that all fimbriated P. multocida 
showed some degree of adhesion. Corbett et al. (1983) and Lee et al. (1991)
examined outer membrane protein (OMP) of P. multocida and found that the
membrane protein patterns were very similar among all strains.
Bacteria attempting to adhere to a mucosal epithelium must also contend with both 
specific (e.g. IgA s) and non-specific (e.g. presence of receptor substance in surface 
fluids) host defence mechanisms which tend to interfere with adherence (Ofek and 
Beachey, 1980). The specific local immune response, consisting of IgA s, is capable 
of blocking adherence by binding adhesins and sterically hindering attachment
(Abraham and Beachey, 1985). Some pathogenic bacteria (e.g. Neisseria
gonorrhoeae, N. meningitidis, Haemophilus influenzae and Streptococcus pneumoniae) 
produce IgA proteases (Plaut et a l,  1975 ; Killian et a l,  1979 and Male, 1979). 
These proteases are remarkable in their restricted specificity for IgA I, with a 
cleavage site localized in the hinge region within a short peptide sequence which is 
deleted in IgA 2 (Plaut, 1983) but the value of possessing such a virulence factor is 
unknown (Gotschlich, 1983). Production of IgA protease by P.multocida could not 
be documented (Kornfeld and Plaut, 1981), but publications are believed to be 
imminent and judgement may therefore be deferred in the meantime.
1.8.4 Endotoxin
Gram-negative bacterial cell wall contain a toxic substance called lipopolysaccharides 
(LPS), for which the descriptive name "endotoxin" is also used. In structure, LPS 
consists of two main regions: a hydrophobic glycolipid termed lipid A and a 
hydrophilic polysaccharide (Poxton and Arbuthnott, 1990). Lipid A is the toxic part 
of the molecule. The lipid structure is more or less common to all LPS molecules that 
are endotoxic, the variation being in the length of the substituted fatty acid residues, 
the type and distribution of the substituents of the fatty acids and the additional
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substituents of the phosphoryl residues. The core oligosaccharide consists of 
monosaccharide units. Micro-heterogeneity exits in the core, especially in the non 
sugar substituents. In the O polysaccharide, variation can be almost infinite. This is 
the part of molecule in which the O-serotype specificity resides. The structure consists 
typically of long chains of repeating units of oligosaccharides, usually made up of 
three or four monomers. For example, there are over 160 O serotypes of E. coli, 
over 60 in Salmonella and 17 in Pseudomonas aeruginosa (Poxton and Arbuthnott,
1990).
The structure of lipid A in relation to fatty acid phosphate substitution is of great 
importance. As a virulence determinant the form of the LPS greatly affects the 
potential of the bacterium to harm the host. Some bacteria (e.g. Bacteroides fragilis) 
possess an LPS of low endotoxicity and this is reflected in the structure of its lipid 
A, especially the fatty acid composition and phosphate substitution (Weintraub et al.
, 1985). The LPS of P. aeruginosa is less toxic than the LPS from other Gram- 
negative bacilli, and some Gram-negative bacteria, for instance Brucella, have a more 
or less nontoxic LPS (Mims, 1987).
The core and O polysaccharide component, however have an influence on the fate of 
LPS in the host and on the mechanisms of virulence and pathogenicity of the 
bacterium. Minor changes in the composition of the sugar substituents of O 
polysaccharide can markedly influence the virulence for mice. Rough, isogenic 
mutants can be at least 1000 times less virulent than their smooth parents (Poxton and 
Arbuthnott, 1990).
The long O polysaccharide chains confer on the bacterium resistance to the lytic 
action of serum. Such bacterial strains are virulent. Their colonies happen to have a 
smooth appearance on agar surfaces and they are therefore called smooth strains. If 
the projecting polysaccharide chains are shortened or removed, antibody reacts with 
O antigens on or near the bacterial surface and can then lyse the bacterium. Strains 
without the projecting polysaccharides are therefore nonvirulent and they have a 
rough colonial morphology (Mims, 1987). It is presumed that the long chains protect
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the inner region of the LPS which is associated with the bacterial outer membrane 
(Thomas et al., 1988). It is likely that the degree of heterogeneity in chain length may 
be of paramount importance to the balance of the interaction between the host defence 
system and the Gram-negative bacterium: the greater the preponderance of long 
chains, the greater the virulence (Poxton and Arbuthnott, 1990).
The biological actions of endotoxin are myriad with virtually every organ system 
being affected in endotoxaemic animals (Morrison, 1985). The accumulated evidence 
indicates that the pathophysiological properties of endotoxin are mediated by 
activation of host cells, especially macrophages. The result is the induction of various 
cytokines and other pro-inflammatory mediators. In the host, the culmination of the 
effect of LPS is endotoxic shock. Depending on the species and strain of animal as 
well as bacterial cell, these effects include fever or pyrogenicity, leucopenia followed 
by leucocytosis, diarrhoea, disseminated intravascular coagulation, prostration and 
death.
The amount of endotoxin released from a Gram-negative bacterium during the course 
of an infection determines the extent to which it is responsible for damage to the host 
(Fenwick, 1990). Destruction of the bacterial cell wall, whether by complement or 
antibiotics, results in release of endotoxin (Flynn et a l ,  1988). Endotoxin may be 
released in the form of microvesicles, or outer membrane "blebs". Membrane "blebs" 
containing endotoxin are spontaneously released into broth culture supernatants from 
some of the Haemophilus, Pasteurella and Actinobacillus group of bacteria (Nowotny 
et a l, 1982). The growth rate also influenced the release of endotoxin in medium 
(Anderson and Solberg, 1988).
Genetic ability to recognise the endotoxin of Gram-negative bacteria appears to be a 
critical factor in the activation of host defences, thus ultimately determining the out 
come of an infection. Mice (C3H/HeJ strain) that are low responders to endotoxin due 
to a defect in the LPS gene are resistant to the pathophysiological effects of endotoxin 
(Pier et al., 1981 ; Hagberg et al., 1985). On the other hand, these mice are also
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much more susceptible to lethal infections by Gram-negative bacteria (Vas et al. , 
1973 ; Eisenstein et al., 1982).
The use of endotoxin low responder mice has provided important insights into the role 
of endotoxin in Gram-negative infections. Marshall and Ziegler (1989) using 
C3H/HeJ mice have recently provided evidence that endotoxin plays a major role in 
the induction of la receptors (histocompatibility locus) on macrophages. Linder et al. 
(1988) using the same strain of mice, showed that endotoxin was necessary for an 
inflammatory reaction to occur following the adherence of Gram-negative bacteria to 
mucosal surfaces.
Chemical analysis has shown LPS from P. multocida contains lipid A, 2-keto-3- 
deoxyoctonate (KDO), L-glycero-D-manno-heptose, glucose and glucosamine (Bain 
and Knox, 1961). However, the complete structure of P. multocida LPS has not been 
determined. Long polysaccharide chains (O-antigens) like those found in S-type LPS 
of Salmonella and other Enterobacteriaceae, have not been demonstrated in P. 
multocida . Chemical and physical evidence suggest that typical P. multocida LPS are 
similar to R-type LPS (Rimler et a l, 1984 ; Manning et a l ,  1986).
The cause of death in animals and birds infected with P. multocida is commonly 
believed to be terminal endotoxaemia due to overwhelming bacteraemia. Disseminated 
intravascular coagulation and endotoxic shock precede death (Collins, 1977 ; 
Maheswaran and Thies, 1979a; Hunter and Woebeser, 1980 ). There have been 
surprisingly few studies on the effects of P. multocida endotoxin preparation 
administered to experimental animals. Extracted LPS fractions from P. multocida 
have been shown to be lethal for turkeys (Ganfield et a l ,  1976), calves and pigs 
(Rhoades et a l,  1967). When fibroblasts from fowl are exposed to LPS from P. 
multocida in tissue culture, marked overall cellular damage was noted with nuclear 
and cytoplasmic damage evident (Furnarola et al., 1982). These authors felt that LPS 
was the most significant product of P. multocida.
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1.8.5 Immunosuppression by Pasteurella
A large variety of microorganisms cause immunosuppression in the infected host. 
This means that host shows a depressed immune response to antigens unrelated to 
those of the infecting microorganisms. Wilkie et al. (1980), found that killed P. 
haemolytica in combination with Freund’s adjuvant induced suppression of the 
primary immune response to sheep RBC in mice. Immunosuppression by P. 
multocida has not been reported.
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1.9 Argument leading to the present work
The account given in the preceding pages of the virulence mechanisms of Pasteurella 
multocida is of necessity incomplete and far from satisfactory. The species is large 
and heterogenous, associated with a variety of pathological conditions ranging from 
chronic, nonfatal respiratory tract infections (atrophic rhinitis and enzootic pneumonia 
of pigs) to peracute septicaemia (bovine haemorrhagic septicaemia and avian 
"cholera") and it would be unreasonable to expect the same set of pathogenicity 
determinants to be shown by strains causing such diverse disease forms. Present 
knowledge suggests that strains associated with a given form of disease, in a 
particular host species, may be found to be characterised by a set of virulence 
determinants from among the following.
Pathogenic endotoxin 
Protein toxin 
Adhesin
Antigenic, anti-phagocytic capsule polysaccharide
Capsular hyaluronic acid
Hyaluronidase
Neuraminidase
The unsatisfactory state of present knowledge arises partly from the uneven attention 
which has been focused on particular groups; workers have tended to examine 
specialised collections of Pasteurellae from a single disease condition, when a more 
comprehensive approach allowing useful comparisons between groups of strains might 
well have been more fruitful. Thus, for example, great interest and attention has been 
aroused in recent years by the protein toxin of atrophic rhinitis isolates, and many 
publications have ensued . By comparison, work on the equally important 
haemorrhagic septicaemia strains has been neglected and there is no satisfactory 
explanation for their acute virulence and lethality for cattle: it is insufficient to cite 
production of an LPS "endotoxin" which has little demonstrable toxicity and which 
is apparently present in all strains of the species anyway.
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It was resolved therefore that the present work should consist of a search for possible 
virulence determinants in a collection of P. multocida strains which should be as 
varied with regard to host and geographic origin as possible, followed by an attempt 
to discern patterns or combinations of properties characteristic of groups of strains. 
Such a collection was available, having been assembled some years previously from 
worldwide sources for a thesis study by S. N. Hussaini, Royal Veterinary College, 
University of London. It had been preserved in the culture collection of the 
Department of Microbiology, University of Surrey, England, though in some cases 
with imperfect details of strain origin. 100 strains of varying origin would be chosen 
from this collection and, in case of objection that prolonged storage might have 
altered their properties, freshly isolated cultures would be added as thought necessary.
No laboratory animal can be expected to be completely satisfactory for study of a 
species which produces such widely varying disease forms in the different natural host 
species. However, the fair degree of regularity with which injection of P. multocida 
isolates of whatever origin will cause septicaemic disease in mice is well known. It 
was therefore thought sensible to include a screening of mouse pathogenicity as one 
of the features to be examined for every strain and, if possible, to find some method 
other than the costly ID50 assessment which would yield an acceptable but cheap and 
rapid grading of relative mouse virulence. Should testing of virulent fractions in mice 
seem desirable, this would also be done.
The classification of P. multocida into serotypes on the basis of antigenic capsular 
polysaccharide is so well entrenched that almost any study of the species must now 
hinge on it. Clearly, it would be an essential feature of the proposed work. There are 
however certain features of P. multocida capsule typing which are far from 
satisfactory and must give rise to unease:
(i) The number of serotypes which have been recognised in some 40 years of 
study is astonishingly small for a major pathogenic species-5 in all (A, B, D, E and, 
more recently, F). This has to be compared with the very large number of capsule
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types exhibited by some other important bacterial pathogens, pneumococci and
Escherichia coli.
(ii) Most workers have experienced technical difficulties with P. multocida 
capsule serotyping: preparation of rabbit antisera is not straightforward; the sera may 
lack potency, or cross reactions may occur; some isolates give feeble or equivocal 
reactions. The view of many is that"untypeable" isolates are common (it is unclear 
whether this is because of lack of reaction, or confusing cross reactions), and it is 
sometimes claimed, probably erroneously, that only "well capsulated" strains (i.e. the 
minority) are typeable.
(iii) It is therefore impossible to know whether the many isolates which are 
never assigned to a capsule type represent unrecognised serotypes other than A, B, 
D, E or F, whether they truly contain too little polysaccharide for typing, or whether 
the lack of success is due to technical ineptness.
It was decided therefore that in the study proposed here, every effort should be made 
to refine the method of antiserum production and to raise the technical refinement of 
subsequent haemagglutination testing to a level which would ensure that as many 
strains as possible-perhaps all-could be unequivocally serotyped. Should there still be 
a substantial residue of untyped strains, reasons for this would be sought.
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1.10 Plan for the present work
Following from the above argument, the plan for the work was thus as follows:
1. Assemble a suitable diverse collection of P. multocida strains for study.
2. Develop serotyping procedure to highest quality attainable, and apply to all 
strains.
3. Develop techniques for testing for putative virulence factors (e.g. capsule zone 
size, protein toxin, neuraminic acid, neuraminidase, hyaluronic acid, 
hyaluronidase) and apply to all strains.
4. Develop inexpensive mouse pathogenicity screening technique to give as high 
information yield as possible and apply to all strains.
5. Consider the results and decide whether further strains should be examined or 
additional techniques applied.
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SECTION 2 
SEROTYPING OF MAIN COLLECTION OF 
100 P.MÜLTOCIDA ISOLATES
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P. multocida isolates may be assigned to five specific serotypes based on capsule 
polysaccharide antigens, i.e. A, B, D, E and F, using the indirect haemagglutination 
(IHA) test. This Section describes the examination of a structured collection of P. 
multocida strains, containing isolates from different host species, different disease 
conditions and different geographical locations by means of the indirect 
haemagglutination (IHA) test.
2.1 Materials and Methods
2.1.1 Source of organisms
One hundred strains of P. multocida were selected carefully in order to cover a wide 
range of host species, variety of infections and geographical locations to examine in 
this study from the culture collection of School of Biological Sciences, University of 
Surrey, England and are shown in Table 1. The majority of these strains came from 
a collection which had been assembled in the early 1960’s at the Royal Veterinary 
College for use in a taxonomic study (Hussaini, 1965). They were obtained by writing 
to persons in various parts of the world who were believed to be active in P. 
multocida research or who had recently published work reporting isolation of the 
organism. The stock cultures had been maintained in the lyophilised state, some for 
as long as 30 years without being opened. Unfortunately, the records preserved were 
incomplete and information regarding the nature of the disease conditions from which 
some of the original isolations had been made was lost though the host species and 
country of origin had been recorded: as far as possible such strains were not included 
in the present study .
The composite distribution of the hundred strains chosen according to their 
geographic origin and host species is presented in Table 2, which shows that strains 
were obtained from cattle (36), buffalo (4), horse (2), sheep (6), goat (1), pig (13), 
dog (1), cat (1), rabbit (6), avian (22), and 8 strains from wild life isolated in four 
continents; unfortunately, no strains from Australia or New Zealand were available. 
Table 3 summarizes the distribution of these stock cultures according to host species
46
and disease categories. 53 strains were isolated from diseases which from the records 
were concluded to be broadly septicaemic in nature. 27 from respiratory diseases and 
5 from localized infections. The disease status of the remaining 15 could not be found 
in the record book of the culture collection. In addition to the 100 stock cultures, 10 
freshly isolated strains from slaughter house pig lung material were examined.
2.1.2 Cultivation and maintenance of cultures
The organisms were freshly grown in brain heart infusion broth (BHIB) and on yeast 
proteose peptone cystine (YPC) media (Namioka and Murata, 1961a) following 
reconstitution of freeze dried cultures in BHIB and incubated at 37°C for 24 hours. 
The cultures were verified as P. multocida (by the methods given under 2.1.4) and 
purity checks were performed before strains were included in the study. The bacteria 
were preserved and maintained on PROTECT bacterial preservatives (from Technical 
Service Consultant Ltd.) for future use as follows.
From YPC media, colonies to be preserved were harvested using a sterile loop and 
a thick suspension made in small vials containing beads and a cryo-preservative fluid. 
Liquid medium was lightly centrifuged in order to mix organism properly with beads. 
The excess fluid was withdrawn and discarded. The tube was capped, labelled and 
stored at -20°C. For cultures, a bead was removed using a sterile inoculating needle 
and was rubbed and streaked with a sterile loop on appropriate media and inoculated 
at 37°C for 24 hours.
2.1.3 Colonial characteristics
Organisms were streaked for single colony formation on YPC and blood agar plates 
(5% defibrinated horse blood in Oxoid blood agar base). The plates were incubated 
aerobically at 37°C for 24 hours and examined for growth and colony form.
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2.1.4 Preliminary identification of strains
The purified isolates were tested for Gram’s staining reaction, morphology, oxidase, 
catalase, indole and urease production and growth on MacConkey agar by standard 
procedures (Cowan, 1974).
2.1.5 Selection of strains for the production of capsular antibody
For the production of type specific capsular antibody, the following representative 
from each serotype were employed: 1113 (A), 925 (B), 876 (D), 978 (E) and P-4679 
(F). Each of these had been used previously, by other workers, for antiserum 
production and had been found reasonably satisfactory. Confirmation of the capsular 
monospecificity of these strains was obtained by IHA tests using reference antibodies 
from the stock collection of the School of Biological Sciences, University of Surrey, 
England. The F capsular strain (P-4679) and antibody was kindly provided by Dr. 
Rimler, Avian Research Unit, USA. There was no cross reactions between any of the 
5 selected strains.
2.1.6 Preparation of antigens for production of capsular antibody
i) Killed whole bacterial cell antigen (plain antigen):- For production of antibody 
against each capsule serotype, the organisms were cultured on YPC media at 37°C 
for 6-8 hours, after which the growth of each plate was harvested by gentle scraping 
with a glass slide in such a way as to take as little medium as possible. For serotype 
A testicular hyaluronidase at the rate of 200 i.u./ml was added and the mixture kept 
at 37°C for two hours for removal of capsular hyaluronic acid. Each antigen was then 
suspended in 0.3% formalized buffered saline to produce a turbidity corresponding 
to tube No. 10 of the McFarland opacity series and incubated at 37°C for two hours 
in order to kill the bacteria. Sterility was checked by plating out a loopful of each 
suspension onto blood agar media and the Indian ink method (Butt et al., 1936) was 
used to check for the presence of capsule.
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ii) Killed whole cell + adjuvant (adjuvated antigen):- Killed whole cell antigen was 
prepared as above but a minimal quantity of formalized saline was used, so that the 
suspension remained very thick; its opacity was not measured. This viscous 
suspension was mixed to homogeneity with an equal volume of incomplete Freund’s 
adjuvant (Sigma). Homogeneity was tested by placing a drop of the mixture in water 
and verifying that it did not spread.
2.1.7 Production of capsular antibody
Two young rabbits were used for each serotype. Prior to injection a small amount of 
blood was withdrawn from the rabbits marginal vein, the serum was separated and 
stored at (-20°C) until use. This was to ensure the absence of natural antibodies 
against pasteurellosis. All the rabbits were kept in the Experimental Biology Unit of 
the University of Surrey, during the course of the study.
The plan was to start the rabbits with adjuvated antigen, any subsequent intravenous 
injection of plain vaccine if necessary. Each vaccinated rabbit received 1 ml total 
quantity of the appropriate serotype antigen (whole cell antigen +  adjuvant), except 
serotype F. Rabbits were sheared on the back, the dose was divided into 0.1 ml 
amounts and injected intradermally. This resulted in the development of sterile 
abscesses and granuloma formation at the site of injection in all the rabbits. Following 
this point, the immunization programme was arrested for a month and blood samples 
were collected for testing of antibody titre. The indirect haemagglutination (IHA) test 
invariably indicated that continuation of immunization was necessary; IHA titres at 
this point for serotypes A and D was 2 and for B and E 8 respectively. The injection 
of killed whole cell (plain antigen) into the marginal ear vein were then started at the 
rate of 0.2 ml per rabbit and subsequently increased weekly by 0.2 ml increments. 
The antigens were freshly prepared for each week’s injection. For serotype A and D, 
IV injections of antigens continued for 8 weeks and for B and E strains, 5 weeks. 
Because of the failure of antibody production with adjuvated antigen, plain antigen 
only was used (for 7 weeks) for raising of capsular antibody against serotype F.
49
One week after each IV injection the rabbits were bled and small amounts of blood 
were collected from marginal vein to check the titre of antibody. Once titre 
considered satisfactory had been reached, sufficient volumes of blood were collected 
by cardiac puncture and serum separated and stored at -20°C. The titre obtained were 
as follows:
Serotype Strain no Titre
Type A 1113 512
Type B 925 4096
Type D 876 512
Type E 978 4096
Type F P-4679 1024
2.1.8 Capsular serotyping of P. multocida
All of the 110 strains of P.multocida were tested by indirect haemagglutination (IHA) 
test (Sawada et a l,  1982) for capsule typing. IHA cross tests were also performed 
to determine capsular type specific reactions in the IHA test.
2.1.9 Indirect haemagglutination (IHA) test protocol
2.1.9.1 Glutaraldehyde fixation of sheep red blood cells
A 100 ml suspension of fresh sheep red blood cells in Alsever solution was 
centrifuged (600 x g for 30 minutes) and the supernatant discarded. The red cells 
were distributed in 30 ml sterile universal bottles and washed by centrifugation (600 
x g for 20 minutes) six times with phosphate buffered saline (PBS). After the last 
wash, the packed cells were suspended in chilled PBS to yield a 10% suspension 
(vol/vol) which was then mixed with an equal volume of a chilled 1 % solution of 
glutaraldehyde. This mixture was incubated at 4°C for half an hour with gentle 
stirring and centrifuged (600 x g for 10 minutes). The packed treated cells were then
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thrice washed in PBS by centrifugation and suspended in PBS containing 0.1% 
sodium azide to yield a 10% suspension. The glutaraldehyde treated sheep RBC were 
stored at 4°C.
2.1.9.2 Preparation of heat extract antigen
The cells of P. multocida grown on heavily seeded YPC agar for 18 hours at 37°C, 
were harvested in 1 ml of 0.02M PBS (pH 7.2) per plate, mixed with an equal 
volume of PBS containing 200 i.u./ml testicular hyaluronidase, incubated for two 
hours at 37°C with occasional shaking to remove capsular hyaluronic acid, which 
interferes with the IHA test (Sawada et a l , 1982). The cell suspensions were then 
heated at 100°C for one hour. The cells were pelleted by centrifugation (1500 x g for 
30 minutes) and the supernatant constituted the heat extract antigen. It was always 
freshly prepared.
2.1.9.3 Sensitization (coating) of glutaraldehyde treated sheep RBC with heat
extract antigen
One ml of antigen was mixed with one ml of a 10% suspension of glutaraldehyde 
treated sheep RBC and incubated at 37°C for one hour with occasional shaking. The 
sensitized cells were washed three times with PBS by centrifugation (600 x g for 5 
minutes) and the packed cells resuspended to 0.5% in PBS containing 0.25% bovine 
serum albumin (BSA).
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2.1.9.4 IHA test (Sawada et al.f 1982)
Serial two fold dilutions of each antiserum were made using plastic micro-titre plates 
in 50 fil volumes of PBS with 0.25% BSA and 50 fil of the glutaraldehyde treated 
sensitized RBC was added to each dilution. The plates were shaken in a micro shaker 
and allowed to stand for 1 to 2 hours at 25°C before sensitized sheep RBC settling 
patterns were read. The IHA titre was expressed as the reciprocal of the highest 
dilution of serum showing a definite positive pattern (flat, granular sediment), as 
compared with the pattern of the negative control (smooth button in the centre of the 
well). Controls consisted of unsensitized glutaraldehyde treated sheep RBC + test 
serum (serum control) and sensitized glutaraldehyde treated sheep RBC + diluent 
(RBC control).
Agglutination of serum control (unsensitized glutaraldehyde treated sheep RBC + test 
serum) sometimes occurred, and was assumed to be due to heterophile antibodies. 
When this occurred, the serum was treated by absorption with unsensitized 
glutaraldehyde treated sheep RBC at 25°C for 2 hours, shaking at intervals before 
being used in the IHA test.
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Table 1. Details of the strains of the P. multocida used
Serial no. Strain no. Country Host Disease/Organ
1 137 UK dog Tonsil
2 532 UK Pig Pneumonia
3 668 UK Cow Trachea
4 678 UK Monkey Pneumonia
5 758 UK Calf Pneumonia
6 775 UK Rabbit Septicaemia
7 776 UK Chicken Fowl cholera
8 823 Congo Bovine HS
9 848 Italy Calf Pneumonia
10 849 Italy Sheep Pneumonia
11 851 Sweden Calf Not known
12 855 Sweden Reindeer Not known
13 864 USA Bovine Shipping fever
14 865 USA Bovine Shipping fever
15 872 Israel Bovine HS
16 875 Cameroon Bovine HS
17 876 France Rabbit Coryza
18 877 France Rabbit Coryza
19 881 Sri Lanka Buffalo HS
20 883 Bangladesh Chicken Fowl cholera
21 884 Italy Pig Not known
22 887 Finland Calf Sepsis
23 891 Finland Pig Pleuritis
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Serial no. Strain no. Country Host Disease/Organ
24 902 Congo Bovine HS
25 903 USA Chicken Fowl cholera
26 905 USA Chicken Fowl cholera
27 907 Burma Chicken Fowl cholera
28 914 India Sheep Lung
29 916 India Pig Not known
30 918 India Buffalo HS
31 921 India Buffalo HS
32 923 India Chicken Fowl cholera
33 924 India Rat Not known
34 925 India Bovine HS
35 934 Poland Goose Septicaemia
36 935 Poland Horse Septicaemia
37 945 Yugoslavia Goose Septicaemia
38 947 Yugoslavia Chicken Fowl cholera
39 953 Romania Horse Septicaemia
40 956 Romania Chicken Fowl cholera
41 960 Romania Boar Not known
42 971 Romania Cow Septicaemia
43 972 Romania Cat Septicaemia
44 976 Egypt ’ Cattle HS
45 978 Cameroon Cattle HS
46 991 Sweden Pig Pneumonia
47 992 Sweden Calf Pneumonia
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Serial no. Strain no. Country Host Disease/Organ
48 997 UK Owl Not known
49 998 Sri Lanka Buffalo HS
50 1002 UK Calf Liver abscess
51 1027 Sri Lanka Cattle Naso-pharynx
52 1042 Philippines Cattle HS ?
53 1044 Nigeria Bovine Pleuropneumonia
54 1049 Nigeria Lamb Pneumonia
55 1050 USA Squirrel Brain
56 1054 USA Duck Cholera
57 1055 USA Pheasant Not known
58 1056 USA Bovine Shipping fever
59 1064 France Pig Pneumonia
60 1066 Japan Pig Pneumonia
61 1068 France Sheep Pneumonia
62 1080 Egypt Cattle HS
63 1081 Egypt Cattle HS
64 1106 S. Africa Calf Pneumonia
65 1112 Taiwan Pig Pneumonia
66 1113 USA Turkey Cholera
67 1116 Burma Cattle Sepsis
68 1121 China Bovine HS
69 1125 UK Cow Mastitis
70 1136 Africa Bovine HS
71 1137 USA Turkey Not known
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Serial no. Strain no. Country Host Disease/Organ
72 1144 Columbia Calf Septicaemia
73 1145 Columbia Cow Septicaemia
74 1159 Brazil Parrot Septicaemia
75 1160 Brazil Calf Not known
76 1162 Brazil Duck Cholera
77 1163 Brazil Chicken Fowl cholera
78 1164 Brazil Rabbit Not known
79 1183 Poland Duck Cholera
80 1184 Poland Chicken Fowl cholera
81 1207 Brazil Pig Not known
82 1266 UK Rabbit Not known
83 1276 Vietnam Chicken Fowl cholera
84 1277 Taiwan Chicken Fowl cholera
85 1290 Poland Pig Not known
86 1292 Czechoslovakia Chicken Fowl cholera
87 1295 USA Sheep Not known
88 1296 USA Goose Fowl cholera
89 1297 Kenya Bovine HS
90 1576 Uganda Sheep Lung
91 1600 Tanzania Bovine HS
92 1759 Tanzania Calf Internal organ
93 2112 Thailand Bovine HS
94 2113 Thailand Bovine HS ?
95 2132 Tanzania Rabbit Lung
56
Serial no. Strain no. Country Host Disease/Organ
96 2134 Tanzania Duck Liver
97 2135 Tanzania Wildebeest Lymph nodes
98 2140 Tanzania Goat Lung
99 2142 Tanzania Pig Lung
100 2786 UK Pig Lung
101 12* UK Pig Lung
102 17 UK Pig Lung
103 19 UK Pig Lung
104 20 UK Pig Lung
105 21 UK Pig Lung
106 33 UK Pig Lung
107 42 UK Pig Lung
108 46 UK Pig Lung
109 58 UK Pig Lung
110 65 UK Pig Lung
* Fresh isolates of P.multocida from slaughter house pig lung.
HS Haemorrhagic septicaemia
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Table 2. Composite distribution of stock strains of P.multocida according to
geographic origin and host species
Continents Cattle Buffalo Horse Sheep Goal Pig Dog Cat Rabbit Avian Wild
life
Total
no.
Asia 8 4 0 1 0 3 0 0 0 5 1 22
Africa 13 0 0 2 1 1 0 0 1 1 1 20
America 6 0 0 1 0 1 0 0 1 8 3 20
Europe 9 0 2 2 0 8 1 1 4 8 3 38
Total no. 36 4 2 6 1 13 1 1 6 22 8 100
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Table 3. Composite distribution of stock strains of P. multocida according to
host species and supposed disease category
Supposed
disease
category
Cattle Buffalo Horse Sheep Goat Pig Dog fCat# Rabbit Avian Wild
life
Total
no
Septicaemic 22 4 2 0 0 0 0 1 3 20 1 53
Respiratory 10 0 0 5 1 8 1 0 1 0 1 27
Localized
infection 2 0 0 0 0 0 0 0 0 1 2 5
Disease not 
known 2 0 0 1 0 5 0 0 2 1 4 15
Total no. 36 4 2 6 1 13 1 1 6 22 8 100
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2.2 Results
2.2.1 Cultivation of P. multocida
All the cultures of P. multocida freeze dried 30 years ago, reconstituted in brain heart 
infusion broth (BHIB) and cultured on BHIB and on YPC agar plates as described in 
materials and methods were found to grow well on both media, only 2 strains (nos. 
579 and 1286) were found to be non-viable. A few strains were found to be 
contaminated and accordingly purified but 3 strains (nos. 520, 880 and 951) were 
heavily contaminated and failed to purify and not included in the study.
2.2.2 Identification of P. multocida
In smears stained by Gram’s method the morphology of the organisms ranged from 
small Gram-negative, cocco-bacilli to rods of various lengths. Degrees of 
pleomorphism were seen in strains. A small battery of tests (catalase, oxidase, indole, 
urea and growth on MacConkey) were carried out to confirm the identity of P. 
multocida. The reaction of the all strains in all tests were consistent with the 
identification of P. multocida, i.e. positive for catalase, oxidase and indole; no 
growth on MacConkey; no ability to utilize urea; no haemolysis on horse blood agar. 
No strain from the stock culture collection had to be rejected because of non­
conformity with these criteria.
Colonies of serotype A on YPC and blood agar were relatively large, viscous, 
transparent mucoid colonies, flowing readily together which tended to become 
confluent (Fig. 1). The growth was adherent to the medium surface and was difficult 
to pick up or remove with a wire loop whereas colonies of serotype D were relatively 
less mucoid, slightly smaller, creamy coloured and not flowing together (Fig. 2). 
Colonies of serotype B, E and F were generally smooth and non-mucoid (Fig. 3) and 
virtually indistinguishable from each other by colony characteristics. The growth of 
"rough" strains (Fig. 4) resembled closely that of smooth, non-mucoid strain except 
that (1) the colonies of rough strain were smaller (1.1 mm in diameter compared
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Fig. 1. P. multocida serotype A grown on YPC agar to demonstrate colonial
appearance
Fig. 2. P. multocida serotype D grown on YPC agar to demonstrate colonial 
appearance
Fig. 3. P. multocida serotype B grown on YPC agar to demonstrate colonial
appearance
Fig. 4. P. multocida rough strain grown on YPC agar to demonstrate colonial 
appearance
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1.6-2.0 mm from well isolated colonies) (2) the confluent growth on the more thickly 
sown part of the plate was distinctly sparser, less moist, thinner, and more uneven 
in appearance than that of the smooth, non-mucoid strain (3) when removed from a 
confluent area of the plate with a wire loop, growth of rough strains was less moist 
("drier") than that of smooth, non-mucoid ones and (4) growth failed to emulsify in 
normal saline.
2.2.3 Capsular antibody titres of immunized rabbits
Table 4 shows the antibody titres of different serotypes in vaccinated rabbits at 
weekly intervals following immunization. None of the rabbits developed significant 
titres against adjuvated antigen preparations of any serotype but it was found that 
following IV injections of killed whole bacterial cells (plain antigen), antibody titres 
started to rise. The onset of antibody production with plain antigen occurred about 
one week after the first intravenous injection and the titre increased with further 
doses. Serotypes B, E and F gave higher antibody titres than A and D (Fig. 5), even 
though the period of immunization for the later was extended to 8 weeks.
2.2.4 Specificity of the IHA test
The results of IHA tests using heat extract antigens of the strains used for antibody 
production in rabbits against both homologous and heterologous sensitized sheep RBC 
are shown in Table 5. With serotypes A, B, D, E and F, IHA titres of 512, 4096, 
512, 4096 and 1024 respectively were obtained against homologous antiserum. 
Minimum cross reactions (titre < 8) occurred with heterologous antibodies. This high 
degree of specificity does not seem to have been the experience of other workers, and 
was attributed to i) the use of young (6-8 hour) cultures on solid YPC medium for 
preparing the injection and ii) the practice of using freshly prepared antigen on each 
injection occasions.
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Table 4. Rabbit capsular antibody titres following immunization with different
serotypes of P. multocida
IHA titre of antibody to capsule serotypes**
Antigen used A B D E F
a) Whole bacteria + 
adjuvant (ID), 
(adjuvated antigen)
2 8 2 8
b) Whole bacteria(IV) 
(plain antigen)
Week 1
Week 2 4 128 4 128 16
Week 3 8 512 8 512 32
Week 4 16 1024 16 1024 64
Week 5 32 2048 32 2048 128
Week 6 64 4096* 64 4096* 256
Week 7 128 128 512
Week 8 256 256 1024*
Week 9 512* 512*
* The titre of antibody was checked one week after each IV injection. Titres considered
satisfactory obtained after the 5th week’s (for serotypes B & E), 7th week’s (for serotype F) and 
8th week’s (for serotypes A & D) intravenous injection of plain antigen and accordingly rabbits 
were exsanguinated in the following week (i.e. 6th week for serotypes B & E, 9th week for 
serotypes A & D and 8th week for type F) and sera obtained from the blood.
** Titres expressed as reciprocal of the highest dilution of sera.
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Fig. 5. Rabbit capsular antibody titres following immunization with different
serotypes of P, multocida
(at 6 weeks) (at 6 weeks)
(at 8 weeks)
(at 9 weeks) (at 9 weeks)
Serotype
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Table 5. IHA cross test of heat extract antigens of P. multocida sensitized with 
glutaraldehyde treated sheep RBC with capsular antibodies
Antigen* IHA titre of antibody to capsule serotype
A B D E F
A (1113) 512 <4 <8 < 4 < 4
B (925) < 4 4096 <4 < 4 < 4
D (876) <8 < 4 512 < 4 < 4
E (978) < 4 <4 <4 4096 < 4
V (P-4679) <4 <8 < 4 < 4 1024
* Strains used to make capsular antibody.
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2.2.5 Capsular serotyping of 110 P. multocida strains
The highest IHA titre against specific capsular antibody was regarded as identity of 
that serotype. The results of the capsule typing of 110 P. multocida strains, with 
details of their IHA titres with different type specific capsular antisera are presented 
in Table 6. Of the 100 stock P. multocida strains, 40 were type A, 16 type B, 20 
type D, 7 type E and 11 type F. The remaining (6) isolates were regretfully 
considered to be of indeterminate capsule serotype (Fig. 6). 5 of the fresh isolates 
were type A, 5 type D. Composite results of different identified capsular serotypes 
of P. multocida according to host species, geographical origins are shown in Tables 
7 and 8.
Serotype A was the predominant serotype in the collection of strains chosen for study 
comprising avian (13), cattle (11), pigs (6), sheep (4), rabbit (3), goat (1), dog (1) 
and wild life (1) [Table 7], Serotype D was associated with cattle (6), pig (5), sheep 
(2), rabbit (3) and wild life (3); one avian isolate was also type D. Eleven out of 16 
cultures of serotype B had been isolated from cattle and buffalo with haemorrhagic 
septicaemia (HS), in Asia (7) and Africa (4). The remaining 5 serotype B strains from 
cattle, 1; horse, 2; pig, 1; avian 1 came from two East European countries (Poland 
and Romania). All the cultures of serotype E were from HS of cattle from Africa 
except one which had been isolated in Israel (Asia) [Table 8]. None of the serotypes 
B and E isolates came from America. Eleven cultures of the new serotype F were 
identified, from avian, pigs, cattle and wild life (Table 7) with different geographic 
origin (Table 8).
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The distribution of serotypes according to disease categories is summarised in Table 
9. This is the least satisfactory presentation because, as previously explained, the 
records for the stock collection strains unfortunately contained only the briefest 
indication of the disease conditions, details supplied by the donor having been thrown 
away. Diseases (broadly septicaemic nature) [as far as could be ascertained] 
constituted the largest group, comprising all 5 capsular serotypes. Strains of serotypes 
B and E were (with strains of one exception) conclusively from septicaemia. Typable 
strains from respiratory disease were exclusively A or D. A few D and F were 
associated with infections described as "localised”.
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Table 6. Details of the capsule typing of 110 P. multocida and the IHA titres with 
different type specific capsular antisera
Si-No» Strain
no.
Host Colony
nature IHA titre
Serotype identified
A B D E F
1 137 Dog Mucoid (1) 256 4 8 4 4 A
2 532 Pig Mucoid (1) 512 4 16 4 4 A
3 668 Cow Smooth 16 64 64 16 64 Not determined
4 678 Monkey Mucoid (2) 8 4 512 4 8 D
5 758 Calf Mucoid (1) 256 4 8 4 4 A
6 775 Rabbit Mucoid (2) 16 8 64 8 8 D
7 776 Chicken Smooth 16 16 8 8 512 F
8 823 Bovine Smooth 2 2 2 4096 4 E
9 848 Calf Mucoid (2) 16 4 64 4 4 D
10 849 Sheep Mucoid (1) 512 2 8 4 8 A
11 851 Calf Rough 16 16 32 8 1024 F
12 855 Reindeer Smooth 32 1024 1024 64 256 Not determined
13 864 Bovine Mucoid (1) 256 2 16 4 2 A
14 865 Bovine Mucoid (1) 256 4 8 2 2 A
15 872 Bovine Smooth 4 4 4 4096 4 E
16 875 Bovine Smooth 4 2048 8 8 8 B
17 876 Rabbit Mucoid (2) 8 4 512 4 4 D
18 877 Rabbit Mucoid (1) 512 4 8 4 4 A
19 881 Buffalo Smooth 4 2048 4 4 4 B
20 883 Chicken Smooth 32 8 4 16 512 F
21 884 Pig Smooth 16 16 8 16 1024 F
22 887 Calf Rough 8 8 64 8 8 D
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23 891 Pig Mucoid (2) 8 4 256 4 4 D
24 902 Bovine Smooth 4 8 4 4096 4 E
25 903 Chicken Mucoid (1) 256 4 8 4 4 A
26 905 Chicken Rough 16 8 32 8 512 F
27 907 Chicken Mucoid (1) 512 2 8 4 4 A
28 914 Sheep Mucoid (1) 512 4 8 4 4 A
29 916 Pig Mucoid (1) 256 4 8 4 4 A
30 918 Buffalo Smooth 4 2048 4 4 4 B
31 921 Buffalo Smooth 4 4096 4 4 4 B
32 923 Chicken Rough 8 1024 4 16 1024 Not determined
33 924 Rat Mucoid (1) 256 4 8 4 4 A
34 925 Bovine Smooth 4 4096 4 4 4 B
35 934 Goose Smooth 4 2048 4 4 4 B
36 935 Horse Smooth 4 4096 4 4 4 B
37 945 Goose Mucoid (2) 16 4 256 4 8 D
38 947 Chicken Mucoid (1) 512 4 8 4 8 A
39 953 Horse Smooth 4 4096 4 4 4 B
40 956 Chicken Mucoid (1) 512 4 8 4
4 /
A
41 960 Boar Mucoid (2) 16 4 512 4 8 ; D
42 971 Cow Smooth 4 2048 4 8 4 B
43 972 Cat Smooth 16 8 16 8 8 Not determined
44 976 Cattle Smooth 4 2048 4 8 4 B
45 978 Cattle Smooth 4 4 4 4096 4 E
46 991 Pig Mucoid (1) 128 8 16 4 4 A
47 992 Calf Smooth 16 1024 8 16 1024 Not determined
48 997 Owl Rough 16 8 32 8 1024 F
49 998 Buffalo Smooth 4 4096 2 4 4 B
50 1002 Calf Smooth 8 8 32 16 1024 F
51 1027 Cattle Rough 16 4 256 4 4 D
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52 1042 Cattle Mucoid (1) 256 4 8 4 4 A
53 1044 Bovine Mucoid (2) 32 4 512 4 4 D
54 1049 Lamb Mucoid (2) 16 4 256 4 8 D
55 1050 Squirrel Rough 8 8 8 4 8 Not determined
56 1054 Duck Mucoid (1) 256 4 32 4 4 A
57 1055 Pheasant Smooth 8 16 16 8 256 F
58 1056 Bovine Mucoid (1) 512 8 8 4 4 A
59 1064 Pig Mucoid (2) 32 4 256 4 4 D
60 1066 Pig Mucoid (1) 256 4 16 4 8 A
61 1068 Sheep Mucoid (1) 512 4 64 4 16 A
62 1080 Cattle Smooth 4 4096 4 4 4 B
63 1081 Cattle Smooth 2 2048 4 4 4 B
64 1106 Calf Mucoid (1) 512 4 16 4 4 A
65 1112 Pig Mucoid (1) 512 4 8 2 8 A
66 1113 Turkey Mucoid (1) 512 4 8 4 4 A
67 1116 Cattle Mucoid (1) 256 2 32 2 4 A
68 1121 Bovine Smooth 4 4096 8 4 4 B
69 1125 Cow Mucoid (2) 16 4 256 4 4 D
70 1136 Bovine Smooth 4 4 4 4096 8 E
71 1137 Turkey Smooth 8 8 16 8 256 F
72 1144 Calf Mucoid (1) 512 4 16 4 4 A
73 1145 Cow Mucoid (1) 512 4 8 4 4 A
74 1159 Parrot Mucoid (2) 8 4 256 4 4 D
75 1160 Calf Mucoid (1) 512 4 8 4 4 A
76 1162 Duck Smooth 16 16 32 8 512 F
77 1163 Chicken Mucoid (1) 512 4 16 4 4 A
78 1164 Rabbit Mucoid (1) 256 8 16 4 4 A
79 1183 Duck Mucoid (1) 512 4 8 4 4 A
80 1184 Chicken Mucoid (1) 512 4 16 4 4 A
71
81 1207 Pig Mucoid (2) 16 4 128 4 8 D
82 1266 Rabbit Mucoid (1) 256 4 8 4 4 A
83 1276 Chicken Mucoid (1) 512 4 16 4 8 A
84 1277 Chicken Mucoid (1) 512 4 32 8 4 A
85 1290 Pig Smooth 8 1024 8 4 8 B
86 1292 Chicken Mucoid (1) 256 4 8 4 4 A
87 1295 Sheep Mucoid (2) 8 4 512 4 8 D
88 1296 Goose Mucoid (1) 256 4 8 4 8 A
89 1297 Bovine Smooth 4 8 8 4096 4 E
90 1576 Sheep Mucoid (1) 512 4 8 4 4 A
91 1600 Bovine Smooth 4 4 4 4096 8 E
92 1759 Calf Mucoid (2) 16 8 512 4 4 D
93 2112 Bovine Smooth 8 4096 4 2 4 B
94 2113 Bovine Mucoid (1) 512 4 8 4 4 A
95 2132 Rabbit Mucoid (2) 16 4 512 4 8 D
96 2134 Duck Rough 8 8 32 8 256 F
97 2135 Wildebeest Mucoid (2) 8 4 256 4 8 D
98 2140 Goat Mucoid (1) 256 2 8 2 4 A
99 2142 Pig Mucoid (2) 8 4 256 4 4 D
100 2786 Pig Mucoid (1) 256 2 16 4 4 A
101 12* Pig Mucoid (2) 8 2 512 2 2 D
102 17 Pig Mucoid (1) 512 2 8 2 4 A
103 19 Pig Mucoid (1) 512 2 16 4 4 A
104 20 Pig Mucoid (1) 512 2 8 4 4 A
105 21 Pig Mucoid (1) 512 2 4 2 2 A
106 33 Pig Mucoid (1) 256 4 8 2 2 A
107 42 Pig Mucoid (2) 2 2 512 2 4 D
108 46 Pig Mucoid (2) 8 2 512 2 2 D
109 58 Pig Mucoid (2) 8 2 512 2 2 D
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110 65 Pig Mucoid (2) 8 2 512 0 2 D
Mucoid (1) =  Large, viscous, transparent mucoid colonies and
flow easily together which tended to become confluent.
Mucoid (2) =  Relatively smaller than mucoid (1), less mucoid and creamy coloured.
Smooth =  Non-mucoid and smooth colony.
Rough =  Colonies were small, thickly sown part of the plate was distinctly sparser,
less moist, thinner, and more uneven in appearance than that of smooth, 
non-mucoid strain and growth failed to emulsify in normal saline.
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Fig. 6. Distribution of P. multocida according to serotype
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Table 7. Summary of occurrence of P.multocida (stock strains) serotypes
according to host species
Host
Serotype
Total
no.A B D E F Not deter­
mined
Cattle 11 8 6 7 2 2 36
Buffalo 0 4 0 0 0 0 4
Horse 0 2 0 0 0 0 2
Sheep 4 0 2 0 0 0 6
Goat 1 0 0 0 0 0 1
Pig 6 1 5 0 1 0 13
Dog 1 0 0 0 0 0 1
Cat 0 0 0 0 0 1 1
Rabbit 3 0 3 0 0 0 6
Avian 13 1 1 0 6 1 22
Wild
life
1 0 3 0 2 2 8
Total
no.
40(40%) 16(16%) 20(20%) 7(7%) 11(11%) 6(6%) 100
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Table 8. Summary of occurrence of P. multocida (stock strains) serotypes
according to geographic origin
Geographic
origin
Serotype
Total
no.A B D E F Not deter­
mined
Asia 11 7 1 1 1 1 22
Africa 3 4 6 6 1 0 20
America 12 0 3 0 4 1 20
Europe 14 5 10 0 5 4 38
Total no. 40 16 20 7 11 6 100
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Table 9. Occurrence of P. multocida (stock strains) serotypes according to 
supposed disease category
Supposed
disease
category
Serotype
Total
no.
A B D E F Not
determined
Septicaemic 19 15 6 7 4 2 53
Respiratory 16 0 9 0 0 2 27
Localized 0 0 2 0 2 1 5
Disease not 
known
5 1 3 0 5 1 15
Total no. 40 16 20 7 11 6 100
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2.2.6 Strains not determined
The overall percentage of strains (stock) which could not be typed in this study was 
only 6% (4 due to cross reactions and 2 due to minimal reaction in IHA test). Heat 
extract antigens of P. multocida were tested with five (A, B, D, E and F) capsular 
antibodies by IHA test and in most cases the antigen reacted only with its homologous 
antibody. Only four strains, despite having a demonstrable capsule, showed cross 
reactions (identical IHA titres with more than one capsular antibody) and could not 
be assigned to type. Two other strains showed only minimal reaction (titre < 16).
But it should be observed that a success rate of 94% is quite remarkable for P. 
multocida serotyping, and can be attributed to the use of high titre antisera of almost 
complete specificity, obtained by immunization with antigens freshly prepared from 
young cultures as described in 2.1.6 and 2.1.7.
2.2.7 Rough strains
A total of 8 strains failed to emulsify in saline. The colony characteristic of these 
strains on YPC medium was smaller and the confluent growth on the more thickly 
sown part of the plate was distinctly sparser, less moist, thinner and more uneven in 
appearance than that of the smooth, non-mucoid strain but, unexpectedly, all had 
capsules demonstrable by the Indian ink method (Butt et a l ,  1936) and 6 of them 
could be capsule serotyped (4 serotype F and 2 D respectively) by the IHA test. 
Strain 923 cross reacted with more than one capsular antibody and strain 1050 
showed a very low titre (<8) with all five capsular antibodies.
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2.3 Discussion
2.3.1 Typing success rate
One of the aims of the present study was to examine a structured collection of P. 
multocida strains by the most efficient method which could be found and employing 
antisera which were of the highest obtainable potency and specificity, to determine 
the kind of success rate which could be expected under near-ideal conditions. Of the 
100 strains chosen for study, 94 gave IHA results which were allowed unequivocal 
allocation to a serotype. There is insufficient published data to enable comparison of 
this success rate of 94%. with other workers findings, but it is undoubtedly far 
higher than the general experience. The view commonly heard is that a high 
proportions of strains are "untypable", a variety of explanations being offered: that 
untypable strains are poorly encapsulated or non-iridescent, or that they are "rough", 
or that many strains give IHA reactions with not one but several sera and cannot 
therefore be assigned, or that IHA reactions are of such low titre that it would not be 
safe to draw any conclusion. It would appear that almost every worker who has 
attempted P. multocida capsule serotyping has experienced difficulties: verbal 
estimates of the proportion of strains which can actually be typed vary but figures like 
"10%." or "less than 50%." can sometimes be elicited. It is significant that there has 
been interest in "alternative" methods of determining serotype, such as the suggestion 
that type D strains can be better recognised by acriflavin agglutination and serotype 
A can be determined by depolymerization of the capsule hyaluronic acid during 
growth in proximity to a hyaluronidase producing bacteria and more recent proposal 
that a simple identification of type B strains can be secured by cross streaking to 
demonstrate hyaluronidase activity. It is scarcely surprising that workers have been 
reluctant to quote success rates with a technique which seems so delicately balanced. 
It is also significant perhaps that in UK at least neither Veterinary Investigation nor 
Public Health Laboratories can offer P. multocida capsule typing routinely.
One of the aims of the study was thus fulfilled by achievement of a high serotyping 
success rate, and possible reasons for this may now be discussed.
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The antisera raised in rabbits were high titre and almost specific and this attributed 
the use of young (6-8 hours) cultures and the practice of using freshly prepared 
antigen on each week’s injection. It was thought that this method of preparation 
ensured that the capsular antigenic material injected was still largely bound to the 
bacterial cell surface, allowing more effective antigenic stimulation and avoiding 
exposure of underlying cell wall lipopolysaccharide which might give rise to cross­
reacting antibodies.
6/8 (4 serotype F & 2 type D) rough strains were possible to be serotyped by IHA 
test. Previously, workers had believedthat rough strains of P. multocida are non­
capsulated and not to be typed for capsule serotyping. It seems to indicate that 
generally rough strains possess microscopically visible capsule and this rough 
characteristic does not interfere with capsule typing by IHA test.
The inclusion of type F antiserum in the study identified a total of 11 (7 from smooth 
& 4 from rough) F strains. If all 8 rough strains had been rejected and no type F 
antiserum available the number of strains typed would have been 100- (7 type F from 
smooth strains +  8 rough strains [of which 4 type F, 2 type D and 2 nonreacted] + 
4 cross reacted strains) = 81. Adding of type F antiserum gave a 14% improvement 
in success rate (81 increased to 92).
Thus, the principal reason to account for the high success rate obtained must be the 
quality and ranged of the antisera. There remains the problem of explaining the 6 (2 
nonreactive and 4 cross reacted) remaining strains which, despite possessing 
microscopically visible capsule zones, could not be determined with the typing 
antisera. Possible reasons for nonreactivity include the following:
i) They contained type specific antibody but in too small a quantity to be detected. 
This is unlikely because clear results were obtained with many other strains of an 
apparently equal degree of capsulation.
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ii) They contained type specific antibody in sufficient quantity but also possessed an 
IHA inhibitor which was not removed by the hyaluronidase treatment routinely 
employed for all extracts. This is possible, since (as will be described in detail in 
Section 3) type D strains have been shown to produce a hyaluronic acid like 
compound which, is refractory to hyaluronidase but does not operate as an IHA 
inhibitor: one can therefore envisage that further hyaluronic acid like capsular 
substances of differing properties might occasionally be found in Pasteurella strains 
and some of these might cause interference with the IHA reaction.
iii) They contained type specific antibody in sufficient quantity for detection, but of 
an unrecognised serotype for which antisera had not been prepared. This seems the 
more attractive hypothesis, perhaps because it is the one which would be most easy 
to test. Time did not permit further work, but it would be very valuable to select one 
or both of the non-typed strains and attempt to raise antisera in the same manner as 
for the other serotypes. As previously observed, 5 recognisable capsule serotypes 
seems extraordinarily low for such a widespread and common parasitic bacterium.
In most of the cases minor cross reactions quickly decreased once the antibody titre 
to homologous antigen increased. Four strains did strongly cross react with more than 
one capsular antibody however and could not be determined. Cross reactions between 
P. multocida, have been demonstrated previously by immunodiffusion methods 
(Prince and Smith, 1966a). The simple explanation for the cross reactions given by 
these 4 strains is that they were due to minor leakage of somatic (lipopolysaccharide) 
antigen during preparation of heat extract antigen.
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2.3.2 Distribution of serotypes of P. multocida
The proportions of serotypes identified (type A 40%, B 16%, D 20%, E7%,F11% 
and not determined 6%) from stock cultures showed that serotype A is the single 
largest group recoverable from a wide range of host species from different geographic 
regions and found to be associated with septicaemia and respiratory disease (Carter, 
1967 ; Smith et al. , 1990). Serotype D strains had also been isolated from wide range 
of host from different geographic regions. A total of 7 and 4 serotype B strains had 
been isolated from haemorrhagic septicaemia (HS) of cattle and buffalo from Asia 
(India, Sri Lanka, China and Thailand) and Africa (Egypt and Cameroon) 
respectively. However, 5 strains of serotype B were also identified from cattle, 
horse, pig and avian sources from East Europe (Poland and Romania). 6 out of 7 
cultures of serotype E had been isolated from cattle in Africa. Strain no. 872 from 
bovine haemorrhagic septicaemia (HS) from Israel was serotype E. For many years 
this serotype has been thought not to occur in Asian countries or indeed outside 
Africa.
Reports in the literature are unanimous that serotype B is mainly confined to Asia and 
type E to African countries respectively (DeAlwis, 1984; Carter and DeAlwis, 1989). 
There are a few reports that both strains were found to be present in Sudan and Egypt 
(DeAlwis, 1984). There are also some unconfirmed reports that serotype B has been 
isolated in South Africa and Madagascar. The spread of livestock diseases from one 
country to another is believed to have commonly occurred by means of normal trade 
in livestock (perhaps also by movement of zoological wild life) and the distribution 
of serotype B must reflect the considerable extent of such trade between Asia, Africa 
and East European countries over a period of centuries.
Of interest also is the identification of serotype F. A total of 11 isolates from different 
parts of the world (2 from cattle, 1 from pig, 6 from poultry and 2 from wild life 
proved to be serotype F. It seems that avian species represent the largest source of 
serotype F. As 11 F strains identified were from the stock culture collection, it is 
obvious that this serotype must have existed as a distinct capsule type for many years
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but it was discovered only in 1987 from American turkeys.
Haemorrhagic septicaemia (HS) is generally diagnosed by Veterinary Field Services 
from clinical history and confirmation is considered complete when a Veterinary 
Investigation Laboratory isolates P. multocida. Strain nos. 1042 and 2113 (both of 
Asian origin) received with a history of haemorrhagic septicaemia but proved negative 
by the IHA test against B and E antibody. Both were readily typed as A serotype. 
Thus clinical history and the isolation of P. multocida, without serotyping can result 
in false reports of haemorrhagic septicaemia (HS) making epidemiological data 
uncertain and raising doubts as to the efficacy of vaccination.
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SECTION 3
DEVELOPMENT & APPLICATION OF TECHNIQUES 
FOR VIRULENCE FACTORS
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P. multocida causes a variety of infections in animals and birds and much is known 
about the diseases; in contrast, surprisingly little is known about the properties which 
contribute to the virulence of the organism. This Section describes the examination 
of 100 stock and 10 fresh isolates of P. multocida for the possession of selected 
virulence factors. The strains of P. multocida used, their source, propagation and 
maintenance were described in Section 2. The virulence factors selected for 
investigation were:
1) Size of the capsule zone
2) Protein toxin
3) Neuraminic acid
4) Neuraminidase
5) Hyaluronic acid and
6) Hyaluronidase
3.1 Materials and methods
3.1.1 Capsule
3.1.1.1 Demonstration of capsule
Methanol fixed smears of growth suspensions from 24 hour YPC agar culture were 
treated by the Indian ink method described by Butt et a/. (1936) but using crystal 
violet to stain the bacteria.
3.1.1.2 Measurement of capsule zone size
High contrast photo-micronegatives were prepared at magnification x 400 on the 
negative. By direct microscopy of the negative image using a x 4 objective with a 
precalibrated scale, measurements 0 t) were made of the maximum length and width 
of individual bacteria and the length and width of their capsule, the capsule zone area 
found by substraction and the mean of 20 values taken.
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3.1.1.3 Measurement of capsule zone size at different periods of incubation
One strain of serotype B (strain no. 925) was tested for its ability to produce a 
maximum capsule zone at different incubation times from the same YPC agar culture. 
Capsules were demonstrated at 4, 8, 12, 16, 20, 24, 36, 48, 72 and 96 hours of 
incubation and capsule zones determined from the photo-micronegative.
3.1.2 Protein toxin
3.1.2.1 Kinetics of toxin production
A toxigenic strain of serotype D (strain no. 960) was selected to study the formation 
of protein toxin in disintegrated pellets and in broth supernatant. Starter cultures of 
this strain were prepared by inoculating 10 discrete colonies from YPC media into 
100 ml of brain heart infusion broth (BHIB) [Oxoid] in flasks; these were incubated 
aerobically at 37°C in a rotator. Volumes of 5 ml were removed at 5, 10, 15, 20, 25, 
30, 35, 40, 50, 60 and 70 hours and bacterial viable counts, expressed as colony- 
forming units (cfu) per ml, were made by the method of Miles and Misra (1938). 
Each time the purity was checked by Gram’s stain and plating out on blood agar. 
Samples at 15, 20, 25, 50, 60 and 70 hours of the growth period were centrifuged 
(10,000 x g for 20 minutes), the supernatant filtered through a 0.22 fim membrane 
(Sartorius) and retained. The deposit containing bacterial cells was washed and 
resuspended in 5 ml PBS, disintegrated for one hour at 4°C in a Mickle tissue 
disintegrator (manufactured by H. Mickle, England) with glass ballotini beads. 
Microscopic examination of Gram stained disintegrated material showed large 
amounts of cell debris with few intact bacteria. The disintegrated material was 
centrifuged (10,000 x g for 20 minutes at 4°C), the pellet discarded, and the 
supernatant fluid filtered and retained.
Undiluted filtrates from the cultures, together with those from the disintegrated cells 
and their two fold dilutions made in sterile BHIB were inoculated into a Vero cell line 
(0.5 ml/well) and examined by inverted microscope daily for five days for evidence
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of cytopathic effect (CPE). The highest dilution (toxin titre) which altered the cell 
morphology and integrity was recorded.
3.1.2.2 Effects of protein toxin
3.1.2.2.1 Cell culture assay
The method used was that of Rutter and Luther (1984) and Pennings and Storm 
(1984) but using the medium made up with the following ingredients.
10 x Eagle’s minimal essential medium (Flow laboratories) 10%
Newborn calf serum (Gibco) 2%
Penicillin G (100 units/ml) [Sigma] 1%
Streptomycin (100 jug/ml) [Sigma] 1%
Glutamine (200 millimolar) [Sigma] 1 %
Sodium bicarbonate (7.5%) [Flow laboratories] 2% and 
Milli Q water 83%
Penicillin, streptomycin, glutamine were sterilized by filtration and milli Q water by 
autoclave respectively. Monkey kidney (Vero), embryonic bovine lung (EBL), HeLa 
and mouse-fibroblast (L-929) cell lines were used in this study.
Initially, cells were grown in cell culture plastic flask (Nunclon) using the above 
medium. After that 6 well cell culture plates with flat bottoms were seeded with 5 ml 
above medium, containing 2xl06 cells in each well. Monolayers formed within 24-48 
hour at 37°C in a humidified atmosphere of 5% carbon dioxide (COj in air.
Thirty minutes prior to testing the cell culture medium was removed, the growth 
washed with sterile PBS and fresh medium added as before but without newborn calf 
serum. After 30 minutes, 0.5 ml of each toxin preparation was added to duplicate 
wells. The cell cultures were then incubated for a maximum period of 5 days and the 
monolayer morphology observed daily with an inverted microscope. The following
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controls were always included: i) cell control (uninoculated well) and ii) medium 
control (uninoculated BHIB added to well).
3.1.2.2.2 Agar overlay method
The method used was that of Chanter et al. (1986a) but using the medium (described 
in 3.1.2.2.1) instead of using Earles lactalbumin medium. Embryonic bovine lung 
(between the 20th and 25th passage) and Vero cells were seeded (approximately 2X105 
cells/well) in 24 well multidishs containing the medium (described in 3.1.2.2.1). 
Monolayers formed within 24-48 hours at 37°C in a humidified atmosphere of 5% 
C 02 in air. The medium was then removed, the cells washed once with PBS and then 
overlayed with the same medium (without antibiotics and newborn calf serum) mixed 
with 1 % (w/v) agar (Sigma, tissue culture grade) in milli Q water, at a ratio of equal 
parts of medium + agar (1:1) and cooled to 45°C before use.
Once the agar overlay had set, strains of P. multocida were inoculated to duplicate 
wells by transfer of some of the growth from an individual colony with a sterile 
plastic loop to the surface of the agar overlay. A positive control (strain no. 960), 
negative control (strain no. 925) and uninoculated well (cell control) were included 
in each plate. The overlay cultures were incubated at 37°C in a humidified atmosphere 
of 5% C02 in air and examined daily using an inverted microscope.
3.1.2.2.3 Mouse lethality (Il’ina and Zasukhin, 1975; Rutter, 1983)
The capability of an isolate to produce toxin was tested in Balb/C mice (18-20 gm), 
using sterile filtered 48 hour BHIB culture supernatant. 0.5 ml was injected 
intraperitoneally (IP). One mouse was used per preparation and uninoculated BHIB 
(0.5 ml) was injected IP as negative control. Mice which did not die within 48 hour 
were killed. Necropsies were performed and heart blood and liver were cultured on 
blood agar.
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3.1.2.3 Screening of P. multocida for protein toxin
For screening of toxigenic isolates of P. multocida, the organism was grown for 48 
hours in static culture of 5 ml BHIB, centrifuged and the supernatant filtered and 
tested. Initially, all 110 strains were screened for toxic activity by Vera cell assay. 
Later, all strains found to be toxigenic on Vero cell assay, together with 25 non- 
toxigenic strains (representing 5 strains from each serotype) were also tested on EBL, 
HeLa and mouse-fibroblast cell lines, by agar overlay and by the mouse lethality test.
3.1.2.4 Effect of heat on protein toxin
Undiluted filtrates from 48 hour culture supernatants of BHIB of all toxigenic strains 
and five non-toxigenic strains (1 strain from each serotype) were heated at 65°C in 
a water bath for half an hour. The treated supernatants were tested both in mouse (0.5 
ml IP) and in EBL and Vero cells.
3.1.2.5 Comparison of test procedures for detection of protein toxin
In one experiment, undiluted filtrates from 48 hour culture supernatants of BHIB from 
all toxigenic strains of P. multocida were inoculated into EBL and Vero cell lines. 
Growth of these toxigenic strains in agar overlays of EBL and Vero were recorded 
noting the time following inoculation for the production of visible cytopathic effect.
3.1.3 Neuraminic acid
3.1.3.1 Hydrolysis of the sample
Each test strain of P. multocida from 24 hours YPC growth was suspended in 5 ml 
volumes of 0.05 M sulphuric acid (H2S04) and 0.1M hydrochloric acid (HC1) to 
produce suspension with a turbidity corresponding to tube no. 10 of McFarland 
opacity. The bacterial suspensions were then hydrolysed at 80°C for 50 minutes (for 
HC1) and at 80°C for 60 minutes (for H2S04) in a water bath with occasional mild
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shaking in order to release total bound sialic acid, if any from the bacteria. After 
hydrolysis, the samples were cooled to room temperature and hydrolysates subjected 
to ultra-filtration (ultrafree-CL, Millipore) in an angle head centrifuge (5000 x g for 
1 hour) at 4°C. The filtrate was then assayed for neuraminic acid.
3.1.3.2 Detection of neuraminic (sialic) acid
The total amount of neuraminic acid was determined colorimetrically by the direct 
Ehrlich reagent (Werner and Odin, 1952). Filtrate 2.5 ml was pipetted into a 
universal bottle and 0.5 ml of Ehrlich reagent added. The reagent was prepared by 
dissolving 1 gm of recrystallised p-dimethylamino benzaldehyde (Sigma) in a mixture 
of 10 ml of concentrated HC1 (BDH) and 10 ml of distilled water and was prepared 
freshly for each batch of samples tested. The universal bottle were heated for 30 
minutes in a boiling water bath and after cooling the sample to room temperature the 
absorbance was read in a spectrophotometer at a wave length of 565 nm.
A reference strain of E. coli K1 (strain no. 47532) [kindly provided by the Public 
Health Laboratory Services, London.] was used as a positive control for neuraminic 
acid. Pure neuraminic acid (Sigma) was used for constructing the standard curve.
3.1.4 Neuraminidase
3.1.4.1 Preparation of P. multocida neuraminidase
Initially, four test strains (one from each serotype except F) were selected to compare 
the amount of neuraminidase in sonicated extract and in broth supernatant. Samples 
(50 ml BHIB) were inoculated with 10 discrete colonies from a 24 hour YPC agar 
culture and incubated for 72 hours at 37°C. Volumes of 10 ml were removed at 24, 
48 and 72 hours and the bacteria separated from the culture fluid by centrifugation 
(10,000 x g for 20 minutes). Five ml of the supernatant was passed through a 0.22 
/xm membrane (Sartorius) and stored at -20°C. The bacterial pellet was washed once
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with 0.1 M sodium phosphate buffer (pH 6) and the cells resuspended in the same 
buffer to produce a turbidity corresponding to tube no. 10 of a McFarland opacity.
To solubilise the cell-bound neuraminidase, washed bacteria were ultrasonicated 
(SON-IM, Model XL 2010) on ice for 25 minutes. Treatment periods did not exceed 
2 minutes with intervals between treatments of 15-30 seconds, in order to avoid heat 
dénaturation of the enzyme. Microscopic examination of sonicated material showed 
large amounts of cell debris with few intact bacteria. After sonication the samples 
were centrifuged (31,000 x g for 20 minutes), the supernatant collected and stored at 
-20°C.
3.1.4.2 Assay for A-acetylneuraminic acid (NANA)
Aminoffs (1961) thiobarbituric acid assay for free sialic acid was followed. The 
reagents were:- Reagent 1: 25mM periodic acid in 0.125 N- H2SO4 (BDH) at pH 1.2 
; Reagent 2: Sodium arsenite (BDH) 2% (w/v) in 0.5 M HC1 (BDH); Reagent 3: 
0.1M 2 thiobarbituric acid (Sigma) adjusted to pH 9 and Reagent 4: acid butanol 
containing 12 M HC15 % (v/v). In routine tests, 0.5 ml samples were assayed in glass 
tubes (125 x 15 mm). Pure neuraminic acid (Sigma) was used as standard. 
Spectrophotometric readings at a wave length of 549 nm were made with disposable 
plastic cuvette in spectrophotometer (SP8-400 UV/VIS).
3.1.4.3 Assay for neuraminidase activity
For the standard test 0.5 ml of reaction mixture was prepared by adding the following 
volumes to glass tubes (125 x 15 mm): 0.1 ml of test enzyme preparation; 0.15 ml 
of 0.1 M phosphate buffer (pH 6) and 0.25 ml of substrate (bovine maxillary gland 
mucin) [Sigma]. Unless stated otherwise, dilutions of substrate or enzyme were made 
in sodium phosphate buffer, pH 6. Reagents were normally held at room temperature 
before making the test mixtures, but were pre-warmed to 37°C when the period of 
incubation was to be less than 10 minutes. After incubation for the appropriate period
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at 37°C in a water bath, Reagent 1 was added to the mixture and the standard NANA 
assay was performed.
To obtain information on the time course of the reaction with different concentrations 
of substrate and enzyme, standard tests were set up and incubated for graded periods 
of time. The timing of experiments was such that test periods of incubation ended 
simultaneously; at that point all tests including time zero (TO) control tests, were 
assayed for NANA in a single batch. For the TO control tests, the standard assay 
volumes of enzyme,substrate and buffer, pre-cooled to 0-l°C, were mixed in a tube 
held in an ice bath at 0-l°C; the assay for NANA was begun immediately by adding 
Reagent 1 and transferring the mixture to a water bath at 37°C.
Each test, and the TO control assay, was normally performed in duplicate and the 
mean value for the extinction at 549 nm wave-length was calculated. Time zero (TO) 
control tests were used for correction of test readings. The spectrophotometric 
readings were converted into equivalent concentrations of NANA using a standard 
curve prepared from purified NANA (Sigma). To express the enzymatic activity in 
units, the amount of NANA (derived from the standard curve) released due to 
enzymatic activity from the substrate was converted into fi moles/ml/minute (by 
dividing the amount of NANA/ml with molecular weight of NANA followed by 
further dividing by 7.5 minutes the incubation time). As the amount of released 
NANA in (jl moles/ml/minute was very small, neuraminidase activity were expressed 
in milli Units (mU = n moles/ml/minute) and specific neuraminidase activity in 
mU/mg of protein.
Clostridium perfringens neuraminidase (Sigma) was used as a positive control.
3.1.4.4 Effect pH on P. multocida neuraminidase
Sodium acetate and sodium phosphate buffers were prepared as described by 
Cruickshank et al. (1975). The pH range (4-5.5) of the sodium acetate buffer was 
extended to give buffers of lower pH (down to pH 4) by the use of higher volumes
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of acetic acid and corresponding smaller volumes of sodium acetate solution. The pH 
range (6-8) of the sodium phosphate buffers was extended to give buffers of higher 
pH (up to pH 8) by the use of smaller volumes of monobasic sodium phosphate and 
corresponding higher volumes of dibasic sodium phosphate.
Tests were performed similar to standard neuraminidase assays except that distilled 
water (instead of 0.1 M sodium phosphate buffer) was used to dilute the bovine 
maxillary gland mucin substrate. The result of the test at each pH value was corrected 
by substraction of the assay value for the corresponding time zero (TO) control test 
prepared with pre-cooled reagents. The maximum assay value observed was regarded 
as 100% neuraminidase activity and the other percentages calculated from that.
3.1.4.5 Enzyme substrate kinetic studies
3.1.4.5.1 Initial velocity of neuraminidase reaction with varying concentration 
of substrate
Sonicated enzyme preparations were used and a range of concentrations of substrate 
(1 mg/ml to 10 mg/ml) prepared in 0.1 M sodium phosphate buffer, pH 6. Reaction 
mixtures were prepared as for the standard neuraminidase assay and were incubated 
at 37°C for graded periods of time before NANA assay. TO control tests were used 
to correct test readings.
3.1.4.5.2 Initial velocity of neuraminidase reaction with varying concentration of 
enzyme
Sonicated enzyme preparations were diluted in 0.1 M sodium phosphate buffer, pH 
6 to give test concentrations of 25, 50 and 100% (v/v). Standard neuraminidase 
assays were carried out with the reaction mixtures incubated at 37°C for 2.5, 5, and
7.5 minutes before the NANA assay. Appropriate TO control tests were used to 
correct test results.
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3.1.4.6 Tests for iV-acetylneuraminate pyruvate-lyase (NAN-lyase) activity
Sonicated enzyme preparations from one strain were tested for the ability to break 
down NANA under conditions equivalent to those of the standard neuraminidase 
assay. Test mixtures, containing 0.1 ml test material (sonicated extract from serotype 
A), 0.15 ml sodium phosphate buffer, pH 6 and 0.25 ml of a solution containing 50 
jug/ml pure NANA dissolved in distilled water, were incubated at 37°C for periods 
up to 2 hour before the assay for NANA. TO (time zero) control tests were used and 
the amount of NANA destroyed was calculated as % of TO value.
3.1.4.7 Protein determination
The protein content of sonicated extracts or culture supernatants was measured by the 
Pierce Protein Assay Reagent 23200 (Pierce Chemical Company, USA). The 
concentrated test samples were properly diluted in 0.1 M sodium phosphate buffer 
(pH 6) in order to get the correct range of readings from the spectrophotometer at 
595 nm. Dilution factor and spectrophotometric absorbance value were used to 
calculate equivalent concentrations of protein using a standard curve prepared from 
bovine serum albumin (Sigma)
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3.1.5 Hyaluronic acid (HA)
3.1.5.1 Capsule extract
Total growth from a thickly sown 24 hour plate culture of a test strain on YPC agar 
was suspended in 0.5 ml cold (+4°C) normal saline, mixed in a vortex mixer for one 
minute and centrifuged at (1500 x g for 30 minutes) at 4°C. The supernatant 
constituted the capsule extract (CE).
3.1.5.2 Cross streaking
Using a method based on that of Carter and Rundell (1975), each test strain was 
inoculated as a single streak across a diameter of a trypticase soy (Difco) blood agar 
plate, a hyaluronidase positive Staphylococcus aureus (strain no. 2673) streaked 
heavily across it at right angles and the plate incubated at 24 hours at 37°C in a 
humidified atmosphere. Narrowing and . loss of mucoid character of the P. 
multocida growth streak at the intersection was considered to indicate hyaluronic acid 
production.
3.1.5.3 Chromatography
Capsule extract (CE) from each strain was subjected to NaCl gradient 
chromatography by the method of Manley (1965), but using 3M NaCl added at a ratio 
of 1 ml per minute to an initial 50 ml distilled water, Whatman DE-81 ion exchange 
paper and a run of 60 minutes at 22°C during which the solvent front moved 
approximately 97 mm; a standard marker of purified hyaluronic acid (HA) and 
chondroitin sulphate (CS) [Sigma] was always included. The paper was then dried, 
stained with 1 % (w/v) Alcian blue in 2% (v/v) acetic acid for 15 minutes and washed 
in briskly running tap water for 15 minutes. Rf  values were calculated as distance, 
origin to band/distance, origin to front: precise replication of values obtained (and 
quoted in the Results Section) would depend on identical chromatographic conditions.
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3.1.5.4 Turbidometric assay
The method was that of Seastone (1943), based on turbidity production by hyaluronic 
acid in acidified horse serum, as modified by Smith (1958) for P. multocida. Capsule 
extract (CE) prepared as above but from a growth suspension adjusted to McFarland 
no. 10 opacity, was mixed with an equal volume of 10% horse serum in 0.5M acetate 
buffer pH 3.1, left for 30 minutes at room temperature and the turbidity measured in 
a spectrophotometer (SP8-400 UV/VIS) at 600 nm wave length. HA concentration 
was determined by comparison with a standard curve prepared using purified HA 
(Sigma).
3.1.5.5 Hyaluronidase treatment
For chromatography, CE was treated with purified hyaluronidase (Sigma) from three 
sources: leech, bovine testicle and Streptomyces hyalurolyticus at a concentration of 
200 i.u./ml, in each of three menstrua, i) distilled water ii) phosphate buffered saline 
and iii) 0.1M acetate buffer, pH 5 containing 0.15M NaCl with gelatin as 
preservative (Rapport et a/., 1951), for 2 hours at 37°C. For investigating the effect 
of hyaluronidase treatment on capsule zone measurements (described in Section 
3.1.1.2), growth suspension was similarly treated, but using testicular hyaluronidase 
only.
3.1.6 Hyaluronidase
3.1.6.1 Detection of hyaluronidase activity
An agar plate method was used (Smith and Willett, 1968). The basic medium 
consisted of BHIB (Oxoid), to which was added 5 gm of purified agar (Oxoid) per 
500 ml and sterilized by autoclaving. On cooling to 45°C filter sterilized hyaluronic 
acid (Sigma) or chondroitin sulphate (Sigma) was added to the medium to give a final 
concentration of 400 jug/ml together with 1 % (w/v) filtered sterile bovine albumin 
fraction V (Sigma). The agar was poured to a depth of 3-4 mm.
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Each test strain was spotted onto a quadrant of a plate in duplicate and incubated for 
48 hours at 37°C in a humidified atmosphere. The plate was then flooded with 2N 
acetic acid for 10 minutes, causing the non-degraded substrate to precipitate as a 
conjugate with the albumin. A clear zone remained around those colonies which 
produced hyaluronidase. No clearing around the P. multocida growth was interpreted 
as negative. Propionibacterium acnes (NCTC 10387) was used as a positive control.
Since false positives could result from the action of bacterial proteinase on the bovine 
albumin, all P. multocida strain were screened for proteolytic activity (gelatinase) by 
inoculating as spots onto a nutrient agar plate containing 0.4% gelatin (Oxoid) and 
incubated at 37°C for 24 hours. The plates were then flooded with 10% (w/v) 
trichloroacetic acid. Clearing around or under the bacterial growth was looked for. 
Pseudomonas aeruginosa was used a positive control for gelatinase activity and 
produced broad zones of clearing. None of the P. multocida strains produced 
clearing.
3.1.7 Statistical analysis
The paired and student "t" tests, the analysis of variance, the Duncan multiple range 
test, the correlation of coefficient test and Spearman correlation test were variously 
used for data analysis throughout this study. Statistical analyses were performed using 
a computer programme "Oxstat” (Walter, 1986) and from the text of Baily (1983) and 
Scott (1991).
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3.2 Results
3.2.1 Capsule
3.2.1.1 Demonstration of capsule
All of the 110 strains of P. multocida examined were considered to be capsulated. 
Microscopically, each strain showed capsule, easily detectable by the appearance of 
a clear space between the stained bacterium and the Indian ink background.
3.2.1.2 Measurement of capsule zone
Each of the 110 strains of P. multocida was subjected to photomicrographic capsule 
zone measurement. No strain gave a zero measurement. Individual values for mean 
capsule zone dimension can be found in Table 22. The following summaries employ 
a comparison of the measurements of mean capsule zone size of the different 
serotypes (taken from Table 22) and is given in Table 10. The mean capsule zone for 
40 type A (stock) was 3.56 ±  0.63; for 16 type B 1.80 ±  0.24; for 20 type D (stock) 
3.39 ±  0.54; for 7 type E 1.92 +  0.19 and for 11 type F 2.59 ±  0.23. Freshly 
isolated type A strains produced larger capsules than the stock ones but there was 
little difference between fresh and stock strains of type D.
An analysis of variance on the mean capsule zone size of the five serotypes showed 
that the difference between them was significant (F= 50.48) at the level of (P < 0.01). 
The Duncan multiple range test was then used to determine which means of capsule 
zone size of different serotypes were significant. It revealed that the capsule of P. 
multocida constituted 3 different sizes, A D F_ E B ( any two serotypes not 
underscored by the same line are significantly different). To particularise,
i) serotype A and D possessed a significantly larger capsule zone size than 
serotypes B, E and F;
ii) the moderate size formed, by only F serotype;
iii) serotypes B and E produced a significantly smaller size.
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Table 10. Mean capsule zone sizes of P. multocida serotype
Serotype No. of 
strains
Mean capsule zone 
(ff)
A (stock) 40 3.56 ± 0.63
A (fresh) 5 4.26 ± 0.49
B (stock) 16 1.80 ± 0.24
D (stock) 20 3.39 ± 0.54
D (fresh) 5 3.40 ± 0.28
E (stock) 7 1.92 ± 0.19
F (stock) 11 2.59 ± 0.23
Not determined 6 2.24 ± 0.30
Note: No strain was devoid of visible capsule (i.e. gave a zero capsule zone measurement)
3.2.1.3 Measurement of capsule zone size at different periods of incubation
Fig. 7 shows the mean capsule zone size of serotype B at different periods of 
incubation from the same YPC agar culture. It appears that the capsule zone was the 
same up to 36 hours of incubation, after which, the zone size started to reduce. At 
72 and 96 hours of incubation, some of the bacteria showed only refractile outlines, 
like decapsulated bacteria, and some had capsule showing a serrated appearance at its 
outer edge.
3.2.1.4 Reproducibility of capsule zone measurement
The reproducibility of the capsule zone size measurement was determined by 
measuring 10 different strains (two from each serotype) on two separate occasions 
(Table 11). The differences from the previous measurements were found to be 
statistically non-significant (P>0.1) by "t" test (F ratio = 1.1329).
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Fig. 7. Measurement of capsule zone size of a serotype B strain at different 
periods of incubation
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Table 11. Results of reproducibility of capsule zone size measurements
Strain no. Serotype Occasion 1 
Capsule zone (n2)
Occasion 2 
Capsule zone (ju2)
877 A 4.68 ± 1.03 4.52 ±  0.99
1113 A 3.40 ± 0.82 3.45 ±  0.89
921 B 1.95 ± 0.33 1.84 ± 0.29
925 B 1.58 ± 0.31 1.70 ± 0.34
1064 D 3.38 + 0.73 3.15 ±  0.63
876 D 3.48 ± 0.73 3.50 ± 0.69
823 E 1.91 + 0.25 1.93 ± 0.21
978 E 2.14 ± 0.56 2.24 ±  0.39
1055 F 2.54 ± 0.64 2.91 ± 0.63
2134 F 2.73 ± 0.58 2.73 ± 0.66
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3.2.2 Protein toxin
3.2.2.1 Kinetics of protein toxin production
Toxic activity was assayed in disintegrated cells and in cell-free culture supernatant 
throughout the growth period of P. multocida as shown in Table 12. Toxin assayed 
after disintegration of the cells reached a maximum titre during the later stage of the 
log phase of growth, and then decreased with the decreasing number of cells during 
the decline phase. In culture supernatant, little cytopathic activity was detected at 15 
hours of incubation. Up to 25 hours, filtrates of disintegrated cells possessed more 
cytopathic activity than the corresponding culture supernatants, but at 50 hours and 
onward, culture supernatants were more cytopathic than the filtrates. It was concluded 
that sufficient cytopathic activity would be present in 48 hour 100 ml batch culture 
supernatants of BHIB to allow screening of isolates for toxin production. This was 
checked with cultures of smaller volume (5 ml) more suitable for screening: the 
results were the same.
3.2.2.2 Effects of protein toxin
The inoculation of sterile-filtered 48 hour culture supernatant of brain heart infusion 
broth (BHIB) of toxigenic P. multocida, elicited clear cytopathic effects on Vero and 
EBL cell lines. On Vero cell lines, "knots" developed, starting at the verge of the 
well and extending throughout the Vero monolayer (Figs. 8a and 8b) whereas on EBL 
cells, protein toxin caused the EBL monolayers to separate from each other, leaving 
spaces between "islands of cells" (Figs. 9a and 9b). No change was seen with 
negative (broth) controls or the uninoculated wells (cell controls). HeLa and mouse- 
fibroblast (L 929) cell lines, failed to show any cytopathic effects with the same 
preparations and were assumed to be insensitive to this protein toxin.
Intraperitoneal injection of 0.5 ml of filtered 48 hour BHIB culture supernatant of 
toxigenic P. multocida killed Balb/C mice, mostly within 24-30 hours. On necropsy,
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Table 12. Production of protein toxin at different times during the growth of P. 
multocida.
Hours of growth Cfu/ml (log 10) Toxin titre
Culture supernatant Disintegrated cells
5 1.07 - -
10 3.69 - -
15 5.90 2 64
20 7.95 8 256
25 9.30 16 512
30 7.85 - -
35 7.69 - -
40 7.47 - -
50 6.84 512 128
60 6.25 512 128
70 5.69 512 64
* Toxin titres are expressed as the reciprocal of the highest dilution of toxin (culture 
supernatants/disintegrated cells) which altered the cell culture morphology.
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Fig. 8 (a). Normal Vero cells stained with Giemsa
Fig. 8 (b). Cytopathic effects of P. multocida protein toxin in Vero cells stained 
with Giemsa
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Fig. 9(a). Normal bovine embryonic lung (EBL) cells stained with Giemsa
Fig. 9 (b). Cytopathic effects of P. multocida protein toxin in EBL cells stained 
with Giemsa
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no gross pathological changes were noticed and no bacteria were recovered by culture 
of heart blood.
3.2.2.3 Screening of P. multocida for protein toxin
All of the 110 strains of P. multocida were tested for protein toxin activity on Vero 
cells, using filtrates of supernatants from cultures grown for 48 hours in 5 ml BHIB. 
8 strains caused cytopathic effect. The same 8 strains were also the only ones causing 
cytopathic effect in EBL cultures and agar overlays of EBL and Vero cells, and 
showing lethality for mice. Details of capsular serotype, host species and country of 
origin of the 8 toxigenic P. multocida isolates are given in Table 13. The toxigenic 
strains were from sheep (4), pig (3) and a goat (1). 5 were of serotype A and 3 
serotype D. No protein toxin activity was detected in serotypes B, E and F.
3.2.2.4 Effect of heat on toxin
48 hour BHIB culture supernatants of the 8 toxigenic and 5 non-toxigenic strains (1 
strain from each serotype) were heated at 65°C for half an hour. The heated 
preparations showed no cytopathic effect in Vero and EBL cells and were devoid of 
mouse lethality.
3.2.2.5 Comparison of procedures for detection of protein toxin
Evaluation of sensitivity of the test procedures was not attempted, as it would have 
involved processing of a large number of dilutions. Table 14 compares the mean time 
following inoculation of toxin, for visible cytopathic effects in cell cultures. The agar 
overlay method, using EBL cells was the most rapid detection method. All 8 
toxigenic strains caused visible cytopathic effect in this system within 18 hours of 
incubation. In Vero cell cultures, cytopathic effect became visible only after 48 hours 
though it increased with time. In spite of these differences there was complete 
qualitative agreement between the results obtained with the different cytopathic 
assays.
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Table 13. Results of different tests for detection of toxigenic P. multocida 
isolates and their serotypes, host species and geographic origin
Strain
no
Host Geographic
origin
Serotype
Tests
Cell culture assay Agar overlay Mouse
lethality
Vero EBL HeLa Fibroblast Vero EBL
21 Pig UK A + + - - + + +
849 Sheep Italy A + + - - + + +
891 Pig Finland D + + - - + + +
914 Sheep India A + + - - + + +
960 Boar Romania D + + - - + + +
1295 Sheep USA D + + - - + + +
1576 Sheep Uganda A + + - - + + +
2140 Goat Tanzania A + + - - + + +
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Table 14. Results of the comparison of the test procedures for the detection of 
cytopathic effect of P. multocida protein toxin
Methods used Time (hours) following inoculation for visible 
cytopathic effect
A, Cell culture
i) Embryonic bovine lung < 30
ii) Vero > 48
B. Agar overlay
i) Embryonic bovine lung < 18
ii) Vero > 24
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3.2.3 Neuraminic acid
3.2.3.1 Screening of P. multocida for neuraminic acid
All 110 strains (100 stock + 10 fresh) of P. multocida were examined for neuraminic 
acid, but none produced a purple colour reaction (characteristic for sialic acids) with 
the Ehrlich assay and the absorbance values of the test samples were the same as the 
reagent blank. A weak purple colour developed for a few (3 or 4) strains following 
boiling with Ehrlich reagent but on cooling the colour faded within minutes. This was 
possibly due to tryptophan or tryptophan-containing protein, which is present in all 
P. multocida and is responsible for their positive indole reaction, whereas the purple 
colour formed from sialic acids by direct Ehrlich assay is stable.
As an additional check, a few suspensions of P. multocida were very thickly 
prepared, hydrolysed and ultrafiltered: but again no colour was formed by the Ehrlich 
assay, precluding the possibility that low amounts of NANA were present in a 
bacterial concentration adjusted to McFarland no. 10 opacity. Further examination of 
25 strains (5 from each serotype) with the thiobarbituric acid assay (Aminoff, 1961) 
also produced negative results. Therefore, it is considered that NANA was absent 
from the P. multocida strains tested in this study.
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3.2.4 Neuraminidase
3.2.4.1 Comparison of cell sonicates and culture supernatants
Comparisons of specific neuraminidase activities of sonicated extracts and their 
corresponding culture supernatants for four serotypes are shown in Table 15; Fig. 10 
shows the same values plotted as a histogram. This preliminary experiment showed 
that P. multocida neuraminidase is cell-bound, and released only on disruption of the 
cells. Only a very small amount of neuraminidase activity was found in cell-free 
culture supernatant. Thus, for screening P. multocida for neuraminidase, a sonicated 
cell preparation was used. It was prepared from growth on YPC media rather than 
broth because of the greater ease of handling.
3.2.4.2 Standard curve
The standard curve obtained from pure neuraminic acid (Sigma) was linear and 
significant. The correlation coefficient (r) value was 0.9960 (Appendix I). The 
standard protein curve obtained from bovine serum albumin (Sigma) was linear and 
significant and the correlation coefficient value was 0.9957 (Appendix I).
3.2.4.3 Effect of pH on P. multocida neuraminidase
The results of neuraminidase activity in sodium acetate buffer (pH range 4-5.5) and 
in sodium phosphate buffer (pH range 6-8) are given in Table 16 and Fig. 11. The 
maximum value occurred at pH 6 was regarded as 100% and the other percentages 
calculated from that.
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Table 15. Specific neuraminidase activity in sonicated extract and in
corresponding culture supernatant of P. multocida serotype
Serotype
Specific neuraminidase activity 
(mUnit/mg of protein)
Sonicated extract at different 
hours of incubation
Culture supernatant at different 
hours of incubation
24 48 72 24 48 72
A 67.08 65.64 65.32 9.65 8.69 7.69
6 22.98 23.05 22.41 6.38 5.63 5.62
D 55.81 55.44 54.40 7.93 7.18 6.38
B 28.08 26.90 25.81 6.49 5.75 5.36
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Fig. 10. Specific neuraminidase activity of P. multocida in sonicated extract and
in corresponding culture supernatant at different hours of incubation*
24  48  72
Hours of incubation
■  (S) Type A i ü  (SE) Type A E l  (S) Type B S #  (SE) Type B
EHHl (S) Type D □  (SE) Type D *  (S) Type E HEl (SE) Type E
(S) supernatant (SE) sonicated extract
* (same data as Table 15)
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Table 16. Effect of pH on P. rnultocida neuraminidase activity
pH Neuraminidase activity 
(n moles NANA/ml)
Neuraminidase 
activity (%)*
4.0 22.0 21.35
4.5 44.0 42.71
5.0 61.0 59.22
5.5 82.66 80.24
6.0 103.0 100.00
6.5 88.0 85.43
7.0 72.0 69.90
8.0 45.0 43.69
* The maximum value observed was regarded as 100% and the other percentages calculated 
from that.
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Fig. 11. Effect of pH on P. rnultocida neuraminidase activity
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3.2.4.4 Enzyme substrate kinetic studies
3.2.4.4.1 Initial velocity of neuraminidase reaction with varying concentration of 
substrate
Fig. 12 shows the plots of values for the amount of NANA released by the enzyme. 
It may be concluded that the amount of NANA released from different concentration 
of substrate by the enzymatic activity was linear, up to different periods of incubation 
time for different concentration of substrates. The maximum concentration of 
substrate (10 mg/ml) was linear for the 7.5 minutes of incubation. The amount of 
NANA released for the initial reaction velocity (v) /minute at each substrate 
concentration [S] and the molarity of corresponding substrate [S] was calculated for 
determination of Km. (Km is the reciprocal affinity of the enzyme for the substrate.) 
The Km and Vmax values were 1.64 x 10"5 moles/litre and 27.2 n mole/ml/minute 
respectively by the Lineweaver-Burk (1/v plotted against 1/S) [Fig. 13] method. A 
computer programme "Enzypac" (Williams and Zaba, 1989) was used to determine 
the Km value.
3.2.4.4.2 Initial velocity of neuraminidase reaction with varying concentration of 
enzyme
Fig. 14 shows that the rate of release of NANA was proportional to the concentration 
of the neuraminidase preparation when the reaction mixtures were incubated for 
periods up to 7.5 minutes. It was therefore, decided to use undiluted sonicated extract 
for lOmg/ml of substrate for 7.5 minutes of incubation.
3.2.4.5 Tests for NAN-lyase activity
The results of NAN-lyase activity, shown in Table 17, indicate only a very low level 
of activity in sonicated extract of P. rnultocida. There was no break down of NANA 
during the first 10 minutes of incubation. After 2 hours only 4.66% of the test dose 
of NANA had been destroyed.
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Fig. 14. Initial velocity of neuraminidase reaction with varying concentration 
of enzyme
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Table 17. Demonstration of NAN-lyase activity in sonicated extract of P. 
rnultocida
Time
(minutes)
Amount of NANA 
(n moles NANA/ml)
Amount of NANA destroyed 
(n moles NANA/ml)
Amount of NANA 
destroyed as % of TO 
value
TO* 87.9 - -
10 87.9 0 0
30 87.3 0.6 0.68
60 86.2 1.7 1.93
90 84.9 3.0 3.41
120 83.8 4.1 4.66
* Time zero control
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3.2.4.6 Screening of P. rnultocida strains for neuraminidase
All 110 strains of P. rnultocida had measurable neuraminidase activity, although the 
levels varied among different capsular serotypes and within each serotype. Individual 
neuraminidase activities (n mole NANA /ml/minute i.e. milli Unit) for each strain of 
P. rnultocida, with corresponding protein value and equivalent specific neuraminidase 
activity are given in Table 22. However, Table 18 summarizes the data by showing 
mean specific neuraminidase activities of the different serotypes.
An analysis of variance on the mean values of specific neuraminidase activity in 
different serotypes showed that the difference in enzyme activity was significant (F= 
18.87) at the level of (P<0.01). The Duncan multiple range test was then used to 
determine which means of activity were significant. Using this test, specific 
neuraminidase activities of P. rnultocida fell into 3 significant sets. A_ D F and 
B E (any 2 serotypes not underscored by the same line are significantly different). 
To particularise,
i) serotype A constituted the highest neuraminidase producers;
ii) serotypes D and F were the moderate producers;
iii) serotypes B and E produced significantly lower neuraminidase than other 
serotypes.
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Table 18. Mean specific neuraminidase activity of P. rnultocida serotype
Serotype No. of strains Specific neuraminidase activity 
(mUnit/mg of protein)
A (stock) 40 51.60 ± 11.39
A (fresh) 5 46.06 ± 6.79
B (stock) 16 30.65 ± 4.56
D (stock) 20 43.40 ± 9.46
D (fresh) 5 42.32 ± 4.13
E (stock) 7 32.45 ± 3.08
F (stock) 11 41.28 ± 6.67
Not determined 6 31.42 ± 8.57
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3.2.5 Hyaluronic acid
3.2.5.1 Standard curve of hyaluronic acid
The standard curve obtained from purified hyaluronic acid (Sigma) was linear and 
significant. The correlation coefficient value was 0.9987 (Appendix II).
3.2.5.2 Detection of hyaluronic acid in P. rnultocida
Composite results of tests for capsular hyaluronic acid on 110 strains, with their 
serotypes, are given in Table 19. Individual values for turbidometric assay can be 
found in Table 22. All 45 type A strains were positive by cross streaking, 
chromatography and turbidometric assay. However, turbidometric assay indicated that 
the 5 freshly isolated cultures were producing significantly more hyaluronic acid than 
the stock ones. Type B, E, F and 6 not determined strains were all negative. Using 
the cross streaking method, the 25 type D strains gave consistently negative results; 
however, the 5 freshly isolated cultures and 18 of the 20 stock ones were apparently 
positive by chromatography and turbidometric assay, though the turbidity values were 
only about half those shown by type A strains. There was no difference between the 
fresh and stock cultures and all 25 gave a positive type D reaction in the indirect 
haemagglutination (IHA) test. In chromatography of both type A and D strains, the 
Alcian blue positive material migrated as a single band with almost identical Rvalues 
(means. 0.69 +  0.06 and 0.70 ±  0.05 respectively) and at the same rate as purified 
hyaluronic acid marker (mean Rf  0.70 ±  0.05); control chromatography of 
uninoculated YPC medium gave no band. In a small experiment using only 5 each of 
type A and D strains, turbidity which formed following mixing of 250 iA of CE with 
250 ii\ acidified horse serum was separated by centrifugation: on chromatography, the 
pellet from each strain yielded an Alcian blue staining band occupying the hyaluronic 
acid position. The CE supernatants no longer gave this band and had lost their former 
ability to produce turbidity with acidified horse serum. Purified chondroitin sulphate 
(Sigma) produced an Alcian blue staining band of distinctly lower Rf  value (mean,
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Table 19. Presumptive tests for hyaluronic acid : reactions of P. rnultocida strains 
of known serotype
Serotype No* of 
strains
Tests
Cross streaking 
(No, +)
Chromatography 
(No. +)
Turbidometric 
(No, + ) Mean /ig/ml
A (stock) 40 40 40 40 15.30 ± 4.30
A (Fresh) 5 5 5 5 21.73 ±  4.40
B (stock) 16 0 0 0 -
D (stock) 20 0 18 18 8.93 ± 3.08
D (fresh) 5 0 5 5 9.58 ± 0.32
E (stock) 7 0 0 0 -
F (stock) 11 0 0 0 -
Not determined 6 0 0 0 -
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0.63 ±  0.08) and co-chromatography sharply separated chondroitin sulphate from CE 
of serotype D (Fig. 15)
Further study of the 45 serotype A strains showed that treatment of CE with 
hyaluronidase of each type (testicular, leech and S. hyalurolyticus) completely 
removed the ability to give any Alcian blue positive chromatographic band (Fig. 16) 
and to form turbidity with acidified horse serum reagent; this was considered 
reasonably safe confirmation that the type A substance was hyaluronic acid. Similar 
treatment of CE from the 23, apparently positive type D strains however failed to 
confirm that their reaction was due to hyaluronic acid: neither the Rf  0.70 
chromatographic band (Fig. 17) nor the turbidity was affected by treatment with any 
kind of hyaluronidase. Lest the type D CE might contain an inhibitor or inactivator 
for hyaluronidase, the 23 positive type D strains were re-examined 
chromatographically with the addition of 20 fig chondroitin sulphate to the CE 
(testicular hyaluronidase depolymerises both hyaluronic acid and chondroitin 
sulphate.) In each case, the characteristic Alcian blue band of chondroitin sulphate at 
Rf  0.63 was removed by treatment with testicular hyaluronidase, indicating 
unimpaired activity of the enzyme, but the band occupying the hyaluronic acid 
position was unaffected.
In a small experiment using only 5 of the type D strains, 250 fi\ of 1:1000 (w/v) 
acriflavin was added to 250 \i\ of capsule extract (CE) giving an immediate precipitate 
which was separated by centrifugation: on chromatography, the pellet from each 
strain, though only partly soluble in saline, yielded an Alcian blue staining band 
occupying the hyaluronic acid position. The CE supernatant no longer gave this band, 
and had lost its former ability to produce turbidity with acidified horse serum. CE 
from type A cultures gave no precipitate with acriflavin.
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Fig. 15. Salt gradient ion exchange paper chromatography. Purified
chondroitin sulphate migration was to a different level from capsular 
extract (CE) of serotype A and D. 1) purified chondroitin sulphate 2) 
CE of serotype A 3) CE of serotype D plus purified chondroitin 
sulphate and 4) CE of type D
1 2 3 4
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Figo 16. Salt gradient Ion exchange paper chromatography of CE of f .
rnultocida serotype A treated with 3 different hyaluronidase. 1) 
Sfrepfomyces Aya/wroZyffCwa 2) testicular 3) leech 4) CE of serotype A 
without treatment and 5) purified hyaluronic acid. Absence of Alcian 
blue spots suggests hyaluronic acid hydrolysis.
1 2 3 4 5
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Fig. 17. Salt gradient ion exchange paper chromatography of CE of P.
serotype D treated with 3 different hyaluronidase. 1) 
purified hyaluronic acid 2) CE of serotype D without treatment
4) testicular and 5) leech. The enzyme 
did not affect the capsular material
1 2 3 4 5
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It was thought worthwhile to compare the effect of hyaluronidase treatment on capsule 
zone size in type A and D strains. Growth suspensions from 5 cultures of each were 
examined before and after treatment with testicular hyaluronidase. Results are 
summarised in Table 20. Type A strains showed a marked diminution of capsule zone 
size after treatment (Figs. 18a and 18b), this being significant at the level of P <  
0.001 (paired "t" test result, 9.0960). The capsule zone size of the type D was 
unaffected by hyaluronidase.
In a small experiment to examine the effect of testicular hyaluronidase treatment of 
serotypes A and D on the indirect haemagglutination (IHA) test, the heat extract 
antigens from 4 strains (2 from each serotype) were prepared (described in Section 
2.1.9.2) with and without hyaluronidase treatment and tested by IHA. Results of the 
tests are shown in Table 21. Hyaluronidase treatment had no effect on type D strains 
but such treatment gave a marked increase in titre with type A strains. Without 
hyaluronidase treatment the titres of both tested type A strains were <2. Following 
hyaluronidase treatment these strains showed unequivocally high titres of 256 and 512 
respectively.
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Table 20. Effect of hyaluronidase treatment on capsule material of P. rnultocida 
types A and D
Serotype No. of Hyaluronidase Tests for hyaluronic acid Mean capsule
strains treatment Chromatography Turbidometric zone size(ja2)
A 5 - 5 5 4.24 ± 0.52
+ 0 0 2.66 ± 0.26
D 5 - 5 5 3.58 ± 0.33
+ 5 5 3.57 ± 0.30
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Fig. 18(a). A light micrograph of normal capsule of P. rnultocida serotype A 
(before testicular hyaluronidase treatment), stained by Indian ink 
method
Fig. 18(b). A light micrograph of capsule of P. rnultocida serotype A (after
hyaluronidase treatment), stained by Indian ink method showed a 
marked diminution of capsule size
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Table 21. Effect of hyaluronidase treatment on results of the IHA test
Strains Indirect haemagglutination titres*
Before hyaluronidase treatment After hyaluronidase treatment
33(A) 0 256
1113 (A) 2 512
46 (D) 512 512
960 (D) 512 512
* against serum of homologous type (A, 1113). Antiserum type D (no. 876) was not included because 
of just forgetfulness.
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3.2.6 Hyaluronidase
3.2.6.1 Screening of P. rnultocida for hyaluronidase
Hyaluronidase (Fig. 19) was detected in 15/16 of the serotype B strains. The same 
15/16 serotype B strains showed clearing around the growth on the medium 
containing chondroitin sulphate (Fig. 20). Only one serotype B strain, isolated from 
a pig, did not show any enzyme activity on either agar medium. Another strain (no. 
923), which could notbeserotyped due to cross reactions in the indirect 
haemagglutination (IHA) test did not produce clearing around growth on chondroitin 
sulphate medium but produced clearing on hyaluronic acid medium. It may be 
observed that this was the only hyaluronidase positive strain in the collection which 
failed to show concomitant clearing around growth of P. rnultocida on the chondroitin 
sulphate medium. All other strains (belonging to serotypes A, D, E and F) were 
negative for hyaluronidase in the plate assay method.
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Fig. 19. Plate containing hyaluronic acid. Clear zone around P. rnultocida 
serotype B, attributed to hyaluronidase production
M B
Fig. 20. Plate containing chondroitin sulphate. Clear zone around P. rnultocida 
serotype B
Table 22. Composite table showing virulence attributes of 110 strains of P. 
rnultocida
SI
no.
Strain
no
Capsule 
zone (ju2)
Protein Neuraminidase HA
equivalence
Otg/ntl)
Hyaluronidase
toxin
N.activity 
(n moles 
NANA/ml 
/minute 
=  mU)
Protein
(sonicated
extract)
(mg/ml)
Specific 
N. activity 
(toU/mg of 
protein)
1 137 3.25 ±  1.10 - 8.2977 0.2004 41.41 10.85 -
2 532 4.10 ±  1.14 - 9.2314 0.2112 43.71 20.32 -
3 668 2.03 ±  0.53 - 3.6291 0.2053 17.68 - -
4 678 3.70 ±  0.44 - 7.2862 0.1988 36.36 9.68 -
5 758 4.29 ±  1.47 - 9.6983 0.2166 44.77 20.10 -
6 775 2.94 ±  0.31 - 7.9086 0.1923 41.13 9.25 -
7 776 2.76 ±  0.76 - 9.6983 0.2076 46.72 - -
8 823 1.91 ±  0.25 - 6.1968 0.1933 32.06 - -
9 848 2.93 ±  0.52 - 10.3208 0.2053 50.27 9.40 -
10 849 3.21 ±  0.96 + 8.4533 0.2101 40.23 13.18 -
11 851 2.53 ±  0.24 - 7.4418 0.1988 37.43 - -
12 855 2.12 ±  0.47 - 5.4965 0.1896 28.99 - -
13 864 3.27 ±  1.06 - 8.6089 0.2074 41.51 11.58 -
14 865 3.52 ±  0.99 - 4.1738 0.2053 20.33 12.17 -
15 872 2.23 ±  0.53 - 5.7300 0.1907 30.04 - -
16 875 2.02 ±  0.34 - 5.4965 0.1890 29.08 - +
17 876 3.48 ±  0.73 - 11.8770 0.2128 55.81 10.27 -
18 877 4.68 ±  1.03 - 12.4994 0.1847 67.67 18.28 -
19 881 1.60 ±  0.29 - 6.5081 0.2009 32.39 - +
20 883 2.45 ±  0.75 - 8.8424 0.1885 46.91 - -
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21 884 2.69 ±  0.45 - 5.8856 0.1917 30.70 - -
22 887 2.59 ±  0.54 - 7.2084 0.2063 34.94 - -
23 891 3.63 ±  0.83 + 6.7415 0.1988 33.91 9.76 -
24 902 1.79 ±  0.35 - 5.8856 0.2096 28.08 - -
25 903 3.93 ±  0.85 - 12.1104 0.2107 57.48 12.23 -
26 905 2.83 ±  0.37 - 6.8971 0.1896 36.38 - -
27 907 3.27 ±  0.88 - 13.2775 0.1977 67.16 11.07 -
28 914 4.03 ±  0.80 + 8.1421 0.2069 39.35 20.18 -
29 916 4.27 ±  1.08 - 9.3870 0.2009 46.72 20.54 -
30 918 1.69 ±  0.31 - 7.2862 0.1858 39.22 - +
31 921 1.95 ±  0.33 - 6.4303 0.1879 34.22 - +
32 923 2.35 ±  0.49 - 6.7415 0.1944 34.68 - +
33 924 4.01 ±  0.97 - 7.7530 0.2096 36.99 17.55 -
34 925 1.58 ±  0.31 - 5.8856 0.1825 32.25 - +
35 934 1.94 ±  0.43 - 5.4187 0.1890 28.67 - +
36 935 1.53 ±  0.26 - 6.5859 0.1988 33.13 - +
37 945 3.72 ±  0.81 - 8.7646 0.2123 41.28 10.05 -
38 947 2.63 ±  0.73 - 11.8770 0.2053 57.85 10.27 -
39 953 1.66 ±  0.54 - 6.1968 0.1852 33.46 - +
40 956 2.82 +  0.88 - 10.8654 0.2096 51.84 14.49 -
41 960 3.28 ± 0.94 + 7.4418 0.1971 37.76 10.05 -
42 971 1.42 +  0.32 - 5.1075 0.1901 26.87 - +
43 972 2.17 ±  0.32 - 6.8971 0.1825 37.79 - -
44 976 1.90 ±  0.31 - 5.8078 0.2009 28.91 - +
45 978 2.14 ±  0.56 - 7.0527 0.1966 35.87 - -
46 991 3.10 ±  0.72 - 10.9432 0.2150 50.90 11.87 -
47 992 1.98 ±  0.36 - 7.4418 0.1782 41.76 - -
48 997 2.77 ±  0.34 - 9.6205 0.1982 48.54 - -
49 998 2.26 ±  0.49 - 4.4072 0.2096 21.02 - +
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50 1002 2.73 ±  0.59 - 6.3524 0.2020 31.45 - -
51 1027 2.84 ±  1.10 - 4.2516 0.2096 20.28 - -
52 1042 4.45 ±  1.09 - 8.2199 0.2042 40.25 26.00 -
53 1044 2.73 ±  0.70 - 6.4303 0.1879 34.22 9.62 -
54 1049 4.23 ±  1.27 - 6.7415 0.1820 37.04 10.56 -
55 1050 2.79 ±  0.71 - 5.6522 0.2047 27.61 - -
56 1054 3.0 ±  0.88 - 10.9432 0.2134 51.28 11.21 -
57 1055 2.54 ±  0.64 - 9.3870 0.1939 48.41 - -
58 1056 2.27 ± 1 .1 9 - 8.6089 0.2063 41.73 10.41 -
59 1064 3.38 ±  0.73 - 9.0758 0.2107 43.07 10.63 -
60 1066 4.41 ±  1.35 - 11.8770 0.1993 59.59 18.65 -
61 1068 3.87 ±  0.90 - 10.8654 0.2172 50.02 20.61 -
62 1080 1.73 ±  0.33 - 5.5743 0.1777 31.37 - +
63 1081 1.61 ±  0.47 - 5.9634 0.2036 29.29 - +
64 1106 2.85 ±  0.56 - 8.7646 0.2085 42.04 12.02 -
65 1112 3.34 ±  0.82 - 13.2775 0.2155 61.61 12.67 -
66 1113 3.40 ±  0.82 - 14.6781 0.2188 67.08 13.47 -
67 1116 2.92 ±  0.69 - 10.1651 0.2107 48.24 11.58 -
68 1121 2.04 ±  0.48 - 6.3524 0.2009 31.62 - +
69 1125 3.52 ±  0.56 - 10.7098 0.1998 53.60 9.61 -
70 1136 1.76 ±  0.19 - 6.6637 0.1825 36.51 - -
71 1137 1.99 ±  0.23 - 7.5196 0.1858 40.47 - -
72 1144 3.36 ±  1.12 - 9.3870 0.2101 44.68 10.49 -
73 1145 4.21 ±  0.80 - 9.8539 0.2069 47.63 21.12 -
74 1159 3.13 ±  0.75 - 11.0989 0.1977 56.14 9.83 -
75 1160 3.49 ±  1.13 - 7.9086 0.2166 36.51 20.12 -
76 1162 2.50 ±  0.43 - 9.8539 0.2101 46.90 - -
77 1163 3.65 ±  0.67 - 13.7444 0.2004 68.59 15.00 -
78 1164 3.79 ±  1.03 - 10.6320 0.2107 50.46 17.19 -
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79 1183 3.14 ±  0.49 - 13.2775 0.1879 70.66 10.56 -
80 1184 2.72 ±  0.66 - 12.1882 0.1907 63.91 10.19 -
81 1207 3.16 ±  0.82 - 10.9432 0.2074 52.76 9.83 -
82 1266 3.56 ±  0.73 - 12.5773 0.2188 57.48 14.42 -
83 1276 4.33 ±  0.92 - 12.9663 0.1907 67.99 20.83 -
84 1277 3.06 ±  0.65 - 11.7213 0.2150 54.52 15.66 -
85 1290 2.22 ±  0.77 - 6.5859 0.1836 35.87 - -
86 1292 2.35 ±  0.40 - 11.0989 0.1977 56.14 11.07 -
87 1295 4.13 ±  0.75 + 8.9980 0.1944 46.29 10.34 -
88 1296 3.32 ±  0.72 - 13.5110 0.2053 65.81 11.00 -
89 1297 1.98 ±  0.22 - 6.4303 0.1907 33.72 - -
90 1576 4.55 ±  1.03 + 9.8539 0.1825 53.99 17.19 -
91 1600 1.70 ±  0.24 - 5.7300 0.1852 30.94 - -
92 1759 4.54 ±  1.60 - 10.3208 0.2085 49.50 10.49 -
93 2112 1.74 ±  0.41 - 4.7184 0.2053 22.98 - +
94 2113 3.59 ±  0.89 - 13.5110 0.2053 65.81 14.35 -
95 2132 2.86 ±  0.68 ' - 12.1882 0.2145 56.82 9.62 -
96 2134 2.73 +  0.58 - 8.2199 0.2042 40.25 - -
97 2135 2.89 ±  0.90 - 8.9202 0.2172 41.07 9.69 -
98 2140 4.61 ±  1.0 + 9.8539 0.2107 46.77 20.10 -
99 2142 3.94 ±  1.10 - 8.6089 0.1890 45.55 10.05 -
100 2786 3.98 ±  1.32 - 9.6983 0.2155 45.0 21.41 -
101 12* 2.99 +  0.93 - 9.6983 0.2107 46.03 9.17 -
102 17 4.31 ±  0.94 - 8.6089 0.1879 45.82 20.32 -
103 19 4.53 ± 1 .1 2 - 8.9980 0.2177 41.33 24.91 -
104 20 4.51 ±  0.99 - 9.6983 0.2015 48.13 25.13 -
105 21 3.41 ±  0.85 + 10.9432 0.1944 56.29 14.64 -
106 33 4.58 ±  1.17 - 8.1421 0.2101 38.75 23.67 -
107 42 3.69 ±  0.63 - 8.7646 0.2150 40.77 9.98 -
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108 46 3.28 ±  0.72 - 9.3870 0.2020 46.47 9.83 -
109 58 3.49 ±  1.03 - 8.2977 0.1977 41.97 9.39 -
110 65 3.58 ±  0.63 - 7.9086 0.2172 36.41 9.54 -
±  =  Mean and standard deviation
= Negative , +  = Positive, * =  fresh isolates
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3.3 Discussion
Preliminary note
The Section discussion which follows will endeavour to discuss for each of the 
selected virulence attributes, (1) the methodology and where appropriate, the 
development of methodologies, and (2) the results obtained and their more immediate 
or obvious implications. The purpose of this is to avoid unnecessary and tedious 
repetition in Section 4, in which an attempt will be made to discuss correlations 
between mouse virulence grade and the individual virulence determinants examined 
and also their implication for the pathogenesis of P. multocida infections. Inevitably, 
this will lead to an apparent over-emphasis here on discussion of technical methods 
and the reader’s patience is requested.
3.3.1 Capsule
In the present study, the method of Butt et al. (1936) for the demonstration of the P. 
multocida capsule proved very reliable. Its simplicity makes this staining technique 
feasible for evaluating large numbers of strains. High contrast photo-micronegatives 
clearly define the capsular and bacterium domains and thus capsule zone size 
measurements can be performed with a high degree of accuracy. The closely similar 
zone size measurements obtained on different occasions (Table 11) gives an indication 
of the reproducibility of the measurement. The Duncan multiple range test revealed 
that the capsule zone sizes of P. multocida fell into 3 significant sets. Serotype A and 
D produced the largest capsule zones, type F produced a moderate size and types B 
and E produced a significantly smaller capsule zones. The high capsule size of 
serotype A is due to the presence of hyaluronic acid together with the antigenic 
capsular polysaccharide and for serotype D a different kind of mucopolysaccharide 
which could not be identified in the present study (this is discussed in detail in Section 
3.3.5). The moderate capsule size of serotype F may indicate a different kind of 
mucopolysaccharide which could not be detected by the methods used in the present 
study, but equally it could be due to a greater amount of capsular polysaccharide
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antigen. It would be worthwhile to investigate this further. It seems likely that the 
small capsule size of serotypes B and E is due to lack of capsular 
mucopolysaccharide, the only capsule substance being the type specific antigenic 
polysaccharide.
One might expect the production rate of capsule to be greatest during the earliest 
phase of culture, decreasing with age of culture. However, in this study, 
measurements of the capsule of type B at different incubation times in the same 
medium showed little difference up to 36 hours, perhaps indicating a high physical 
stability of the serotype B capsule, which may enhance survival in vitro and may 
facilitate spread of bacteria from one host to another by retarding desiccation.
A reduction in capsule dimension was observed after 36 hours incubation of YPC 
agar culture. The reason for this was not investigated, but possible explanations-each 
one capable of experimental testing-would be:
1) Detachment of a proportion of capsule material and dispersal into medium. This 
could be investigated by growing P. multocida in broth medium and followed by 
quantitative precipitation (optimal proportion) tests on the centrifuge supernatant of 
broth cultures grown for different hours.
2) Break down of capsule polysaccharide by a hydrolytic enzyme secreted by the 
bacterial cell during the stationary or decline phase of growth, following depletion of 
nutrients in the medium, the resulting mono-or oligosaccharides being assimilated by 
the resting cells. Verification of this would be difficult though not impossible and 
would entail attempting to isolate, concentrate and characterise the putative enzyme.
3) Spontaneous hydrolysis of capsular polysaccharide. This could be tested for by 
storing a cell-free capsule extract at 37°C and testing at intervals for free hexose 
sugars either by chromatography or by testing for reducing ability.
4) Colloidal shrinkage (syneresis) of capsule polysaccharide with age, resulting in a
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reduction in its water-holding (hydrophilic) capacity (this might have to be assumed 
if (1), (2) and (3) were eliminated).
3.3.2 Protein toxin
The synthesis of the protein toxin, which forms intracellularly during the logarithmic 
phase of growth and is then released into the culture medium during the late 
logarithmic and decline phase, already well substantiated, seems to be confirmed by 
the present results, although there have been differences in the reports of protein toxin 
distribution between cells and culture medium. For example, Nakai et al. (1985) did 
not find the toxin in the culture medium. Such discrepancies could be explained by 
differences in the efficiency of methods for cell lysis and detection of toxin (Chanter 
and Rutter, 1989). Nakai et al. (1985) used dermonecrosis in guinea pigs to detect 
toxin, an insensitive method compared with the test for toxin action on cultured cells 
(Chanter and Rutter, 1989). However, there is little dispute that the greatest amounts 
of protein toxin are formed in older culture supernatants (Chanter and Rutter, 1989).
Originally, toxigenic strains were differentiated from non-toxigenic strains because 
cell-free extracts were lethal for mice (Il’ina and Zasukhin, 1975; Rutter, 1983)) or 
were cytopathic for Vero cells (Pennings and Storm, 1984), EBL cells (Rutter and 
Luther, 1984) or the EBL agar overlay (Chanter et ah, 1986a). In this study, there 
was complete agreement among the results of the above assay systems for strains of 
P. multocida’, 8 strains being positive and the remainder negative. The toxin activity 
in both mouse and cell culture assays was lost completely after heating at 65°C for 
30 minutes. All evidence suggests that cell culture assay is detecting the same toxin 
as the mouse assay. However, final proof that the same toxic component is active in 
different assays will depend on purification studies.
The EBL agar overlay method was found to be most rapid among all the assays 
performed in this study (Table 14). In the EBL agar overlay, within 18 hours of 
incubation, enough toxin is produced by toxigenic P. multocida to diffuse through the 
agar, such that affected cells can be seen with an inverted microscope (Chanter et al. ,
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1986a). By comparison the preparation of filtrates from disintegrated cells was 
laborious. The production of protein toxin in culture fluids took 48 hours and 
detection of toxin on inoculation of samples took another 2-5 days i.e. the whole 
process required 4-7 days and, due to the nature of the work, the number of samples 
to be processed is limited. The agar overlay is easy to perform, more sensitive, a 
reliable method and large numbers of tests could be handled. Most importantly it has 
the potential to replace the mouse assay. This technique is well suited for 
epidemiological studies and thereby help predict virulence for animals (Chanter et al. , 
1986a).
Toxigenic strains of P. multocida commonly belong to serotype A and D and this 
appears to be confirmed by the present results. 5 were of serotype A and 3 serotype 
D recovered from sheep, pig and goat from different geographic regions. The 
aetiological significance of toxigenic P. multocida in atrophic rhinitis and pneumonia 
in pigs is well established (Il’ina and Zasukhin, 1975 ; Rutter and Rojas, 1982 ; 
Rutter, 1983 and Chanter et a l , 1986b) but the role of toxigenic P. multocida in 
species other than pigs is not known, although there is report that goats may suffer 
a natural disease equivalent to atrophic rhinitis (Baalsrud, 1987).
In the present study, 4/8 toxigenic strains of P. multocida were from sheep 
pneumonia. P. multocida is not generally regarded as among the more important 
bacterial pathogens of sheep, but is said to be present in some cases of pneumonic 
pasteurellosis (enzootic pneumonia) together with Pasteurella haemolytica, the 
primary causal agent of the condition. There is no record of such isolates of P. 
multocida ever having been serotyped. It would be interesting to attempt to make a 
collection of P. multocida isolates from enzootic pneumonia cases in sheep or lambs; 
the strains could then be examined to discover 1) their serotype and 2) what , 
proportion of them, if any, were toxigenic.
No strains of human origin were included in the collection of P. multocida under 
study, though the organism is sometimes isolated from cat or dog bite wounds and 
more rarely, from internal sepsis in man. There is no report of any human isolate
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having been tested for protein toxin production. However, cat and dog bite wounds 
in man infected with P. multocida are reported to be refractory to treatment, the 
infection often persisting for several months, and also to have a tendency to cause 
changes in underlying bone (Schipper, G. J. 1947; cited by Smith, 1959). This latter 
observation may be of importance since the toxin has been described as having 
"osteolytic" properties, this referring to the snout changes in pigs with atrophic 
rhinitis. It would be of value to examine isolates from bone infection following bite 
sepsis in man, to discover whether they produce toxin and, if so, whether it 
contributed to the pathogenesis of the bone condition.
3.3.3 Neuraminic acid
It is usual to release bound sialic acids by mild acid hydrolysis from carbohydrate 
units to which they are linked in glycoprotein, glycolipid and other complex 
molecules before chemical methods are used for their identification. In this study, 
hydrolysis of P. multocida samples was done with two concentrations of inorganic 
acids for two different times, because a greater resistance of the glycosidic bonds 
towards acid hydrolysis has been reported for O-acetylated sialic acids compared to 
the unacetylated compounds (Neuberger and Ratcliffe, 1973). The sialic acids are 
easily split-off in acid milieu and are stable in mild acid conditions as shown by the 
positive control (£. coli K1 strain). The kinetics of acid degradation was studied by 
Karkas and Chargaff (1964) who noted that sialic acids are quite stable/seating at 
100°C for 1 hour at pH 3 causing no harm.
Methods (direct Ehrlich and thiobarbituric acid) used for investigating the neuraminic 
acid of P. multocida gave consistently negative results indicating that neuraminic acid 
is absent in P. multocida. The procedure for hydrolysis and methods of detection of 
neuraminic acid was shown to be sensitive in that the positive E. coli K1 strain 
reacted in the test procedures. There is moreover, no compelling evidence in the 
literature that neuraminic acid is present in P. multocida.
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3.3.4 Neuraminidase
3.3.4.1 Assay for neuraminidase activity
Assays for neuraminidase require a procedure that detects only the free sialic acids 
released from an excess of substrate by action of the enzyme. The present studies 
used Aminoff s (1961) procedure based on the detection of free sialic acid with the 
thiobarbituric acid reagent. A number of factors are known that may interfere with 
this assay, and this possibility should be taken into account when neuraminidase 
assays are performed with unpurified enzyme preparations. In the present studies care 
was taken to include control tests in order to determine the basal value before action. 
The test and control assays were performed in duplicate and average values used to 
calculate of results; this minimised the chances of error arising from an occasional 
anomalous test or control assay. To obtain evidence that sialic acid was indeed being 
liberated from bovine maxillary gland mucin (substrate) by the P. multocida 
neuraminidase, the purified known C. perfringem neuraminidase (Sigma) was used 
as control.
A source of error with the thiobarbituric acid assay occurs if there is NAN-lyase 
activity in the test material, since the NANA released by neuraminidase action might 
be destroyed during incubation of the reaction mixture. The present studies included 
careful tests to assess this possibility and no insuperable problems were encountered. 
Sonicated extracts destroyed as much as 4.66% of the added NANA during 2 hours 
of incubation (Table 17) and there was no destruction at 10 minutes of incubation 
under conditions equivalent to those of the neuraminidase assay. This amount of 
NANA destruction would not appreciably reduce the ability of the assay to detect 
small amounts of neuraminidase. Drzeniek et al. (1972) reported higher activity of 
NAN-lyase present in cell-free culture supernatants of P. multocida.
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3.3.4.2 Production of neuraminidase by P. multocida
The present study demonstrated that P. multocida neuraminidase is cell-bound and all 
strains had measurable neuraminidase activity. This is agreement with the findings of 
others (Scharmann et ah , 1970 ; Drzeniek et al., 1972) and it appears that activity 
levels among the isolates were serotype associated. The highest was found in serotype 
A, moderate in D and F and lowest in B and E respectively. This is in agreement 
with earlier report by Drzeniek et al. (1972) who demonstrated the highest 
neuraminidase activity in serotype A and D and lowest in serotype B and E. No 
serotype F was included in their study although these authors observed high levels of 
enzyme in some untyped P. multocida. The association of neuraminidase with the 
virulence of P. multocida is discussed in Section 4.
3.3.5 Hyaluronic acid
The presence of hyaluronic acid in the capsule material of P. multocida type A, 
already well substantiated, appears to be confirmed by the present results: no strain 
of the 45 strains examined was deficient, though lyophilised stock cultures from 
various sources contained on average less than strains freshly isolated from pig lung. 
Diethyl aminoethyl (DEAE) dextran and cellulose acetate electrophoresis have 
previously been used to demonstrate P. multocida type A hyaluronic acid (Cifonelli 
et al., 1970 ; Maheswaran et al., 1973); NaCl gradient paper chromatography 
described by Manley (1965) for examination of human clinical material but not 
hitherto employed in the characterization of bacterial acidic polysaccharides, proved 
simple and reliable in use.
The failure of cross streaking with a hyaluronidase producing Staphylococcus aureus 
to produce diminution of growth of type D strains was noted also by Dejong et al. 
(1980). The indirect haemagglutination (IHA) titre (Table 21) of serotype D remains 
the same before and after testicular hyaluronidase treatment indicating that the 
capsular substance of type D is not a hyaluronic acid which interferes with the IHA 
test. On the other hand, serotype A strains can be shown to be type A only if prior
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treatment with testicular hyaluronidase is applied. Present results show however that 
capsule material from type D strains contains a substance of unknown identity which 
stains with Alcian blue and migrates under the stated conditions of NaCl gradient 
chromatography at the same rate as the hyaluronic acid of type A, yet resists 
degradation by hyaluronidase from various sources: it appears to be precipitated from 
crude capsule extract by acriflavin and may therefore be the substance associated with 
the stringy form of acriflavin agglutinability shown by type D cultures, though further 
investigation is desirable. Hyaluronic acids are described as chain polymers of 
molecular weight (MW) 2 x 105 to 9 x 106 comprising D-glucuronic acid and A-acetyl 
D-glucosamine in equimolar proportions. Meyer et ah (1956) found no chemical or 
enzymatic differences between preparations from different origins. An anomalous 
bacterial hyaluronic acid would therefore seem unlikely, but elaboration of a form 
which by mimicking host hyaluronic acid and defeated phagocytosis yet resisted tissue 
hyaluronidase could be seen as a double advantage for a parasitic organism. It is also 
possible that the type D substance is a another acidic Alcian blue positive 
polysaccharide, distinct from hyaluronic acid. Rodrignez et ah (1988a) reported the 
production of a chondroitin-like polymer by E. coli K4. Unlike chondroitin sulphate, 
which Jeanloz (1970) found to be degraded by testicular hyaluronidase, the P. 
multocida type D substance was hyaluronidase resistant; it also migrated more rapidly 
in NaCl gradient chromatography. It might nonetheless be an acidic polysaccharide, 
differing from both chondroitin sulphate and hyaluronic acid, but incapable of being 
resolved from the latter by NaCl gradient chromatography. Further study of the type 
D substance would be of much interest and it may be noted that there appears to have 
been no attempt at direct chemical analysis of any putative hyaluronic acid synthesised 
by P. multocida.
3.3.6 Hyaluronidase
In most of assays for hyaluronidase, measurement of activity involves the conjunction 
of bovine serum fractions with non-depolymerised substrate in dilute acetic acid. The 
agar plate method used in this study was found to be a rapid and sensitive technique. 
Following acidification of media containing each substrate with 2N acetic acid, +  the
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albumin produced only a faint opacity which does not interfere with the interpretation 
of a positive test. In positive cases, the produced clear zone remains stable and plates 
can be refrigerated for comparing with other strains tested at different times.
The present study confirmed that P. multocida serotype B is capable of producing 
hyaluronidase. Since gelatinase activity was not found in any of the P. multocida 
examined, they were unlikely to have false positive enzyme (proteinase) activity. 
Carter and Chengappa (1980, 1991) demonstrated hyaluronidase production only in 
serotype B cultures that had been recovered from cases of HS. In this study, 15 of 
the 16 serotype B strains were recovered either from cases of haemorrhagic 
septicaemia (HS) or from animals with a history of disease of a septicaemic nature. 
Only one strain (no. 1290) recovered from a pig (disease not known) did not produce 
hyaluronidase. The fact that type B strains produced hyaluronidase is particularly 
interesting in that these strains are highly virulent. It was surprising that no type E 
strains produced hyaluronidase (see also Carter and Chengappa, 1980) yet this 
serological variety also causes haemorrhagic septicaemia (HS) in cattle in Africa. It 
is difficult to say why serotype E do not produce any hyaluronidase. However, two 
lines of speculation, or theories, on the origin of the African haemorrhagic 
septicaemia type E Pasteurellae and their lack of hyaluronidase production are 
suggested in the General Discussion (see Section 5.4.4).
The close though not complete correlation between hyaluronidase and the ability to 
depoly merise chondroitin sulphate is puzzling. Without further proof, it is highly 
unlikely possibility that two activities are due to two separate mucopolysaccharidases 
(a hyaluronidase and a chondroitin sulphatase) because of the fact that 
mucopolysaccharidases are known to have overlapping substrate activity (Walker, 
1961). Secondly, hyaluronic acid and chondroitin sulphate are chemically close. 
Hyaluronic acid consists of A-acetyl D-glucosamine and D-glucuronic acid whereas 
chondroitin sulphate is composed of A-acetyl D-galactosamine and D-glucuronic acid 
and one sulphate group.
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Davidson and Meyer (1954) and Meyer et al. (1956) believed that chondroitin 
sulphate was resistant to hydrolytic splitting by pneumococcal hyaluronidase and one 
could suppose from this that the ability to depolymerise chondroitin sulphate relies 
on the action of two separate enzymes. However, no Gram-negative bacteria were 
included in their study. This raises the possibility that P. multocida hyaluronidase 
might be different from Gram-positive hyaluronidase. No one has previously 
examined the substrate specificity of P. multocida hyaluronidase, and in the present 
study, only one additional mucopolysaccharide, chondroitin sulphate, was available.
In this study, only one strain (no. 923; serotype could not be determined due to cross 
reactions) acted on hyaluronic acid but not on chondroitin sulphate, and it is logically 
more satisfactory to regard the results for this one strain as unexplained paradox, than 
to attempt to infer from a single observation that two enzymes exist along side each 
other in all of the remaining strains. All other positive type B strains seemed to have 
a conjoint activity and therefore, probably the same enzyme. However, final 
resolution of whether there are two different enzymes with two different activities, 
or a single enzyme with two different activities, will depend on purification of the 
enzyme (s).
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SECTION 4 
MOUSE VIRULENCE
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P. multocida has been infrequently studied for its virulence towards laboratory or 
other animals and such studies as exist have utilized a small number of strains. This 
Section investigates the variation in mouse virulence of 110 P. multocida strains 
from various sources and attempts to discover relationships between the observed 
variations and the virulence factors demonstrated in the strains, as described in 
Section 3. The strains of P. multocida used were shown in Section 2 (Table 1).
4.1 Materials and Methods
4.1.1 Approximating bacterial cfu/ml by measuring optical density
It was necessary to prepare standardized bacterial inocula for the mouse virulence 
experiments. One strain from each serotype except F was grown in 15 ml of brain 
heart infusion broth (BHIB) at 37°C for 18 hours. (At the time of this experiment, no 
serotype F strain could not be identified from the stock collection because of non­
availability of type specific antibody for F). The culture was then centrifuged (10,000 
x g for 20 minutes) at room temperature and the pellet resuspended in 15 ml of sterile 
saline. 10 fold dilutions of the suspension were made in sterile saline and the optical 
density of each measured at of 540 nm in a spectrophotometer. Estimation of viable 
cfu/ml of the corresponding bacterial suspensions was obtained by the method of 
Miles and Misra (1938). A graph of optical density versus cfu/ml was plotted for 
each serotype. In this manner different inocula could be standardized to contain 
approximately the same concentrations of bacteria. The standard curves obtained are 
given in Appendix III. (In the event, they were all so similar that it seemed 
unnecessary to allow for strain or serotype differences.)
4.1.2 Determination of mouse virulence
The method employed was based on that of Curtis and Ollerhead (1980) with 
modifications, who used a single mouse method to assess virulence of P. multocida 
(avian isolates from UK) at 24 hours post inoculation and rated virulence on a scale 
from 0 to 5 according to symptoms, presence or absence of a haemorrhagic local
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lesion, and mortality. For the present study, mouse virulence was assessed at 48 
hours post inoculation because (1) during initial studies, it was noticed that mice 
infected with moderately virulent strains, (later categorised as grade 2 virulence), 
survived more than 24 hours, and (2) this study covered isolates from wide range of 
host species, different geographic regions and of five recognisable capsule serotypes; 
thus the results might be expected to show a wider scatter than those obtainable using 
a restricted collection of e.g. avian strains.
One Swiss Sneider mouse male or female, 6 weeks old and weighing 23-25 gm was 
used to assess the virulence of each strain of P. multocida. The effect of minor 
differences in mouse size could not be controlled. The mice were derived from stock 
maintained in the Experimental Biological Unit of School of Biological Sciences, 
University of Surrey, England. The test dose in each case was 0.1 ml adjusted to 
contain approximately 106 bacteria in saline according to the optical density method 
given above (see Section 4.1.1). Intramuscular (IM) injections were made into the 
thigh. A control group was inoculated similarly with sterile saline. The mice were 
observed for 48 hours after inoculation and mortality recorded. Symptoms were 
assessed by reference to the general appearance of the mouse, including eyes and 
body coat, and its behaviour, including signs of lameness, evidence of huddling and 
the degree of mobility. By consideration of the time of death and the results of these 
symptoms an estimate of the virulence grade was assessed in accordance with the 
scheme shown below:
Virulence grade Criteria
1: Highly virulent Mouse died within 24 hours of
inoculation. Lameness on injected limb, 
reduced activity, huddling, eyes closed, 
coat raised, shaking, cyanosis of the 
extremities and respiratory distress.
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2: Moderately virulent Mouse died within 48 hours of
inoculation. The symptoms were 
similar as described for "highly virulent" 
but more pronounced.
3: Avirulent Mouse alive at 48 hour, with no
appreciable symptoms. Continued to 
to eat and behave normally.
4.1.3 Pathological observation
After the death of the mouse or at the termination of the experiment, i.e. 48 hours 
after inoculation, survivors were killed by C02 asphyxiation and autopsies performed 
on all experimental animals. They were examined for a haemorrhagic local lesion at 
the injection site and also gross changes in internal organs. Impression smears were 
prepared from the heart blood and liver of the dead mouse and stained by Gram’s 
method to confirm that deaths were associated with P. multocida infection. No 
organisms were seen in similar smears from the controls.
4.1.4 Measurement of rectal temperature of mouse
In routine mouse virulence testing, the animal’s rectal temperature was recorded (by 
means of an electronic instrument [Sensortek, model BAT-12] with the probe of the 
instrument carefully inserted 1 cm into the rectum) at 5 and 10 hours after inoculation 
and again just prior to the death or killing of the mouse. However, in some mice 
rectal temperature before death could not be recorded because they were found dead 
in the cage. The pattern of temperature following infection proved to be relatively 
consistent within each mouse virulence grade.
Though not part of the virulence screening process, it was thought worthwhile to
record the hourly changes of mouse rectal temperature throughout the course of
infection by each virulence grade (1: highly, 2: moderately and 3: avirulent) of P.
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multocida. A group of three Swiss Sneider mice for each virulence grade were 
injected intramuscularly with 106 cells of an appropriately selected P. multocida (for 
grade 1, strain no.925; grade 2, strain no. 960; and grade 3, strain no. 1027). Rectal 
temperature was recorded at approximately hourly intervals until the death of the 
mouse for highly and moderately virulent infections. In case of avirulent strain 
temperature was recorded for up to 40 hours. The temperatures of three uninfected 
Swiss Sneider mice were taken simultaneously to serve as a control.
4.1.5 Determination of phagocytosis
Five strains of serotype B, known to be highly virulent, were used to test for 
phagocytosis in 25 gm Swiss Sneider mice. Two mice were used for each strain and 
0.1 ml of a suspension containing approximately 106 bacteria was injected 
intramuscularly. Smears of the heart blood were prepared from the moribund mice 
and stained with Giemsa. Two determination were made: (1) the number of ingested 
organisms per 100 polymorphonuclear cells; (2) the percentage of polymorphs 
containing 1 or more ingested organisms.
Unfortunately, this experiment was not repeated with other serotypes.
4.1.6 Endotoxin response
C3H/HeJ mice, known to have a genetically controlled refractivity to the biologic 
effects of lipopolysaccharide (LPS) or endotoxin from Enterobacteriaceae were 
investigated in this study to determine if this genetic defect would also limit their 
response to P. multocida or P. multocida endotoxin. Male C3H/HeJ mice were 
purchased from Harlan Olac Ltd. England. They weighed 24-25 gms at the start of 
the experiment and were acclimatized for one week in the Experimental Biological 
Unit, University of Surrey, before use. A conventional strain of mouse (Swiss 
Sneider) was also used for comparison.
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4.1.6.1 Endotoxin preparation
Purified LPS of E. coli (0111: B4) was purchased (Sigma) and a heat killed (15 
minutes in a boiling water bath) suspension of a serotype B strain of P. multocida was 
used as a source of crude endotoxin. The lethal effects of purified E. coli LPS and 
P. multocida crude endotoxin were compared in groups of 3 C3H/HeJ and Swiss 
Sneider mice by IP injection of 250 mg/kg body weight of LPS in 0.5 ml saline. The 
dose of P. multocida endotoxin (also 250mg/kg body weight) was calculated by 
considering 25% of the biomass of P. multocida as LPS.
Biomass was measured by a nominal dry weight of bacterial cells. For this, a 
bacterial suspension in saline containing approximately 107 cells/ml (10* cells/0.1ml) 
was filtered through a 0.22 pm dry membrane previously weighed. The membranes 
were re-dried (for 3 and 5 minutes in a microwave oven and in a desiccator 
respectively), re-weighed and the bacterial dry weight calculated by difference. The 
mean of four replicates was taken as the biomass of 10* P. multocida. A correction 
was made for saline content.
Endotoxaemia was evaluated from symptoms: diarrhoea and the degree of mobility 
exhibited. Rectal temperature of both strains of mice was measured following 
inoculation of endotoxin.
4.1.7 Susceptibility of C3H/HeJ mouse to P. multocida infection
Three C3H/HeJ and three Swiss Sneider mice were injected with approximately 10* 
P. multocida of a serotype B (strain no. 925) intramuscularly. Clinical signs including 
rectal temperature and death time were noted. Autopsies were performed and 
impression smears were prepared from the liver and heart blood and stained by 
Gram’s method. Bacterial cultures were prepared from the liver and heart blood to 
confirm that deaths were associated with P. multocida infection.
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4.1.7.1 Bacterial recovery from tissues
The liver and spleen were removed from each dead mouse, weighed and thoroughly 
homogenised by grinding in a Griffith’s tube. Appropriate dilutions in normal saline 
were inoculated drop wise onto blood agar according to the method of Miles and 
Misra (1938) and incubated at 37°C. The plates with optimal colony numbers for 
counting were used to calculate numbers of organisms present in the liver and spleen 
per gm of tissue.
J
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4.2 Results
4.2.1 Approximating bacterial cfu/ml by measuring optical density
The standard curves from viable cfu/ml versus optical density of different serotypes 
of P. multocida except F are shown in Appendix III. The correlation coefficient (r) 
values for serotypes A, B, D and E were 0.996, 0.9985, 0.9929 and 0.9927 
respectively. All the 4 standard curve lines were parallel and statistically significant 
at the level of (P <0.001). In the light of this consistent results, for the rest of the 
strains the number of bacteria was determined from these standard graphs. For 
serotype F, standard curve for serotype B was used because it revealed from the "r" 
values that standard curves for all 4 serotypes look much same and therefore it was 
considered reasonably safe to use serotype B standard curve for F. For strains of 
undetermined serotypes standard curve for serotype B was also used.
4.2.2 Mouse virulence test
One hundred stock and ten fresh isolates were tested in mice for their virulence and 
the results are shown in Table 32. Summaries of mouse virulence in relation to 
serotype, host species and disease category are given in Tables 23, 24 and 25. Table 
23 and Fig. 21 show that nearly all serotype B and E strains were of grade 1 
virulence. The three mouse virulence grades were more evenly distributed within 
serotype A, D and F stock strains, with serotype A containing the higher proportions 
(50%) of grade 1 virulence strains. It is puzzling that the freshly isolated type A and 
D strains, which might have been expected to display greater virulence than stock 
culture, were in fact mainly of grade 3 virulence (i.e. avirulent).
In regards to host species, Table 24 shows that most strains isolated from avian 
species( 18/22), buffalo (4/4) and horse (2/2) were of grade 1 virulence. Isolates from 
other host species varied.
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Table 23. Summary of mouse virulence grade in relation to capsular serotype
for 110 strains of P. multocida
Host
Mouse virulence grade
Total no.
1: (highly 
virulent)
2: (moderately 
virulent)
3: (avirulent)
A (stock) 20 16 4 40
A (fresh) 0 1 4 5
B (stock) 15 1 0 16
D (stock) 7 7 6 20
D (fresh) 0 1 4 5
E (stock) 7 0 0 7
F (stock) 5 3 3 11
Not determined 2 2 2 6
Total no. 56 31 23 110
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Fig. 21. Summary of mouse virulence grade in relation to capsular serotype for
110 strains of P. multocida*
25
Grade 1 Grade 2 Grade 3
Mouse v i ru lence  grade
■  Type A (S) Type A (F) ■  Type B B #  Type D (S)
m  Type D (F) EZZZ1 Type E H ü  Type F ^  Not determined
(S) stock (F) fresh
* (same data as Table 23)
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Table 24. Summary of mouse virulence in relation to original host species for 110
strains of P. multocida
Host
Mouse virulence grade
Total no.1: (highly 
virulent)
2: (moderately 
virulent)
3: (avirulent)
Cattle 19 10 7 36
Buffalo 4 0 0 4
Horse 2 0 0 2
Sheep 1 4 1 6
Goat 0 1 0 1
Pig 5 8 (Stock 6) 
(Fresh 2)
10 (Stock 2) 
(Fresh 8)
23 (Stock 13) 
(Fresh 10)
Dog 0 1 0 1
Cat 0 1 0 1
Rabbit 4 2 0 6
Avian 18 2 2 22
Wild life 3 2 3 8
Total no. 56 31 23 110
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Table 25 summarises virulence grade in relation to what was known about disease 
category of the isolates. 53 strains were from disease of apparently septicaemic 
nature: the majority of these (43) were of grade 1 virulence. A much smaller 
proportion 8/27 of stock strains from respiratory tract conditions showed grade 1 
virulence.
4.2.3 Clinical signs in the mice
Considerable variation occurred in the symptoms observed, from apparent normality 
to evident sickness and immobility. Approximately 2-4 hours after infection with a 
grade 1 virulence strain the mouse became febrile and its body coat started to rise . 
From 12 hours onward the mouse demonstrated a reluctance to move and during this 
period reduction in the consumption of water and food was noticed. Slight lameness 
was observed. From 12 hours also, some of the mouse developed mild cyanosis of 
the extremities, becoming more evident shortly before death. Respiratory distress was 
observed in most of the mice at the latter stage of the disease. In some of the mice, 
crusting around the eyes and nose were observed. Mice still alive at 20-24 hour were 
very depressed and reluctant to move.
Mice infected with a grade 2 virulence strain died within 48 hours and their 
symptoms were similar to those given grade 1 virulence strains, but more 
pronounced, probably because of the longer survival time. Mice infected with a grade 
3 virulence strain remained alive at 48 hours, with no appreciable symptoms, and 
continued to eat and behave normally.
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Table 25. Mouse virulence grade of 110 P. multocida strains in relation to
supposed disease category
Supposed disease 
category*
Mouse virulence grade
Total no.
1: (highly 
virulent)
2: (moderately 
virulent)
3:(avirulent)
Septicaemic 43 8 2 53
Respiratory 8 15 (Stock 13) 
(Fresh 2)
14 (Stock 6) 
(Fresh 8)
37 (Stock 27) 
(Fresh 10)
Localized 1 1 3 5
Disease not 
known
4 7 4 15
Total no. 56 31 23 110
* Note: the information recorded for many strains was poor and allocation to a category is therefore 
not folly reliable
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4.2.4. Pathological observations
On necropsy some gross pathological changes were evident. Mice which died within 
24 hours (grade 1) usually had a small haemorrhagic oedematous lesion at the 
inoculation site. The degree of haemorrhagic oedema was much more extensive in 
mice which died 24-48 hours of inoculation (grade 2). In some of these, the injected 
limb was grossly swollen. A small area of congestion without oedema was seen in the 
musculature at the inoculation site of avirulent strains. An attempt was made to score 
the severity of the haemorrhagic local lesion on a 1, 2, 3 basi s and complete values 
are listed in Table 32, but no further use was made of these scores.
Other pathological changes comprised by splenomegaly with congestion, and slightly 
congested livers. The lungs were congested following infection with grade 1 and 
grade 2 strains. With grade 3 (i.e.avirulent) infection, the lungs were unaffected. The 
gall bladder and urinary bladder were usually distended in infection with grade 1 and 
grade 2 strains.
4.2.5 Measurement of rectal temperature of mouse
The temperature response in groups of 3 Swiss Sneider mice following infection with 
three mouse virulence grade of P. multocida is shown in Fig. 22. The temperature 
response in mice differed according to virulence grade. The grade 1 virulence strain 
caused a pyrexia which began 2-4 hours after infection and increased to 38.5°C at 7-8 
hours; the temperature then fell to below normal and continued to fall until death at 
17-18 hours. The grade 2 virulence strain caused a more slowly developing pyrexia 
which did not peak until 22-24 hours after infection, after which the temperature fell 
to below normal, until death. The avirulent (grade 3) strain had almost no effect on 
temperature apart from an almost imperceptible rise at about 10-12 hours. The mean 
temperature of normal Swiss Sneider mice was 37.17 ±  0.12 in the morning, 37.3 
±  0.08 in mid day and 36.98 ±  0.09 in mid night respectively.
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Fig. 22. Patterns of temperature response in mice following infection with P. 
multocida of grade 1, grade 2 and grade 3 virulence
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4.2.6 Phagocytosis determination
The phagocytic activity of mouse polymorphs on 5 strains of P. multocida type B is 
shown in Table 26. Only 15.76 ±  3.24% polymorphs from moribund mice blood 
showed phagocytosis and the mean phagocytic index was 27.5 ±  3.98. Thus, almost 
all organisms remained non-cell associated throughout the infection and it would seem 
that P. multocida serotype B is remarkably resistant to phagocytosis by mouse 
polymorphs. Unfortunately, this part of the work was carried out as a pilot study in 
the early stages, and the interesting nature of the results was overlooked until it was 
too late to repeat with other serotypes. It seems however likely that the resistance of 
type B strains to phagocytosis by mouse polymorphs must be connected with the 
regular grade 1 virulence shown by other strains.
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Table 26. Phagocytic activity of mouse polymorphs on 5 strains of P. multocida
serotype B
Strain no. Phagocytic index* % of polymorphs showing phagocytosis
875 30.5 ± 4.94 14.19 ± 2.35
925 21.5 ± 6.36 16.25 ±  5.30
976 29.0 ± 4.24 21.11 ± 1.56
1080 25.5 ± 2.12 12.69 ± 2.24
1081 31.0 + 2.24 14.58 ± 2.94
Mean 27.5 ± 3.98 15.76 ± 3.24
* Phagocytic index:- numbers of organisms ingested per 100 polymorphs.
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4.2.7 P. multocida endotoxin
As endotoxin is heat stable, it was thought sufficient to use a heat killed suspension 
of P. multocida as a crude endotoxin preparation, though it was appreciated that cell- 
bound endotoxin might not have the same effect as a cell-free endotoxin extract. The 
calculated biomass of 106 bacteria was 25 ±  1.25 /zg and considering 25% biomass 
as LPS, the equivalent dose of 250 mg/kg body weight was approximately 1010 
bacteria which was measured from standard graph of serotype B (Appendix III). The 
assumption of 25% LPS content was largely conjecture, but was considered a 
sufficiently safe estimate having regard to the accuracy of other parts of the 
experiment.
4.2.8 Response of endotoxin in C3H/HeJ and Swiss Sneider mice
The results of injection of E. coli (0111: B4) and P. multocida crude endotoxin is 
shown in Table 27. As expected, E. coli LPS was without lethal effect on C3H/HeJ 
mice at doses 250 mg/kg body weight but all Swiss Sneider mice died. The heat 
killed P. multocida suspension calculated to contain the same weight of LPS was 
entirely non-lethal to either strain of mouse.
With E. coli endotoxin, C3H/HeJ mice developed slight diarrhoea within one hour 
of inoculation but recovered 3-4 hours later. During this period, their rectal 
temperature fell slightly (Fig. 23) but returned to normal about 8 hours after 
inoculation and they regained spontaneous activity. In case of Swiss Sneider mice, 
hypothermia developed within an hour of inoculation of E. coli endotoxin and the 
temperature continued to fall until death (Fig. 23). The drop in temperature was 
accompanied by clinical signs (depression, reluctance to move, huddling and cessation 
of spontaneous activity). The Swiss Sneider mice also developed slight diarrhoea 
within hour of inoculation and 3-4 hours later became non-diarrhoeic. Clinical signs 
persisted until the death of all mice. On necropsy, no appreciable changes were 
noticed other than a slight splenomegaly.
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Table 27. Susceptibility of C3H/Hej and Swiss Sneider mice to E. coli (0111: B4) 
and P. multocida endotoxin
Inoculum Dose of endotoxin Mouse strain (died/total)
(intraperitoneal) (mg/kg body wt.)
C3H/HeJ Swiss Sneider
E. coli 
endotoxin
250 0/3 3/3
P. multocida 
heat killed cells
250 0/3 0/3
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Fig. 23. Patterns of temperature response in C3H/HeJ and Swiss Sneider mice
following intraperitoneal inoculation of E. coli endotoxin
(normal mouse body temp.)
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With P. multocida crude endotoxin, rectal temperature fell for four hours in both 
strains of mouse (C3H/HeJ- 36.8 ±  0.25; Swiss Sneider-36.0 ±  0.20°C) but returned 
to normal by 6-7 hours and 12-15 hours in C3H/HeJ and Swiss Sneider mice 
respectively (Fig. 24). Slight diarrhoea developed in both strains of mice within 2 
hours of inoculation but they became non-diarrhoeic after 4-6 hours. During the brief 
hypothermic period, the mice were disinclined to move but they regained spontaneous 
activity after the temperature returned to normal. No other abnormality was noticed. 
All mice were killed after 48 hours by CO2 and on necropsy no changes were seen 
in internal organs of either strain of mouse, except slight splenomegaly, and no 
bacteria were recovered following culture from liver and heart blood on blood agar.
4.2.9 Susceptibility of C3H/HeJ mice to P. multocida infection
All three C3H/HeJ mice died at a dose of 106 bacteria intramuscularly and their mean 
time to death was 14.33 ±  0.57 hours. Conventional Swiss Sneider mice also died 
but with a slightly greater mean death time of 17.66 ±  1.15. Pyrexia developed in 
both strains of mice following inoculation of virulent P. multocida and afterwards 
the usual fall in temperature commenced, followed by death (Fig. 25). The mice of 
both strains showed raised body coats, respiratory distress, depression and reluctance 
to move and they offered little resistance and were easily caught.
4.2.9.1 Gross pathology of C3H/HeJ mice
On necropsy of the C3H/HeJ mice, gross pathological changes were characterized by 
splenomegaly and slightly congested lungs and livers. All mice had a small 
haemorrhagic oedematous lesion at the inoculation site.
The mean numbers of P. multocida present in spleen and liver of both strains of 
mouse are shown in Table 28 and were approximately the same. No organisms were 
cultured from the mice from the control groups.
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Fig. 24. Patterns of temperature response in C3H/HeJ and Swiss Sneider mice
following intraperitoneal inoculation of P. multocida endotoxin
(normal mouse body temp.)
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Fig. 25. Patterns of temperature response in C3H/HeJ and Swiss Sneider mice
following infection with a serotype B P. multocida, (strain no. 925)
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Table 28. Viable counts of P. multocida (serotype B) in spleen and liver of 
infected C3H/HeJ and Swiss Sneider mice at time of death
Mouse strain Ciu/gm of tissue (log 10)
Spleen Liver
(n — 3)
0
0
1
#
0
1
I
S
C3H/HeJ 9.47 ± 0.06 9.17 ± 0.08
Swiss Sneider 9.43 ± 0.03 9.14 ± 0.07
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4.2.10 Correlation between virulence determinants and mouse virulence grade
In the following sub-sections, an attempt has been made to analyse the relationship 
of virulence determinants described in Section 3 to the mouse virulence grades 
described in the present Section.
4.2.10.1 Size of the capsule zone
The mean capsule size (randomly selected) for strains of mouse virulence grades 1, 
2 and 3 (i.e. highly, moderately and avirulent) of P. multocida according to serotypes 
is shown in Table 29. Analysis of variance showed that for serotype A there was a 
significant difference (F=4.11, P < 0.05): unexpectedly, the high-virulence (grade 
1) strains had smaller capsules, and the avirulent (grade 3) strains, the larger. There 
was no significant difference in capsule zone size of mouse virulence grade of 
serotype D (F= 1.42, P > 0.05) and serotype F (F= 0.62, P > 0.05).
The Duncan multiple range test was then used to confirm which means of capsule 
zone size of mouse virulence grades of serotype A were significant. The result 
obtained is conveniently expressed as follows:
1: HIGHLY VIRULENT 2: MODERATELY VIRULENT 3: AVIRULENT
Any virulence grades not underscored by the same line are significantly different, i.e. 
the mean capsule size of avirulent strains of serotype A was significantly larger than 
highly virulent strains. Although there was a difference between avirulent and 
moderately virulent, and moderately and highly virulent strains, it was not 
significant.
It was not possible to check the difference in capsule zone size among the three 
mouse virulence grades of serotypes B and E by analysis of variance because these 
two serotypes contained predominantly highly virulent (grade 1) strains. However,
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Table 29. Comparison of the mean capsule zone size of randomly selected strains 
of P. multocida of three mouse virulence grades and known capsule 
serotype
Serotype Mouse virulence grade
1: (highly virulent) 2: (moderately virulent) 3: (avirulent)
A 3.41 ± 0.61 
(n =  20)
3.68 ± 0.68 
(n = 17)*
4.14 ± 0.44
(n = 8)*
B 1.78 + 0.23 
(n = 15)
2.22 ± 0.77 
(n =1)
-
D 3.20 ± 0.26 
(n = 7)
3.62 ± 0.55 
(n = 8)*
3.32 ± 0.55 
(n = 10)*
E 1.92 ± 0.19 
(n = 7)
- -
F 2.60 + 0.15 
(n = 5)
2.69 + 0.15 
(n = 3)
2.47 ± 0.42 
(n = 3)
* includes both fresh and stock isolates.
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further inspection of the data given in Table 29 suggests that the phenomenon found 
in type A strains, whereby the mean capsule size was inversely related to virulence 
grade, may not be found in other serotypes. The type D and F strains (for which 
strains of all 3 virulence grades were available) appear to have much the same capsule 
size, irrespective of virulence grade. It is tempting to suppose that the more highly 
capsulated, avirulent type A strains owe their larger capsule size to greater content 
of a substance associated with colonizing ability for the mucous surfaces of the 
natural host, rather than with virulence for the non-natural species, the mouse; and 
that this substance could be the capsular hyaluronic acid.
4.2.10.2 Protein toxin
All 8 strains which produced the protein toxin (5 from serotype A and 3 from 
serotype D) were of grade 2 virulence, suggesting that this toxin, despite its well- 
documented lethality for mice, is not the principal factor involved in the rapid 
lethality of live cultures of grade 1 for mice.
4.2.10.3 Neuraminidase
The mean specific neuraminidase activity for strains (known capsule serotype) tested 
of the three mouse virulence grades (grade 1, 2 and 3) is given in Table 30. An 
analysis of variance in specific neuraminidase activity of three virulence grades of 
serotypes A, D and F showed that in all three serotypes the difference was indeed 
significant (F value for serotype A= 40.90 ; for D = 12.12 and for F =  16.74) at the 
level of (P < 0.01). The result of the Duncan multiple range test was:
1: HIGHLY VIRULENT 2; MODERATELY VIRULENT 3: AVIRULENT
Any mouse virulence grade not underscored by the same line are significantly 
different i.e. grade 1 strains expressed significantly higher specific neuraminidase 
activity than grades 2 or 3, but there was no significant difference between grades 2 
and 3.
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Table 30. Comparison of the mean specific neuraminidase activity (mUnit/mg of
protein) of selected P. multocida strain of three mouse virulence grades
and known capsule serotype
Serotype Mouse virulence grade
1: (highly virulent) 2: (moderately virulent) 3: (avirulent)
A 60.67 ± 6.79 
(n = 20)
45.12 ± 6.90 
(n = 17)*
39.48 ± 8.88 
(n = 8)*
B 30.30 ± 4.49 
(n = 15)
35.87 ± 0 
( n = l )
-
D 52.64 ± 4.79 
(n = 7)
41.47 ± 5.38 
(n = 8)*
37.87 ± 7.47 
(n = 10)*
E 32.45 ± 3.08 
(n = 7)
- -
F 47.49 ± 0.90 
(n = 5)
35.09 ± 3.19 
(n = 3)
37.14 ± 5.58 
(n = 3)
* includes both fresh and stock isolates.
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4.2.10.4 Hyaluronic acid equivalence
The term "hyaluronic acid equivalence" is chosen because the turbidometric method 
employed for determination of hyaluronic acid (Seastone method 1943, modified) was 
not specific for hyaluronic acid but detected also the unidentified hyaluronic acid-like, 
hyaluronidase resistant substance of type D. Hyaluronic acid equivalence (^tg/ml) of 
strains of serotypes A and D of various mouse virulence grades is presented in Table 
31. Using an analysis of variance, the mean hyaluronic acid equivalence of serotype 
A strains was significantly different (F= 7.62) at the level of (P < 0.01) in the 3 
mouse virulence grades. The Duncan multiple range test was then used to determine 
which mean differences were significant and the results are conveniently expressed 
as follows:
1: HIGHLY VIRULENT 2: MODERATELY VIRULENT 3: AVIRULENT
Any two mouse virulence grades not underscored by the same line are significantly 
different. The avirulent grade 3 showed significantly higher hyaluronic acid 
equivalence than grades 1 or 2. There was no significant difference between grades 
1 and 2. It will be recalled that the grade 3 (avirulent) strains were the ones that 
showed significantly larger capsule zones (see under 4.2.10.1).
It was therefore thought essential to check correlation between the amount of 
hyaluronic acid and the corresponding capsule zone size of serotype A. A Spearman 
rank correlation coefficient test was used to determine the relationship between the 
capsule zone size of all 45 (40 stock +  5 fresh) serotype A strains and their 
corresponding hyaluronic acid equivalence (jug/ml) and it was found that the 
correlation (RS= 0.8256 at 43 degrees of freedom, P <0.001) was highly 
significant. Since type A strains did not contain the hyaluronic acid-like compound 
of type D, it may be concluded that the substance conferring larger capsule 
dimensions on avirulent type A strains is indeed hyaluronic acid itself.
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Table 31. Comparison of the mean of hyaluronic acid equivalence (pg/ml) of 
P. multocida serotype A and D strains of three mouse virulence grades
Serotype Mouse virulence grade
1: (highly virulent) 2: (moderately virulent) 3: (avirulent)
A 13.90 ± 3.39 
(n = 20)
16.34 ± 4.83 
(n = 17)*
20.62 ± 4.30 
(n = 8)*
D 9.88 ± 0.43 
(n = 7)
9.85 ± 0.48 
(n = 8)*
7.87 ± 4.16 
(n = 10)*
* includes both fresh and stock isolates.
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An analysis of variance on the hyaluronic acid equivalence of serotype D strains of 
the three mouse virulence grades showed no significant difference (F = 1.55, P 
>0.05).
4.2.10.5 Hyaluronidase
Nearly all strains of serotype B produced hyaluronidase and all of these were of grade 
1 virulence (highly virulent for mice). One strain (no. 1290) isolated from a pig, did 
not produce hyaluronidase and was of grade 2 virulence (moderately virulent) for 
mice. Strain 923 which could not be typed due to cross reactions possessed 
hyaluronidase and was highly virulent for mice; (it may be observed that this was the 
only hyaluronidase positive strain in the collection which failed to show concomitant 
clearing around growth in the medium containing chondroitin sulphate).
4.2.11 Strain-by-strain data
For reference, and to allow checking of other tabulations, the complete data for the 
whole collection of 110 isolates are given, strain-by-strain, in Table 32. This Table 
gathers together all of the information on serotyping, analysis of virulence attributes 
(capsule size, protein toxin, neuraminidase, hyaluronic acid and hyaluronidase 
detection) and mouse virulence (grade and haemorrhagic local lesion score) for all of 
the strains. Table 32 is not discussed further, since all of its points of interest are 
subsumed in preceding tabulations.
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4.3 Discussion
4.3.1 Virulence of P. multocida for mice
4.3.1.1 Measurement of virulence in mice
The picture of disease following administration of virulent P. multocida has been well 
documented in mice but there is no absolute criterion for grading of mouse virulence. 
The results of mouse virulence based on mortality in mice suggests that there is 
considerable variation of virulence among isolates of P. multocida. All strains of 
serotype B (except one) and E regardless of their hosts and geographic origin were 
of grade 1 virulence. Strains of serotypes A, D and F varied from grade 1 to grade 
3. However, it is apparent that a number of strains are not capable of multiplying to 
the crucial disease-producing number and these strains produce no local infection 
when injected intramuscularly and neither is there systemic illness. Such strains may 
be regarded as avirulent. A second group of strains cause local infection at the 
injection site followed by gradual systemic infection leading eventually to collapse and 
death. These strains may be considered as moderately virulent. Third group of 
strains, clearly highly virulent, produce rapid systemic clinical symptoms leading 
rapidly to the acute phase of the illness and death. These three mouse virulence 
grades correspond to different temperature responses (Fig. 22) in the mouse, which 
tends to give additional credence to the grading system. However, comparison of the 
abilities of strains to produce disease in the mouse gives only an indication of high 
or low virulence for that animal and not a complete picture for the natural host. It 
should be borne in mind that solid evidence depends on experiment with the natural 
hosts.
The term "experimental animal model" (or "laboratory animal model" or "disease 
model") has enjoyed a vogue which may not be entirely conducive to scientific 
understanding. No definition of the term can be found. A model is "a representation 
created for the purpose of studying, in a simplified and usually smaller form, a larger 
or more complex structure or system". This definition, drawn with modification from
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the Collins Dictionary of the English Language, applies to both physical and 
mathematical forms of model. The weakness of the so called "model" which purports 
to study a natural disease by discovering a laboratory animal in which a superficially 
similar condition can be induced by the same agent, is that although it makes study 
easier and cheaper, it achieves no real simplification and thus fails to satisfy the 
primary role of a model. It attempts to represent a complex biological system (the 
interaction of disease agent and natural host) by another equally complex one (the 
same agent’s interaction with another host which, though physically smaller, is not 
simpler in its responses). A small degree of control is achieved by ability to 
determine the manner in which the infective agent and the host are brought together: 
thereafter, events take their course and the pathogenesis of the experimental condition 
is no less complex than that of the natural one, and probably different in unperceived 
ways. The use of the laboratory animal in fundamental disease studies is probably 
safest when a particular, defined aspect of pathogenesis is addressed, as for example 
the use of guinea pigs in mycobacterial research where the role of the macrophage 
is of key importance; and of mice in scrapie research where attention is focused on
(1) brain histopathology and (2) strain related variations in incubation period. In 
neither instance does the overall disease in the laboratory animal bear more than a 
broad resemblance to that in the natural hosts. The most that can be expected of the 
laboratory animal "model" is that it should mirror one small aspect of pathogenesis 
in the natural disease: for study of the disease itself there can be no complete model 
other than captive experimental animals of the natural host species.
The mouse cannot be considered a satisfactory "model" for studying pasteurellosis, 
a condition showing considerable variation in its different natural hosts from the 
chronic subclinical pneumonia seen in enzootic pasteurellosis in pigs to the acutely 
fatal and highly transmissible haemorrhagic form occurring in cattle in the tropics. 
The mouse shows essentially one reaction only: fatal septicaemia, and this is seen 
only when organism is introduced artificially by injection. The mouse is not even an 
adequate model for the latter form of pasteurellosis, haemorrhagic septicaemia, for 
reasons which include the following:
188
(1) The pathological changes in infected mice are congestive, not haemorrhagic. The 
characteristic petechial haemorrhages below serous and mucous membranes and 
haemorrhagic discharges which distinguish the disease in cattle and buffaloes are 
never found in mice.
(2) Oedema, a common feature in bovine haemorrhagic septicaemia, is not seen in 
experimentally infected mice.
(3) Haemorrhagic septicaemia, once an outbreak in cattle has gained momentum, is 
highly contagious; the experimental disease in the mice is not in the slightest degree 
so. Non-infected mice remain healthy even if placed in the same cage as moribund 
mice or with the bodies of animals which have succumbed.
(4) The carrier state, considered to be essential for the perpetuation of haemorrhagic 
septicaemia between outbreaks in cattle or buffaloes, cannot be induced in mice.
(5) The condition in mice occurs only when the organism is injected. Inhalation and 
ingestion, the natural methods of transmission in cattle, are relatively ineffective in 
mice: aerosol infections can be set up but require high dosage, feeding produces no 
result.
Although it is difficult to postulate what aspect of P. multocida virulence is actually 
being measured by the mouse virulence grade, it is probably little more than a 
measurement of the ability of the strain, following injection (which bypasses body 
surface defence mechanisms), to give rise to septicaemia. This in turn is likely to 
resolve into:
1: ability to evade phagocytosis by mouse cells, and thus multiply;
2: ability of the multiplying bacteria to produce a lethal form of 
endotoxin at a rate sufficient to overwhelm whatever mechanisms 
the animal may have for its removal or detoxification.
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Despite its simplicity, the above two-part hypothesis did not suggest itself until an 
advanced stage of the present work and it is particularly unfortunate that the potential 
significance of the observation (made quite early on) that mouse neutrophils seemed 
rather ineffective in phagocytosing P. multocida serotype B, was not realised until it 
was too late to set up a fuller investigation. This aspect - which has been likewise 
neglected in most published studies on P. multocida virulence - certainly merits a 
renewed effort. Some attention was given to the possible role of P.multocida 
endotoxin, and this is described in a following sub-section. The main approach to 
elucidating the nature of the mouse virulence of P. multocida was by attempting to 
find correlations between virulence grade and the individual chemical virulence 
determinants examined: these will be discussed in detail.
4.3.1.2 Temperature response and hypothermia
As has been mentioned, each mouse virulence grade of P. multocida produces its 
distinctive pattern of temperature response (Fig. 22). In highly (grade 1) and 
moderately virulent (grade 2) infections pyrexia is followed by severe hypothermia 
and death. In avirulent (grade 3) infection, there is mild rise in temperature followed 
by normal temp.. A rise in body temperature is one of the most frequent and familiar 
responses to infection. The precise reason for these distinct patterns of fever with P. 
multocida infection is difficult to determine. According to Mims (1987) the 
temperature rise in infectious disease is largely due to an increase in heat production 
and the raised metabolic rate, together with reduced food intake. In infectious diseases 
there is a common mediator of the febrile response known as endogenous pyrogen 
(Interleukin 1) released by macrophages and polymorphs. It is present in 
inflammatory exudates and in the plasma during fever and acts on the temperature- 
regulating centre in the hypothalamus, resetting the body thermostat.
The development of hypothermia in mice at the latter stage of virulent P. multocida 
infection suggests a role of endotoxin in the latter stage of infection because in both 
strains of mice (C3H/HeJ and Swiss Sneider) hypothermia developed following 
inoculation of endotoxin. There is no evidence that would enable one to judge
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whether this hypothermia is some direct effect of endotoxin on the hypothalamus, or 
merely the result of cessation of bodily movement in a sick or moribund mouse. 
Small quantities of endotoxin may be released in soluble form during bacterial growth 
but for the most part they remain associated with the cell wall until the death and 
disintegration of bacteria and are likely to exert pathogenic effect only in the later 
stages of septicaemia (Mims, 1987; Rutter, 1988).
Little is known about the effect of hypothermia on mice but it is possible that the 
severe hypothermia shown in the present work to ensue from virulent P. multocida 
infection in mice may hasten or even cause the animal’s death. Blair (1964) described 
the greater adverse effects of hypothermia in humans and dogs as follows. In 
hypothermia an oxygen deficit occurs which causes a reduction in the metabolism of 
carbohydrates. The heart rate falls progressively with cooling. The cardiac output is 
low mainly because of a venous return. The effect of hypothermia on the lungs is 
most important. Ventilation is among the first functions to be depressed and death is 
often attributable to respiratory failure. During hypothermia, the pulmonary bed 
becomes more and more distended and adverse consequences such as pulmonary 
oedema and haemorrhage are common. These adverse consequences of hypothermia 
could possibly account for some of the symptoms and lesions produced in mice during 
infection. However, it was not a purpose of the present study to investigate the 
adverse consequences of hypothermia in mice and despite the disadvantage of the 
small size of the animal, this could be an interesting peripheral area for future study 
in elucidation of pathogenesis of virulent P. multocida infections.
4.3.1.3 The local haemorrhagic lesion in mice
The cause and significance of the local haemorrhagic oedematous lesion at the 
intramuscular injection site in mice is unknown. It occurred with both virulence grade 
1 and grade 2 strains and was probably more marked in the latter because of their 
longer survival time. Ronnenberger (1974) showed that subcutaneous or intramuscular 
injection of purified V.cholerae neuraminidase into rabbit or guinea pigs produced 
transient localized inflammatory signs.
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The haemorrhagic nature of the mouse local lesion may however be of greater 
significance than would appear at first sight. The principal pathological change 
observed in cattle which have died of haemorrhagic septicaemia is naturally enough, 
haemorrhage, taking the form of petechial extravasations in all parts of the body, but 
mainly visible below serous and mucous membranes. This must be a direct toxic 
effect on capillary endothelium. The absence of corresponding haemorrhages in mice 
dead from septicaemic P. multocida infection is curious. Perhaps the mouse is too 
small an animal for haemorrhages to be visible macroscopically; one might have to 
resort to histological examination. Another possibility is that the concentration of 
toxin (which might be endotoxin or another substance) in the blood necessary to lead 
to capillary damage and haemorrhagic is higher, in the mouse, than the concentration 
necessary to kill it: thus, the mouse dies before the threshold concentration necessary 
for generalised haemorrhage is ever reached. In this case, the injection site 
haemorrhage is interesting, because it signifies that for a while after the injection the 
local concentration of toxin is sufficient to cause capillary endothelial damage. Thus, 
the only point in the experimental mouse at which the haemorrhage, so characteristic 
of natural haemorrhagic septicaemia, is seen, is the injection site. A useful experiment 
would be to inject a very large dose of live virulence grade 1 P. multocida 
intravenously into a mouse, and kill it a few hours later. If the foregoing hypothesis 
is correct, it would show at autopsy widespread multiple haemorrhages mimicking 
those found in natural haemorrhagic septicaemia.
4.3.1.4 Endotoxin
Purified E. coli endotoxin at the dose of 250 mg/kg body weight killed Swiss Sneider 
mice within 24 hours but endotoxin hypo-responsive C3H/HeJ mice were totally 
resistant to same dose. The C3H/HeJ mouse strain is well known for its unusually 
low response to most LPS preparations of E. coli (Pier et a/., 1981). The large dose 
of purified of E. coli endotoxin could probably overwhelm the mouse detoxification 
and reticulo-endothelial (RE) system and ultimately cause death. The crude P. 
multocida endotoxin (heat killed whole cells) in doses calculated as the same killed 
neither C3H/HeJ or Swiss Sneider mice. Some symptoms suggestive of endotoxin
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poisoning did appear in both strains of mice and the initiation of hypothermia 
coincided with diarrhoea and signs of depression. However, in disease, the endotoxin 
released ("natural endotoxin") is probably a mixture or complex containing not only 
LPS but also capsular polysaccharide, LS-associated proteins and perhaps also outer 
membrane proteins. The biological activity of in vivo released endotoxin may be 
different from endotoxin produced by laboratory culture and the effect of cell-bound 
endotoxin may be different from that of free endotoxin released from the bacterial 
cells.
The dynamics of production, release, effect and destruction of endotoxin during the 
course of an infection, whether natural or experimental must be very complex, due 
to the large number of factor involved, and mutual interactions. Factors involved in 
the rate of toxin build up in body fluids (rate of increase of bacterial biomass, rate 
of formation of endotoxin by biomass, rate of release of free endotoxin, rate of death 
of bacteria) would themselves be moderated by host’s defensive factors. The 
defensive factors (rate of phagocytosis and intracellular destruction of bacterial cells, 
rate of detoxification of endotoxin by tissues including liver, rate of uptake of 
endotoxin by reticulo-endothelial cells such as Kupffer cells of the liver and other 
macrophages) would themselves be moderated by the presence of endotoxin: for 
example, (1) liver function would doubtless be progressively impaired; (2) the ability 
of host cells to take up endotoxin must slow as saturation point is neared. 
Presumably, death occurs when the free endotoxin level in body fluids rises above a 
threshold and is maintained for a certain period; or, in hypothermic death, when the 
body temperature falls below threshold and continues so, for a certain period. 
Investigation of the endotoxin formation/action/destruction system by direct 
experiment would be a formidable task. A different approach, and one which it could 
be highly interesting to try, would be to attempt to set up a series of mathematical 
(computational) models of the system, of increasing complexity, with only a few of 
the parameters determined initially by experiment, the remainder being added one by 
one and investigated by computation (re-iterative optimisation) to obtain a fit which 
approximated to what was known or expected. With some adjustments, such a model 
might be useful for explaining other similar systems: for example the dynamics of
endotoxin release/action/elimination in the intestine during Gram-negative enteric 
infections.
C3H/HeJ mice are as susceptible to virulent P. multocida infection as other strains 
of mouse; all deaths occurred with a mean time of 14.33 ± 0 .5 7  hours of inoculation 
with a very rapid clinical course, which was similar to the results observed in Swiss 
Sneider mice. High fever followed by severe hypothermia ultimately leading to death 
of all mice, was a common feature with both mouse strains. The results of cfu counts 
(Table 28) show that bacteria proliferate to the same extent in both strains of mice 
and reach lethal levels when the bacterial load in the liver and spleen is approximately 
109 cfu/gm of tissue. It is interesting that C3H/HeJ mice, though resistant to E. coli 
endotoxin, are susceptible to infection with P. multocida as Swiss Sneider mice. Vas 
et al. (1973) compared several strains of mice for susceptibility to infection with 
Klebsiella as well as to endotoxin. They observed that the C3H/HeJ strain was highly 
endotoxin resistant but, surprisingly, the least resistant to the infection and they 
concluded that these two traits are inherited separately. Very similar results to those 
of Vas et al. (1973) were reported by Van Jeney et al. (1977) following infection 
with Salmonella typhimurium. The C3H/HeJ mice were by far the more susceptible 
strain in comparison with the other strains examined. In contrast, Sultzer and 
Goodman (1977) found C3H/HeJ mice to be significantly more resistant to E. coli 
infection than A/HeJ mice. It would thus appear that relative resistance may depend 
upon the type of infecting organisms. This concept has been discussed by Morrison 
and Ryan (1979) who were able only to conclude that resistance to lethal effects of 
endotoxin does not necessarily confer upon the mouse strain an equal resistance to 
Gram-negative infection.
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4.3.2 Correlation between virulence determinants and mouse virulence
Experiments to elucidate the role of possible virulence determinants frequently involve 
a comparison between strains possessing the virulence factor and mutant strains from 
which the factor is absent. This approach has the advantage that the only difference 
between the strains should be presence or absence of the factor under investigation.
It is however, not always certain that a strain displaying only the single, desired 
mutation has been selected and, since only small numbers of strains are investigated, 
the ability of strains to compensate for one deficiency by the increase in importance 
of other characteristics cannot be assessed. The approach reported in this study was 
different: a large number of strains were examined and attempts made to relate their 
virulence to the frequency of expression of virulence attributes. Since not all the 
characteristics of the strains could be studied many of their deficiencies remain 
unknown, and may also relate to virulence. This criticism is however equally true of 
other approaches. The next sub-section contains a discussion of the correlation 
between the virulence determinants and the mouse virulence.
4.3.2.1 Capsule zone size
In the present study, it was clear that all mouse avirulent (grade 3) strains of serotype 
A had significantly larger mean capsule zone size than the mean values for the 
virulent strains (Table 29). Half of the avirulent strains were freshly isolated from 
apparently healthy slaughter house pig lung in which the organism is possibly doing 
little more than colonizing an area of lung already damaged by virus or mycoplasma. 
These large capsules appeared to owe their size to possession of more hyaluronic 
acid. Biologically, hyaluronic acids are relatively inert and possession of hyaluronic 
acid in addition to antigenic polysaccharide in the capsule could constitute a 
significant advantage for survival of P. multocida by providing protection from serum 
killing and surface phagocytosis in the host. Maheswaren and Thies (1979b) 
demonstrated that P. multocida having hyaluronic acid capsule are relatively resistant 
to phagocytosis to normal serum. The capsular hyaluronic acid was non antigenic and 
moreover, impaired the antigenicity of the type-specific polysaccharide capsule
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antigen, as was observed during production of capsule antibody against serotype A 
in rabbits (Section 2). P. multocida type A capsular hyaluronic acid appears never to 
have been examined by analytical chemistry but must be presumed to be closely 
similar to the hyaluronic acid moieties found in connective and other tissues of 
mammals (Jeanloz, 1970) since it is susceptible to hyaluronidase. Even if the identity 
is partial, the capsular hyaluronic acid of P. multocida type A might by mimicking 
host polysaccharide, avoid immune recognition of itself and also impair recognition 
of contiguous molecules of the type A specific capsular antigen. Effective 
opsonization of encapsulated bacteria requires specific anti-capsular antibody. In this 
context, failure of the production of antibody would obviously be an advantage to the 
organism, since cells would not be cleared from the host tissues by opsonization and 
phagocytosis. It is likely that serotype D strains also, by virtue of their large size 
capsules and impaired immunogenicity of capsular antigen remain protected in the 
host. It has been demonstrated by Anderson et al. (1984) that strains of serotype D 
are resistant to intracellular destruction by rabbit polymorphonuclear neutrophil 
(PMN) but no reason for this could be found.
It is possible that capsule antigens of serotypes B and E (which have small capsules), 
may be qualitatively different from those of serotypes A, D and F, perhaps more anti­
phagocytic. The striking low phagocytic index found in mouse polymorphs following 
serotype B infection suggests that this might be the case (Table 26).
Although knowledge of the role of the P. multocida capsule in the pathophysiology 
of disease is accumulating, the chemical structure, synthesis and genetics of the 
polysaccharide antigen production remain yet to be elucidated. An integration of 
biochemical and genetic approaches is desirable.
4.3.2.2 Protein toxin
The production and significance of the P. multocida protein toxin in atrophic rhinitis 
of pigs has been well established. Investigators have shown that the progressive 
changes in the snout and turbinate bones can be reproduced by using toxigenic strains
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of serotypes A and D or by a single injection of a very small amount of purified toxin 
and the novel protein toxin is considered to be the main virulence factor in atrophic 
rhinitis isolates.
In the present study, 8 strains producing protein toxin were found. Intramuscular 
injection of 106 cfu of any one of these strains, regardless of serotype, host and 
country of origin, killed mice in less than 48 hours. Although intraperitoneal injection 
of filtered 48 hour brain heart infusion broth culture supernatant of all 8 toxigenic 
strains killed Balb/C mice, suggesting that, the protein toxin appears unlikely to be 
the main factor involved in the rapid lethality of live cultures of grade 1 for mice, 
since the majority of them fail to produce it.
Although toxigenic P. multocida has been considered to be the main cause of atrophic 
rhinitis, the exact mechanism of action of toxin, either in atrophic rhinitis or in the 
in vitro cell culture or mouse lethality, is not known (Chanter and Rutter, 1989). 
Recently, Rozengurt et al. (1990) and Staddon et ah (1991) demonstrated in cultured 
cell lines that toxin, in low concentration behaves as a potent growth factor. It has 
also been observed by Staddon et ah (1991) in vitro cell culture that toxin initiates 
alterations to the lipid metabolism of the cell membrane and activates protein kinase 
C which is thought to be part of the way in which cells are instructed to grow and 
divide. The toxin could also initiates other changes as well which at the moment are 
unknown. However, the discovery that the protein toxin is a growth factor may 
provide more new insight into the mechanism by which toxigenic P. multocida causes 
atrophic rhinitis.
4.3.2.3 Neuraminidase
In the present work, mouse virulent (grade 1) strains of serotypes A, D and F had 
significantly greater in vitro production of specific neuraminidase activity than grade 
2 and 3 strains and the same may be generally true. It is tempting to postulate that, 
within these serotypes, neuraminidase may be a virulence determinant. The converse, 
however, applies to serotypes B and E, which cause dramatic infections in mice (and
197
indeed in the natural host) but were found to produce significantly less neuraminidase.
Neuraminidase is produced in vivo during various infections (Gadalla et a l ,  1968; 
Pardoe, 1974). Sialic acids are important constituents of glycoproteins and occur on 
the surface membranes of a wide variety of fixed and circulatory cells in man and 
animals. Mammalian neuraminidase is predominantly intracellular and its activity 
subject to regulation in the normal animal. It is possible that bacterial neuraminidase 
produced during infection by P. multocida may hydrolyse NANA residues from 
important cell surface components, affecting their function, the life span of various 
glycoproteins and the cells which bear them, and ultimately upsetting delicate 
regulatory mechanisms in the host. Muller (1974) reviewed the possible roles of 
neuraminidase in bacterial infections. He argued a correlation between virulence and 
ability to produce large amounts of neuraminidase in vivo in a variety of strains and 
species of bacteria, and suggested that neuraminidase producing organisms, are more 
likely to be successful in a wide range of infections. He demonstrated altered 
electrophoretic patterns of serum glycoprotein in guinea pigs infected with P. 
multocida. One pathological result of such alterations of serum glycoproteins could 
be a reduction of their life span in the circulatory system. Such glycoprotein changes 
would presumably accompany systemic disease while organisms were actively 
growing and producing the enzyme in blood and other body fluids. Before systemic 
invasion, the enzyme could play a role in the initial phase of colonization or 
penetration of the mucosal surface, necessary for the organism or its toxin ultimately 
to gain access to a preferred target site or receptor. Drzeniek (1972) and Schauer 
(1982) demonstrated that exposure of tissues to neuraminidase eliminated sub-terminal 
sugars, resulting in an increased adherence capability for certain bacteria. The 
substrate utilized for neuraminidase assays in this study was a complex glycoprotein, 
bovine maxillary gland mucin, which is normally present in the serous and mucous 
salivary secretions of cattle. Gottschalk (1960) originally demonstrated that removal 
of terminal sialic acid residues from salivary glycoproteins caused a loss in the 
viscosity and adhesiveness of these secretions. This would tend to hinder the normal 
protective function of the epithelial mucosal lining (e.g. the entrapment and removal 
of invading organisms). Thus the enzyme appeared to have function, probably
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adaptive, in enhancing survival of microorganisms in the respiratory/intestinal tract.
Since (1) the mammalian cell surface universally contains bound sialic acid and (2)
the epithelium is constantly exposed to sialic acid containing mucins, it seems more
than coincidental that organisms such as P. multocida which mostly colonize in the
respiratory tract are able to produce neuraminidase. Further evidence for the
importance of sialic acid in cell surface attachment phenomena have come from
studies by Aminoff et al. (1977) who have shown that neuraminidase treated
erythrocytes are rapidly eliminated from circulation by the liver and spleen. Although
reaction
this mechanism may be a normal physiological/for removing senescent blood cells 
from circulation, the process could conceivably be accelerated during systemic disease 
involving a microbe producing neuraminidase in vivo and might well apply to other 
cells, including the removal of leucocytes which have become repleted and weakened 
by uptake of endotoxin and other bacterial products.
Attention has focused on neuraminidase as a probable toxic factor in the pathogenesis 
of pneumococcal infection. Kelly and co-workers (Kelly et al., 1966, 1967; Kelly and 
Greiff, 1970) found that the enzyme was produced by all clinical isolates of 
Streptococcus pneumoniae and purified neuraminidase from these strains was lethal 
in mice when given either by the IP or direct intracerebral injection. The enzyme was 
detected in human cerebro spinal fluid (CSF) in pneumococcal meningitis and it has 
been suggested that its presence may correlate with coma and brain damage in the 
(human) patient (O’Toole et al., 1971). There appears also to be a correlation 
between virulence and neuraminidase production in Vibrio species; large amounts are 
produced by virulent strains isolated from human infections but much lower levels by 
environmental strains and "non cholera vibrios" (Soloviev et <2/., 1972; Muller, 
1973).
4.3.Z.4 Hyaluronidase
The results show clearly that serotype B is the only form of P. multocida capable of 
producing hyaluronidase and production of this enzyme thus appears to have some 
association with mouse virulence. The one stock collection of serotype B (isolated
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from a pig) devoid of hyaluronidase was moderately virulent (grade 2) whereas all 
other serotype B strains produced the enzyme and were highly virulent (grade 1) to 
mice. It might be that the enzyme is present only in serotype B strains associated with 
septicaemia (all of the positive strains came from septicaemic disease). Unfortunately 
the disease status of the pig from which the hyaluronidase negative strain came could 
not be ascertained from the culture collection records.
Inflammatory processes frequently take place in connective tissues which contain a 
wide variety of colloidal macromolecular constituents, including glycosaminoglycans 
(Phelps, 1975). Hyaluronic acid and (probably chondroitin sulphate) represent the 
most widely occurring and protean of these macromolecules since hyaluronic acid 
occurs in concentrations ranging from 0.05-3 mg/ml in all connective tissue matrices 
which have been examined (Comper and Laurent, 1978). It is generally considered 
that bacterial enzymes capable of hydrolysing natural polymers or altering surface 
structures of connective tissue matrices of host cells can probably play a part in at 
least minor inflammations and directly or indirectly facilitate entrance of bacteria into 
capillaries and lymph vessels: (indeed, the term "spreading factor" gained acceptance 
for bacterial hyaluronidase effects in disease, though it was originally employed with 
a different meaning). Two considerations suggest a need for caution as regards the 
above view. The first is the concept of critical concentration. Enhancement of 
bacterial lesions will possibly be observed if the initial concentration of the microbe 
and its diffusible products at the site of inoculation is sufficiently high. Otherwise the 
scattering effect of the "spreading factor" will reduce the infecting agent by dilution 
to below the critical concentration and inhibition rather than enhancement may result. 
Duran-Reynals (1935) demonstrated that subcutaneous spread of one strain of 
staphylococcus in the rabbit was totally suppressed by injection of the bacteria mixed 
with filtrate from cultures of the same strain. This paradoxical result suggests that a 
delicate balance is required between the pathogenicity of a strain and the amount of 
spreading factor it secretes if inoculation is to be followed by successful infection 
(Duran-Reynals, 1942). The second consideration is the effect of the overall 
inflammatory reaction on hyaluronidase induced spreading. Inflammation results in 
both local and general lowering of tissue permeability. When skin is treated by
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subcutaneous injection of staphylococcal culture filtrates prior to the injection of 
spreading factor into the prepared area, spreading is suppressed. Likewise the 
injection of living staphylococci into such prepared areas results in negligible lesions, 
although the same organism injected into non-prepared areas induces large spreading 
abscess (Favilli and McClean, 1937). It was clear that effect was negotiated through 
the agency of the inflammatory reaction.
Although not of particular relevance to the present work, it is worth noting the 
suggestion that in combined infections, Hase producing bacteria could be expected to 
promote not only their own spreading but also that of other organisms unable to make 
the enzyme themselves. All types of tubercle bacilli are devoid of hyaluronidase and 
some experimental evidence suggests that staphylococcus infection contributes to the 
dissemination of tuberculous lesions (Packalen, 1947). The spreading factor produced 
by staphylococci and other secondary organisms in pyogenic dermatosis was believed 
by Delmotte (1955) to play an aetiological role in eczema.
Reports (Peterson et a l,  1983; Fitzgerald and Repesh, 1987) have indicated that the 
treponemal hyaluronidase acts as a spreading factor to enhance dissemination to other 
tissues through superfluence enzymatic degradation of host hyaluronic acid, 
facilitating treponemal movement through the viscous extra-cellular matrix. The same 
mechanism, it is suggested, would enable the treponemes to penetrate the thick 
hyaluronic acid layer surrounding vessels, to eventually reach the vascular basement 
membrane. A similar system may operate for P. multocida serotype B which is highly 
virulent for mice and indeed for natural hosts. Indeed, it may well be that the 
capillary haemorrhage responsible for the wide spread petechiation in bovine 
haemorrhagic septicaemia and also probably for the local haemorrhagic lesion seen 
in injected mice, may be attributable, at least in part, to hyaluronidase. It would be 
interesting to know whether petechial haemorrhage is such a regular feature in 
African haemorrhagic septicaemia, the agent of which (P. multocida serotype E) does 
not produce demonstrable hyaluronidase in culture.
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5. GENERAL DISCUSSION
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The central task of the present study was to identify the capsular serotype in as many 
as possible of a structured collection of P. multocida strains recovered from a wide 
range of host species, infections and geographical locations (Section 2). Recognition 
of the specific capsular polysaccharide antigen is the basis of serotyping and this was 
successfully carried out using the by indirect haemagglutination (IHA) test (Sawada 
et al., 1982). Cross reactions were found to be minimal. The serotypes were found 
to be quite distinct and test results with 94% of strains allowed unequivocal allocation 
to a serotype.
5.1 The structured collection
In retrospect, it may be said of the structured collection of strains, that it was a sound 
idea, but too small. Some of the more interesting incidental findings would have been 
unlikely to have occurred except from a structured collection. Examples of these are 
(1) the discovery of the ovine toxin producing strains of serotypes A and D; and (2) 
the identification of European type B strains. On the other hand, the limitation to 100 
strains repeatedly frustrated comparisons between categories of differing serotype, 
host species and disease condition of origin, because each category was too small. 
Even under these limitations, a few quite reliable generalisation were possible, for 
example the total restriction of hyaluronic acid formation to serotype A and of its 
unidentified analogue to serotype D; and universal production of neuraminidase, yet 
at differing levels in the different serotypes.
It was valuable to examine laboratory preserved strains, yet the study would have 
been of greater worth if it had been possible to extend the structuring of the collection 
so as to include freshly isolated strains in each of the categories, instead of only the 
porcine type A and D strains. There was very little evidence that the freshly isolated 
strains were, in fact much different. On the contrary, one gained the impression that 
P. multocida strains are remarkably stable in their properties over long periods of 
preservation in the lyophilised state; perhaps this impression would have been altered 
if search had been made for plasmids, or for factors under plasmid control.
203
5.2 Capsule serotyping
The other part of the central task, capsular serotyping, was felt to be a positive and 
rewarding achievement. The relatively high success-rate in P. multocida serotyping 
obtained in this work has not been the general experience of others. Indeed, the 
challenge accepted at the start of this study was to discover the difficulties, overcome 
them as far as could be done, and to type as high proportion of strains as possible, 
perhaps even 100%. It may therefore be valuable to others attempting similar work 
to have a summary of the experience gained here.
Easily the most important single factor, in the writer’s judgement, is the possession 
of high-titre, high-specificity antisera. It is likely that most failure in P. multocida 
serotyping can be attributed to poor quality antisera.
5.2.1 Preparation of typing sera
Antisera of high specificity and adequate titres for the different capsular serotypes of 
P. multocida were raised in rabbits by intravenous injection (starting 0.2 ml and 
subsequently increased weekly by 0.2 ml increments) of plain antigen (formalized 
killed whole bacterial cell). This high degree of specificity does not seem to have 
been the experience of other workers and was attributed to 1) the use of young (6-8 
hours) cultures on YPC agar medium for preparation of antigen and 2) the practice 
of using freshly prepared antigen on each injection occasion. Provided these two 
aspects were strictly followed, there seemed to be no need to screen a number of 
strains to select one of high capsule antigenicity. The important factor was judged to 
be the freshness of the injection material.
The capsule of P. multocida is seemingly not as robust a structure as that of, say, 
enteric bacteria; it (or at least, some of it) detaches fairly readily from the cell, and 
it may be that detached capsule material is less antigenic than that which is more 
firmly cell-bound, as in the very young cell. Perhaps capsule material (whether cell- 
bound or not) undergoes some ageing process which progressively impairs its
204
antigenicity or antigenic specificity. Another possibility is that loss of capsule material 
from the cell surface exposes underlying LPS which than competes immunogenically 
with capsule polysaccharide, suppressing antibody formation against capsule material 
or leading to formation of cross reacting "O" antibodies which confuse test results. 
The fact that suspensions for injection are treated with formalin in order to kill them 
should not lead one into imagining that the capsule is necessarily "preserved" or more 
firmly "fixed" to the cell surface by such treatment. If the P. multocida capsule was 
a protein/polysaccharide complex, perhaps this might be so: the protein moiety might 
be mildly denatured by the formalin; but in fact the capsule appears to be devoid of 
protein. Whatever the explanation, it is so little trouble to prepare a fresh formalized 
suspension for each injection, and then discard it, that one would not recommend any 
substitute method.
Production of capsular antibody was not possible using killed whole cell antigen in 
combination with incomplete Freund’s adjuvant. This was unexpected, and the precise 
reason for the inability of adjuvated antigen to produce antibody is not known but the 
same difficulty was encountered by Mahmood (1991) and Rimler (personal 
communication). The general experience is contrary, i.e. that immunity is enhanced 
by the incorporation of adjuvants. For this reason adjuvants have a wide application 
in bacterial immunizing vaccines, though some investigators (Webster, 1965; 
Davenport et a l , 1968) have considered that complex antigens such as bacteria or 
viruses do not need adjuvants to be immunogenic and adjuvants add little to their 
immunogenic properties. Jolies and Paraf (1973) concluded that adjuvants could 
modify antigen localization and could also change antigen catabolism by macrophages 
of the medullary sinuses of lymph nodes and of lymphoid follicles. The negligible 
capsule antibody response found to Freund-adjuvated suspension in the present work 
may well be connected with the ageing or detachment of capsule material discussed 
above. Bain (1963) stated that some adjuvants cause or allow decapsulation of the 
organisms and that during the immune response, phagocytic action can eliminate 
capsular material, contributing to a failure of capsular antibody production. Musa’s 
(1985) demonstration that complete Freund’s adjuvant stimulates somatic antibodies 
of P. multocida earlier than capsular antibodies may support the view that adjuvant
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induced decapsulation can occur.
The capsular antibody titres attainable against serotypes A and D were lower than for 
serotypes B, E and F. The capsular substance of type A is hyaluronic acid together 
with the antigenic capsular polysaccharide. Hyaluronic acid is non immunogenic and 
the bacterial substance is presumed to be closely similar to the hyaluronic acid 
moieties found in connective and other tissues of mammals. The capsular hyaluronic 
acid of P. multocida type A might by mimicking host polysaccharide, avoid immune 
recognition of itself and also impair recognition of contiguous molecules of the type 
A specific capsular antigen. Hydrolysis of capsular hyaluronic acid of type A by 
testicular hyaluronidase during the preparation of antigen enhances the antibody titre 
against P. multocida type A type specific polysaccharide; this was done in the present 
work, and would seem to be advisable when preparing type A antisera in rabbits. The 
capsular substance of type D is not a hyaluronic acid and hyaluronidase treatment 
does not seem to have any effect on it. There is no point, therefore, in treating type 
D suspension for rabbit immunization with hyaluronidase; the value of treating 
suspensions of P. multocida strains with hyaluronidase prior to IHA test however 
remains, since one does not know whether they contain hyaluronic acid or not, but 
the treatment has no effect on the IHA titre of type D strains (see Table 21). The type 
D capsular mucopolysaccharide might share some degree of identity with host tissues 
which, like hyaluronic acid itself, prevents antibody formation at a high titre. This 
would be well worthwhile investigating further.
5.2.2 The indirect haemagglutination (IHA) test
The IHA titres (against their homologous strain suspension) desirable for typing sera 
would seem to be as follows,
Type A 
Type B 
Type D 
Type E 
Type F
512
4096
512
4096
1024
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Once the vital typing sera have been obtained, there seem to be few technical pitfalls 
in the IHA test itself. The heat extract antigens from the strains to be typed were 
always prepared freshly, from heavily seeded YPC agar plates to ensure an extract 
of adequate strength but is not known whether this was crucial or otherwise. Perhaps 
more important was a degree of care in preparation of the glutaraldehyde treated 
sheep KBC suspension. Once treated, the cells appears to store well at 4°C, but a 
previous worker in the Department (S. Acha, personal communication) had 
experienced failure with a batch of sheep RBC which had been left at 4°C for some 
days before glutaraldehyde treatment. Care was therefore taken to use fresh sheep 
cells, to use the same lot of glutaraldehyde cells for a batch of strains and to check 
the treated cells with a known positive strain as control.
5.2.3 Information gained from serotyping
The proportions of serotypes identified (type A 40%, B 16%, D 20%, E7%,  F 11% 
and not determined 6%) from stock collection showed that serotype A to be the 
largest group (Section 2). A total of 7 and 4 serotype of B strains had been isolated 
from haemorrhagic septicaemia of cattle and buffalo from Asia (India, Sri Lanka, 
China and Thailand) and Africa (Egypt and Cameroon) respectively however, 5 
strains of serotype B were also identified from cattle, horse, pig, and avian sources 
from East Europe (Poland and Romania). 6 out of 7 cultures of serotype E had been 
isolated only from cattle of Africa. One strain (no.872) from bovine haemorrhagic 
septicaemia from Israel was serotype E which for many years has been thought not 
to occur in Asian countries. These observations represent useful extensions to existing 
knowledge on the distribution of P. multocida serotypes in animals, and 
geographically. A further interesting result to arise from this study was the 
identification of serotype F. A total of 11 isolates from different parts of the world, 
of which 2 from cattle, 1 from pig, 6 from avian and 2 from wild life proved to be 
serotype F. It seems that avian species are the largest source of serotype F (Rimler 
and Rhoades, 1987) but it is clearly not entirely restricted to birds.
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5.3 Virulence in P. multocida
The other aspect of the study was the attempt to investigate virulence factors (Section
3): 1) size of capsule zone 2) protein toxin 3) neuraminic acid 4) neuraminidase 5) 
hyaluronic acid and 6) hyaluronidase in a structured and serotyped collection of P. 
multocida strains. The investigation revealed that two features, possession of capsule 
and neuraminidase, occur in all. However, the size of the capsule zone and the 
amount of neuraminidase varies between different serotypes and within each serotype. 
Protein toxin was detected in 8 strains (5 from serotype A and 3 from D). 
Hyaluronidase was produced only by serotype B strains. Capsular hyaluronic acid was 
present in serotype A and an Alcian blue staining substance of closely similar 
chromatographic properties occurred in capsule extracts of serotype D strains. The 
serotype D substance resisted hyaluronidase and was thought to be an acidic 
polysaccharide differing from hyaluronic acid: it was not chondroitin sulphate.
5.3.1 Whole-animal virulence: the single mouse virulence test
The whole collection of P. multocida strains was tested for mouse virulence (Section
4). The test was in general performed in single animal, using a fixed challenge dose 
of 106 cells, after a method originally described by Curtis and Ollerhead (1980). A 
number of strains were clearly virulent, able to cause rapid lethal infection, others 
were lethal, but more slowly, and some were incapable of producing infection. This 
enabled an easy classification of strains into three virulence grades, 1 (highly 
virulent), 2 (moderately virulent) and 3 ( avirulent).
The single mouse virulence test can certainly be recommended as a screening method, 
on grounds of ease, and economical use of laboratory animals. As a comprehensive 
test for distinguishing between high virulence, moderate virulence and non-virulence 
(at least, for the mouse) it probably gives as much information as the more laborious 
and extravagant titration of LD50 in mice. It would be of no value in determining 
challenge doses for evaluations of vaccines, antisera or therapeutic substances: for this 
it is still necessary to give a measured small multiple of a previously determined LD50
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A whole-animal virulence test has two limitations, (1) it does not necessarily measure 
overall virulence for any species other than the laboratory animal chosen; and (2) it 
throws little light on the factors responsible for the effect measured (in this case, 
lethality). However, as described in Section 4, there was a broad correlation between 
mouse lethality and strains isolated originally from lethal septicaemic disease.
In addition, the virulence screening exercise uncovered a point of some interest which 
may have a bearing on the mechanism of pathogenesis, namely the haemorrhagic 
oedematous lesion at the injection site. This lesion was regularly seen in mice given 
grade 1 and 2 virulence strains, being more marked in the latter (moderate virulence) 
perhaps because it had a little more time to develop. The local lesion has been 
described before, but little attention has been payed to it. It may be that the 
haemorrhagic lesion is a direct local effect of the same factor that produces 
widespread petechiation in septicaemic pasteurellosis in cattle (haemorrhagic 
septicaemia). This factor could be endotoxin, or might on further work be resolved 
into several factors: hyaluronidase might also be involved, for example. The oedema 
which accompanies the haemorrhage should be noted: it is reminiscent of the effect 
of the oedema factor of Bacillus anthracis which causes local haemorrhagic oedema 
in guinea pigs. Oedema occurs in natural haemorrhagic septicaemia of cattle. It is not 
seen in any tissue of infected mice, except for the minute region around the point of 
injection, where presumably the concentration of preformed factor is at its highest.
5.3.2 Virulence factors
Bacterial virulence is a very broad topic. For a virulent bacterium to produce disease, 
damage to host cells must occur, following or from colonization, invasion, 
multiplication and resistance to host defences. Since virulent bacteria must accomplish 
all these processes, each one of which process is complex, a large assembly of 
virulence determinants are usually involved in the overall effect. The full array of 
virulence factors of P. multocida involved at each these steps is not fully known but 
current dogma suggests that the best mechanisms for counteracting host defences 
include anti-phagocytic capsules and elaboration of toxins and enzymes that act on
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host immune cells and break down anatomic barriers.
It was evident in this study that highly mouse virulent strains of serotypes A, D and 
F are strong neuraminidase producers in vitro and it could be possible that the ability 
to produce high levels of enzyme is a factor in virulence of some forms of this 
organism. Bacterial neuraminidase may well have a role in attacking protective 
mucous layers and reducing viscosity, preventing bacterial entrapment and allowing 
access to target cells for bacteria or their toxins. Intensive research on sialic acids 
sustains the general proposition that sialic acids are important molecules on the host 
cell surfaces and possession of neuraminidase by a bacterium must imply its 
involvement in the interaction of the bacterial cell or its toxic products with the host 
cell membrane.
It was striking that serotypes B and E which produce a fulminating septicaemic 
infection in both mice and in the natural hosts, produce significantly less 
neuraminidase in vitro. It is difficult to say why they have less neuraminidase. Is it 
because type B has hyaluronidase which might facilitate tissue penetration leading to 
rapid septicaemia in which neuraminidase plays little or no part ?.
In considering possible roles for the acidic mucopolysaccharide component present 
in the capsule of P. multocida types A and D, two functions might be suggested: (1) 
evasion of phagocytosis; (2) inhibition of antibody production; (3) impairment of 
antibody effect (e.g. opsonization). It seems highly significant that these two serotypes 
are the commonest ones found in more chronic infections, such as the chronic lung 
lesions of porcine enzootic pneumonia, whilst the other serotypes (B, E and F) tend 
to be associated with the acute septicaemia. In chronic type A and D infections both 
inhibition of antibody production and inhibition of immune phagocytosis 
(opsonization) could be of benefit to the parasite: in type B and E septicaemic 
infections, the host would be dead before antibody levels could rise sufficiently to 
affect the organism or the ease of phagocytosis. The organism’s ability to evade early 
(non-immune) phagocytosis would be important in acute disease, and is more 
probably mainly a function of the antigenic capsule polysaccharide rather than of the
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mucopolysaccharide: capsules of type B strains lack mucopolysaccharide and contain 
only antigenic polysaccharide, yet type B organisms successfully evade phagocytosis 
by mouse neutrophils and probably bovine ones as well. This line of reasoning leads 
to the conclusion that the function of the non-antigenic mucopolysaccharide is 
probably interference with antibody formation or function (opsonization) rather than 
direct inhibition of phagocytosis.
5.3.3 Adaptive expression of virulence (virulence factor "switching")
Many potentially pathogenic bacteria undergo stages when they are carried without 
major detriment to the host. Variations are sometimes noted between different isolates 
of what appears to be the same strain, according to whether the source is a carrier or 
a diseased individual. Hypotheses to account for such variation have considered 
adaptive enzymes or enzyme-systems; spontaneous mutation; and selection by 
environmental factors of variants already existing in a mixed population. In recent 
years, evidence has accumulated that some of these variations may be explained by 
switching mechanisms contained within the organism’s genome: during carriage, 
expression of some virulence genes may be modified (switched off) in response to 
environmental factors, or their absence, only to be switched on when the organism 
is in the environment of the diseased host. Thus the phenotype of the organism 
changes, primarily to escape host defence mechanisms. In particular, there may be 
variation in surface antigens, such as production of capsule and the antigenicity of 
Class 5 proteins. Genetic switching may involve signal transduction and histone-like 
virulence regulating-or coordinating-substances.
In Neisseria meningitidis, both capsule and lipooligosaccharide (LOS) expression 
appear to be thus controlled. Loss of capsule expression occurs during nasopharyngeal 
carriage in healthy persons: at some stages in the infection process, capsule is 
switched on though it is unclear whether this occurs before or after the bacterium 
enters an invasive phase either in the same individual or after transmission to another. 
Lipooligosaccharide is responsible for immunotype in N. meningitidis: the 
lipooligosaccharide of a given strain may differ in antigenic expression (immunotype)
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and also in molecular size, according to whether the isolate is obtained from a carrier 
or a clinical case (Jones, 1992).
In human cystic fibrosis, lung infection with Pseudomonas aeruginosa is a common 
feature. Initial colonisation is by a non-mucoid strain and is asymptomatic. Later, 
when the strain undergoes dissociation and mucoid variants (which also produce 
alginate) occur, the clinical picture changes to one of debilitating chronic colonisation 
(Govan, 1992) and it is suggested that genetic switching controls (or augments) the 
adaptive change in the bacterium.
Genetic switching is also said to be responsible in Candida albicans for changes in 
colony morphology, lipid and steroid content, protease production, resistance to 
antifungal agents and antigenicity. Bumie (1992) reexamined Candida isolates from 
the first outbreak of disseminated candidiasis, described at the London Hospital, and, 
using pulsed field gel electrophoresis, detected DNA variations which suggested that 
genetic switching had occurred within the outbreak.
5.3.3.1 Possible roles of virulence switching in P. multocida pathogenesis
In P. multocida infections the range of host species and conditions is wide, and 
carriers occur. The accepted view of the epidemiology of bovine haemorrhagic 
septicaemia postulates that outbreaks are initiated when stress allows P. multocida 
present in the nasopharynx or throat lymphoid tissue of a carrier animal to increase 
in virulence (creating the index case) and transmissibility (resulting in spread to other 
susceptible individuals). No differences have been described between strains from 
carriers and disease isolates, though, as pointed out elsewhere, they appear hardly to 
have been looked for. The bacteriology of enzootic pneumonia of pigs bears some 
resemblance to that of cystic fibrosis in man: both conditions lead to a state of 
chronic mixed bacterial colonisation. The characteristic isolation of mucoid P. 
multocida (of types A and D) in the later stages of enzootic pneumonia is reminiscent 
of isolation of mucoid P. aeruginosa from cystic fibrosis noted in the previous 
Section. Mucoid P. multocida isolates are far commoner in pigs than non-mucoid
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ones, suggesting that the production of hyaluronic acid or similar acidic 
polysaccharide in addition to the regular capsule antigen is in some way essential for 
the organism’s survival in the chronically diseased pig lung environment. There is 
nothing at present to suggest that capsular hyaluronic acid in P. multocida might be 
controlled by genetic switching: no instance of transformation from non-mucoid to 
mucoid in laboratory cultures has been reported, and the experience is that isolates 
which are mucoid remain so even after many subcultures. Non-mucoid type A and 
D isolates are thought to be uncommon, but it would be nonetheless interesting to 
look for them in the throats of healthy pigs, which have been studied much less than 
diseased lung material collected at slaughter houses. It seems possible that the 
properties of the organism conducive to initial colonisation of pig lung mucosa might 
differ from those which favour persistent survival in the chronic lesion or pathological 
bronchial secretion, and that a form of switch could be involved.
Indeed, it is difficult to understand how a permanently capsulated organism could 
effect initial colonisation of respiratory mucous epithelium. Rapid attachment to the 
surface of an epithelial cell would be necessary to prevent the organism being carried 
away by mucociliary flow; yet this would seem unlikely unless there was contact by 
the organism’s cell wall adhesins or fimbriae, which could scarcely operate through 
the thickness of a capsule layer. One of the functions of capsule may be to mask 
adhesins which, besides attaching to the mucosal epithelium, are also recognisable by 
phagocytic cells. Some uropathogenic E. coli have adhesins of two types, one 
recognised by receptors on both epithelial cells and phagocytes, the other recognisable 
by epithelial cells only: the former are described as being "shed" when there is need 
to avoid phagocyte recognition, and the implication is that a genetic switch is 
involved. In P. multocida fimbriae have been described only in type A strains, but 
it is unclear whether they are produced together with capsule and capsular hyaluronic 
acid, or whether alternation between a fimbriated and a capsulated form occurs, as 
described for some strains of E. coli. If adhesins (or fimbriae) are conducive to 
epithelial attachment, and capsule to avoidance of phagocytosis (either within mucus 
or in invaded tissues) it seems improbable that a bacterial cell would produce both at 
the same time. Bacteria divide rapidly, and the most likely stage for a switch to
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operate is at the time of cell division. Two general hypotheses are suggested:
i) The switch from capsulated/non-adhesive to noncapsulated/adhesive occurs when 
cell division takes place in the immediate vicinity of a host epithelial cell membrane, 
the trigger being the proximity of host receptor molecules. The noncapsulated 
daughter cells adhere to the host cell surface, in which site they are sheltered from 
phagocytic cells, and undergo further divisions there until all available local receptors 
have been used, after which subsequent daughter cells detach into the mucus layer and 
are of the capsulated form.
ii) The external trigger postulated under (i) does not exist. Bacterial cell division 
results in the formation of daughter cells which may be in either of two forms, 
capsulated/non-adhesive or noncapsulated/adhesive, the relative incidence of the two 
being genetically determined. When a bacterium entrapped by respiratory mucus 
begins to multiply, the noncapsulated daughter cells are destroyed by phagocytosis. 
Most of the capsulated daughter cells are removed by mucus flow, but a few remain 
to divide, again replenishing both forms. When a noncapsulated, adhesive daughter 
cell attaches to a host epithelial cell, those of its progeny which are noncapsulated 
increase the population on that cell’s surface whilst the capsulated progeny are 
detached into mucus.
Perhaps relevant to hypothesis (ii) is the observation previously discussed, that when 
smears from a capsulated P. multocida culture are examined by a method capable of 
showing capsule, it is sometimes noticeable that not all of the cells possess a visible 
capsule layer.
It might be that P. multocida attach to a neuraminic acid host cell receptor which 
leads to multiplication of organism on cell surface (i.e. colonization) and 
neuraminidase probably allows subsequent release of daughter cells to colonize fresh 
host cells. This could entail postulating a "neuraminidase switch".
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5.4 Pasteurella infections and the carrier state
5.4.1 Adhesion vs evasion
Both adhesion and evasion are facets of the organism’s interaction with the surface 
of host cells: the organism requires to adhere to its susceptible target cells (mucous 
epithelia, in the case of initial colonization) but may at the same time have to evade 
entrapment by mucus, or by defensive cells which might phagocytose and kill it. 
Factors in P. multocida which may be connected with these activities are (1) adhesins 
or fimbriae (not studied in the present work); (2) capsule; (3) neuraminidase. In 
considering how they may might operate, contradictions arise, perhaps more apparent 
than real.
At the initial infection of a mucous surface, the bacterial cell encounters not the 
epithelial cell layer, but its overlying mucous sheet, containing sialic acid 
polysaccharides and slowly moving by mucociliary flow. A role for bacterial 
neuraminidase can be distinguished here, in detaching the multiplying bacterial cells 
from the impeding sialopolysaccharides which attach to their adhesins, permitting 
gradual penetration of the mucous layer; if multiplication is rapid enough to replenish 
the cells which are carried away by the flow of mucus, the organism may succeed in 
reaching the cellular epithelial surface itself to which it must become attached. If, as 
is probable, the membrane receptor on the host cell surface is a sialic acid residue, 
neuraminidase activity may, for the moment, be quite the reverse of beneficial to the 
bacterium, since it would be likely to impair the receptiveness of the required 
membrane attachment sites. If successful microcolonization occurs and the bacterium 
multiplies to crowd the host cell surface, a point must be reached where bacterial 
neuraminidase would again be an advantage, allowing some cells to detach, re-enter 
the mucus layer and be available for infection of contiguous host epithelial cells. In 
short, it is difficult to explain the role of neuraminidase if it is produced equally, 
continuously and in an active state by all cells of the colonizing bacterial population.
Attempted appraisal of the value of the bacterial capsule during mucous membrane
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colonization likewise uncovers some contradictions. The polysaccharide capsule may 
well assist the organism in avoidance of phagocytosis by wandering cells inhabiting 
the mucus layer; at the same time it may be of use in physically protecting underlying 
cell wall adhesins from neutralisation by omnipresent sialomucopolysaccharides. 
However, when the host target cell surface is reached, it is difficult to see the 
organism’s capsule as anything but a hindrance to attachment; and once attachment 
has occurred it is not needed, any way, since the most avid phagocyte could scarcely 
be capable of engulfing both bacterium and host cell together.
Adhesion factors or fimbriae were not studied at all in the present work but have been 
demonstrated in serotype A P. multocida, (Trigo and Pijoan, 1988) and probably 
occur in other serotypes. Their function can only be exercised by a bacterial cell 
when it is in contact with a susceptible host cell. When the bacterial cell is 
surrounded by mucus, adhesins could be a positive disadvantage if they facilitated 
entrapment by sialomucopolysaccharide and thus led to the organism being carried in 
the mucus flow to the oropharynx, and thence swallowed. It is not known whether P. 
multocida adhesins serve to anchor the organism to epithelial cells only, or whether 
they lack selectivity and facilitate attachment to phagocytes as well: if the latter, it 
would be important to know whether the organism is capable of suppressing adhesin 
production when it reaches the invasive phase of infection and enters tissues which 
contain a greater abundance of phagocytic cells than the mucosae.
The sequence of events may be simpler in the case of a highly virulent, septicaemia- 
producing strain infecting a susceptible animal (for example, a type B strain 
transmitted to a young cow or buffalo during an outbreak of haemorrhagic 
septicaemia). Here, preliminary colonization of a mucous surface may not even be 
necessary. All that may be required is for one bacterial cell alighting on the mucous 
membrane to be taken up by a phagocyte ( it will be recalled that the phagocytosis 
rate of type B is low but not zero), to survive in its cytoplasm long enough to be 
taken into the lymphatic or blood circulation and released there: the generally high 
resistance to phagocytosis found in type B then ensures unimpeded multiplication and 
a fulminating septicaemic infection. When the infecting cell is given by injection, as
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in experimental infection of laboratory mice, it is unnecessary to postulate even brief 
transportation in a phagocytic cell: one bacterial cell introduced into the bloodstream 
or entering a mesenteric lymph duct following intraperitoneal injection bypasses all 
surface and tissue defences and leads straight to septicaemia.
Laboratory studies of attachment or virulence factors, such as reported here, may 
create misleading impressions. They seek to detect substances present in large 
populations of the bacterium multiplying under highly favourable conditions in a rich 
growth medium. There is no guarantee that the level or pattern of production is 
similar to that in the infected host. There is not even any way of determining whether 
all of the cells in the population are equally active in producing the substance assayed, 
or whether the yield might be due to production being expressed in a proportion of 
active cells, the remainder being non-producers. During the photomicrographic 
determination of capsule dimensions carried out on all strains, it was sometimes 
noticed that in a given strain a proportion of the cells were apparently devoid of 
capsule. This was shown not to be a function of the age of the culture, and appeared 
unlikely to be connected with the age of the individual cell: the cells without capsule 
were capsule-free apparently from the time of division, and remained in that state, 
whilst the others were fully capsulated, or nearly so. Too much can be made of a 
small observation, but there may be implications that the proportions of capsulated 
to non-capsulated daughter-cells produced at division varies according to strain or, 
more interestingly, is influenced by the conditions or environment in which the cells 
divide: in short, capsule is switched on or off as needed, by regulation of the ratio 
of capsulated to non-capsulated daughter-cells. In the infected animal, a high 
proportion of capsulated cells might result from multiplication in a tissue environment 
where phagocytic cells were active, whilst the proximity of host epithelial structures 
or substances might switch off capsule formation in a much higher proportion of 
daughter-cells. Indeed, switching could be envisaged with all of the factors discussed 
above, capsule, neuraminidase, adhesin, and others as well, and the switch might be 
regulated by contiguity of host materials or even by substances released by the 
bacteria themselves: for example, the neuraminidase switch (if it exists) might go 
"on" in the presence of sialomucopolysaccharide, "off" when host cell-membrane
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substances are nearby (allowing attachment), and "on" again when the microcolony 
on the host cell surface has reached a size at which there is a local build-up of the 
concentration of bacterial metabolites (allowing a proportion of daughter-cells to free 
themselves and drift away to colonise other host cells.)
Such hypothetical events could not be detected easily, if at all, by conventional 
bacteriology, microscopy or histopathology. Investigation would require devising 
specific cytochemical or immunocytochemical techniques of considerable 
sophistication, coupled with electron microscopy, and applying them to many 
specimens of pathological material obtained from experimental animals infected in the 
most careful manner.
5.4.2 Colonisation and generalisation in P. multocida infections
One should not expect to find the same array of virulence factors in all forms of a 
bacterium capable of producing such diverse manifestations as P. multocida. Taking 
a very broad view, these disease manifestations fell into two types, (1) septicaemic 
and rapidly fatal, as haemorrhagic septicaemia; (2) more local, mucous membrane 
colonisation, which may or may not progress to further invasion, best typified by the 
bronchopneumonia (enzootic pneumonia of pigs; calf pneumonia)
In the first type , colonization mechanisms are scarcely required by the organism: it 
is unlikely that the highly virulent haemorrhagic septicaemia strains of serotypes B 
and E which transmit readily by aerosols between cattle during an outbreak of acute 
disease, have any respiratory colonization stage at all. All that they require is the 
ability for a single cell to gain access to the bloodstream and thereafter to multiply 
without restriction. Such strains have no need for neuraminidase: perhaps they do not 
even require fimbriae. Hyaluronic acid capsules to retard antibody stimulus are of no 
importance, since the animal will quickly die. Their paramount need is for an anti­
phagocytic mechanisms which is found in the polysaccharide capsule antigen and 
would appear to be of high efficiency in protection against host blood neutrophils. 
Thus, the haemorrhagic septicaemia strains:
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Possess anti-phagocytic capsule antigen 
Possess hyaluronidase (type B only)
Lack hyaluronic acid 
Have less neuraminidase
In the second type, the organism’s mode of pathogenesis is to establish itself on a 
mucous surface and remain there, during which time local defences and inflammatory 
responses occur, but no generalisation through vascular invasion. Attachment and 
survival is the strategy for the organisms of serotype A and D. Fimbriae occur ( or 
are said to occur) in type A. Both produce ample neuraminidase. Their capsule 
antigen suffices to protect them from local macrophage activity and from 
inflammatory neutrophils. Long term survival in such a process would be threatened 
by development of antibody, either IgG or local IgA, which would defeat anti­
phagocytosis. Both serotypes A and D possess non-antigenic capsular 
mucopolysaccharide of the hyaluronic acid type, the primary function of which is 
likely to be the delay or avoidance of antibody stimulation (and there is at least 
evidence of this in their weaker antigenicity when attempts are made to raise 
hyperimmune sera in rabbits). Thus, the "colonization" strains, typed by serotypes 
A and D:
Possess more neuraminidase 
Possess hyaluronic acid (or 
an analogue of it)
Possess fimbriae (type A)
Lack hyaluronidase
(This broad generalization refers mainly to the mammalian host, and founders when 
exceptions are looked for. For example, the strains which produce septicaemia in 
birds (avian cholera) are of serotype A: when attempting to categorise disease 
manifestations, it is clearly necessary to take into account the host species as well.)
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5.4.3 The carrier state in haemorrhagic septicaemia
Cattle haemorrhagic septicaemia strains are postulated to occur in 2 forms: 1) the 
carrier form colonizing throat lymph node and pharyngo-tonsillar mucous membrane 
and 2) the transmissible septicaemic form. This is entirely hypothesis. Nobody has 
ever shown any difference between the two forms and no - one has ever seriously 
tried. It is part of the hypothesis that transformation from the carrier type of organism 
to the haemorrhagic septicaemia takes place in the initial case ("index case") of an 
outbreak, which occur in a stressed animal.
The part played by the fluctuating levels of specific resistance in the animals has also 
been the subject of speculation. Only a single fact has been clearly established: that 
resistance to P. multocida in cattle is unusually short-lived. This knowledge comes 
not from controlled experiments, but a body of experience over many years use of 
simple formalized broth cultures (bacterins) as haemorrhagic septicaemia vaccines, 
which has led field workers to the firm conclusion that 6 months is the limit of useful 
resistance resulting from a single dose vaccine. Many attempts have been made to 
extend this period of protection- by multiple dosage, high level dosage, use of 
aluminium hydroxide or oil as adjuvants - but if any added protection occurs at all 
it is no more than an extra month or so. It has therefore been concluded that a factor 
in determining when an outbreak of haemorrhagic septicaemia is to occur, must be 
the degree to which specific resistance has waned. The carrier rate between outbreaks 
is said to be low (not more than 5%). It may be that the factor which determines 
whether a recovered animal shall remain a carrier, or rid itself of infection entirely, 
is the degree of individual resistance acquired during the immediately previous 
outbreak.
It is likely that both general explanations figure in the actual events which initiate an 
outbreaks, i.e. resistance wanes, and also there is some "change" in the organism in 
response to that diminution of resistance: the third, precipitating factor is then some 
form of stress.
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The hypothetical "change” in the organism may be the acquisition or expression of 
a virulence factor, and therefore of relevance to the subject of this thesis. In the work 
described here, search was made for virulence-associated substance or properties 
which were expressed during growth in laboratory culture media. Others, however, 
have wondered whether a factor which was expressed only when the organism 
multiplied in the environment of the sick animal, might be responsible. If so, its 
expression is likely to be genetically controlled in a manner which allows response 
to alteration in the organism’s environment. Prince (1966) believed she had 
demonstrated such a factor in the tissues of infected calves and termed it an "m vivo" 
antigen.
5.4.4 Significance of the haemorrhagic septicaemia serotypes
One of the outstanding problems in Pasteurella epidemiology is the difference 
between the agents of Asian and African haemorrhagic septicaemia. The present study 
did not address this problem, but some of the results obtained are of relevance, and 
serve to emphasise the lack of knowledge. It is useful to state the problem. In 
haemorrhagic septicaemia of cattle in Asian countries, only P. multocida type B is 
isolated, almost always B:2. Until the present study chanced on a single type E strain 
from Israel, type E has never been isolated outside Africa, where it is the most 
widespread form; strains have been identified from cattle disease termed 
haemorrhagic septicaemia in the Cameroons, the Central African Republic, Chad, 
Congo, Egypt, Guinea, Ivory Coast, Mali, Nigeria, Senegal, South Africa, the Sudan, 
Tanzania and Zambia (Carter and DeAlwis, 1989). In Africa, type B has been 
identified only in Egypt, and the Sudan (DeAlwis, 1984). Apart from their capsule 
antigen, a further difference between type B and E strains is that hyaluronidase 
production is detectable only in the former.
The situation as outlined above is clear from the reports cited, and numerous others: 
yet none offers any comment on ways in which it might have come about. 
Assumptions, largely untestable, would be required on possible routes of evolution 
in the haemorrhagic septicaemia Pasteurellae. The problem is one of the current
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dilemmas of veterinary bacteriology. Perhaps the author of a thesis for a degree in 
philosophical science might be allowed some greater indulgence in venturing into a 
few speculative trains of thought.
Haemorrhagic septicaemia Pasteurellae must owe their origin to wildlife Pasteurella 
strains, probably from wild ruminants, which become further adapted to cattle and 
other ruminants when these undergo domestication: such adaptation doubtless takes 
different directions, one of which results in the emergence of highly transmissible, 
high-virulence disease strains. Outbreaks of conditions described as haemorrhagic 
septicaemia are occasionally recorded in wild ruminant species- North American 
bison, elephants, deer and others. Carter and DeAlwis (1989) observed, largely from 
experience in Sri Lanka, that in domesticated cattle, widespread haemorrhagic 
septicaemia is most characteristically found in large nomadic herds reared and driven 
under conditions which can have changed little over many centuries. It seems possible 
that type B P. multocida and indeed haemorrhagic septicaemia itself may have 
originated in Asia through adaptation of archetypal wild ruminant strains occurring 
when cattle-herding of this primitive description began to be practised. Thus, the 
principal factor allowing emergence of type B haemorrhagic septicaemia Pasteurellae 
in Asia long ago may have been a particular form of livestock domestication which 
became prevalent in low country plain areas, the large nomadic cattle herd, probably 
of a susceptible breed or strain. (The water buffalo, widely regarded as highly 
susceptible to haemorrhagic septicaemia in Asia, though curiously, not in Africa may 
or may not have played a part in the evolutionary process.)
Two lines of speculation, or theories, on the origin of the African haemorrhagic 
septicaemia type E Pasteurellae (which must have taken place in Africa, because they 
are found nowhere else) now become possible. Theory I supposes that type E arose 
by mutation or adaptation from type B strains carried into Africa following an earlier 
origin in Asia, theory II that it evolved independently, from African wildlife strains.
Theory I. There is no problem in understanding how Asian haemorrhagic septicaemia 
Pasteurellae would have been brought to Africa. A large proportion of the
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domesticated African cattle population is of Asian, not African stock, for example the 
Zebu and Sahiwal cattle. These were introduced into Africa by importation over 
extended periods and a proportion would have been already carrying type B strains. 
The difficulty lies in guessing how a mutation or adaptation involving such major 
changes in the organism as (i) modification of ability to synthesise one capsular 
polysaccharide into ability to synthesise another of absolutely different antigenic 
specificity and (ii) loss of hyaluronidase production as well, could have resulted from 
what would seem to be a mere change in location from one tropical region to another. 
The organism’s habitat is almost obligately parasitic, it survives hardly at all outside 
the animal body and has no need to, since it encounters environmental conditions only 
briefly when passing from one infected individual to another. The host animals 
themselves were genetically the same, at least to start with. They may be assumed to 
have themselves undergone some degree of gradual adaptation in a new continent, 
perhaps to other forms of disease indigenous there, such as trypanosomiasis, or to a 
unaccustomed range of stress factors: if this is so, the organism may have responded 
by slow adaptation also. A different possibility is that transformation of the organism, 
if such occurred, took place by passage of the original type B form through 
indigenous African domesticated cattle or buffaloes, or through African ruminant 
wildlife, which is abundant and varied.
Theory II This supposes that type E evolved in Africa from archetypal Pasteurellae 
indigenous to the wildlife there, either (i) in response to domestication of cattle strains 
through primitive herding, in much the same way as type B arose in Asia, or (ii) 
when importation of susceptible domesticated cattle breeds from Asia took place (in 
which case there would have been no haemorrhagic septicaemia in Africa before that 
time): the divergence in capsule polysaccharide and hyaluronidase could have arisen 
far earlier through the differences between the African and Asian wild host fauna. 
This line of speculation is the more satisfying, in that if a certain sequence of 
evolutionary events could take place in one continent there is no reason why 
something similar should not have occurred in another. What is lacking is any form 
of data on wild ruminant Pasteurellae, either in Africa or Asia: if independent, or 
parallel,evolution is the explanation, then it should be possible to isolate type E P.
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multocida, or at least related strains, from secluded African wild ruminant populations 
and likewise strains resembling type B from Asian wild fauna. A difficulty with 
theory II is that it seems to offer no explanation of what happened to the type B 
haemorrhagic septicaemia strains which must have entered Africa in successive 
importations of Asian cattle, and vanished. However, it is know that anti-pasteurella 
immunity in cattle is highly serotype-specific: consignments of Asian cattle entering 
Africa would presumably have possessed some resistance to type B but none to the 
type E already present there. Under those conditions, it seems possible that type B 
might have continued to exist in the imported stock alongside type E for a while (both 
in carrier animals and in disease incidents), but sooner or later became supplanted by 
type E and disappeared altogether. It is also possible, as pointed out earlier, that no 
form of haemorrhagic septicaemia occurred in cattle in Africa until the arrival of 
suitable stock made large scale nomadic herding possible, giving type E or its 
precursor the opportunity to emerge as a widespread pathogen and leaving no room 
for its type B competitor.
(Neither theory seems at first relevant to what little is known about haemorrhagic 
septicaemia in South America. It is not certain that the disease occurs there at all: 
what is claimed as haemorrhagic septicaemia may in fact be North 
American/European type pneumonic pasteurellosis. A number of South American 
countries have very large cattle populations particularly of beef breeds herded in great 
numbers in plains areas. However, these herds are descendants of imported and 
acclimatised European stock, including British Devon, Hereford, Ayrshire and 
Shorthorn animals, and therefore probably no more susceptible to true haemorrhagic 
septicaemia than their forebears. Veterinary bacteriology in many South American 
countries has been slow in developing, but it would not be a great surprise if the main 
form of fatal cattle pasteurellosis there proved to be an acute P. 
haemolytica/multocida pneumonia of the "shipping fever" type prevalent in North 
America.)
Returning to the greater problem: the explanations suggested above for the natural 
history of P. multocida serotypes B and E are theoretical and neither is capable of
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proof. However, some further investigations would be of considerable biological and 
epidemiological interest. These might entail (i) serological studies of wildlife 
Pasteurella from both continents; (ii) attempts- which do not appear ever to have been 
made- to infect Asian cattle stock, in Asia, with type E P. multocida and African 
cattle stock, in Africa, with type B; (iii) parallel genetic studies on the cattle 
themselves, in an attempt to relate differences in DNA or ribosomal RNA type to 
susceptibility or resistance to one or other Pasteurella serotype.
In the whole, current knowledge of the candidates for virulence genes of P. multocida 
and molecular complexity of the bacteria-host interaction is poor. Environmental 
conditions in host tissues under attack are largely undefined. At first the conditions 
may be physiological, but inflammatory and pathological processes soon produce an 
almost continuously changing environment as infection proceeds and microbes spread 
in the host. The availability of nutrients varies with the stage of the disease and the 
tissue invaded. These conditions can not be reproduced totally in vitro. Some 
virulence determinants may be expressed only under conditions in vivo; due to 
selection of types and phenotypic change, bacteria grown in vitro may be deficient 
in such determinants. It may be that full genetic competence for virulence can be 
expressed completely only during growth in vivo. It is therefore worthwhile to 
mention that we have absolutely no knowledge of how important hyaluronic acid, 
hyaluronidase and neuraminidase production of P. multocida are in vivo or even 
whether they occur at all in vivo. We know them only as laboratory phenomena and 
it must be kept in mind that this is not the normal environment that these organisms 
find during infection in host. The bacteriologist who essays to study disease producing 
agents must study them, eventually, in the diseased host organism itself. No- one 
should doubt the value of whole-animal virulence experimentation, but experience of 
recent decades has shown that inspection of the host-parasite interaction must be 
carried down to the cellular, and indeed molecular level. It is the application of 
molecular biology within the areas and disease biochemistry, pathophysiology, 
pathocytology and genetics, both of the causal agent and the susceptible animal, that 
the avenue towards better understanding of the virulence of P. multocida, its 
interaction with the host, and pathogenesis of varied diseases it causes, will be found.
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6. FUTURE CONSIDERATIONS
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Implications for further work on broad issues raised by the present study have been 
pointed out and discussed in the various Sections. General areas which would appear 
to be potentially most fruitful as follows.
1: Further serotyping. The ability to achieve nearly 100% success rate in
serotyping should be a great encouragement for further surveys and studies 
entailing as knowledge of serotype, e.g. epidemiological. The structured 
collection of 100 strains was too small. With ability to type many more 
strains, it may be anticipated that further toxigenic strains would be found - 
from various host species other than the pig, that the true distribution of the 
haemorrhagic septicaemia serotypes could be ascertained, that a more accurate 
picture of cattle pasteurellosis in South America might be drawn, and a host 
of other possibilities. Fresh isolates should now be examined: the study of 
stock cultures has served its purpose and need not be pursued further.
2: It has to be admitted that more is known about peripheral matters in P.
multocida pathogenicity - the capsular hyaluronic acid, the protein toxin of a 
minute proportion of strains, for example - than central issues. Attention must 
be directed to the core of the P. multocida pathogenicity problem, namely the 
unascertained virulence factor of the haemorrhagic septicaemia strains. The 
likely candidates are (i) capsule, and (ii) endotoxin.
3: The exciting question of the differences between the Asian and African
haemorrhagic septicaemia serotypes and possible reasons for this, should be 
opened up for study. Host differences in phagocytic cell competence must be 
the first aspect to be addressed.
4: On a more fundamental level, there is much to be done on the role and mode
of action of endotoxin, both in pasteurellosis and other infections. An attempt 
must be made to work out the dynamics of endotoxin production 
formation/release/destruction and consequent effects on host physiology. The 
chemistry and pharmacology of P. multocida endotoxin (and there may be
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more than one form) needs to be known and compared with, say, E. coli 
endotoxin: the differences are likely to be great.
The above are large problems, not to be solved in a year or so. It may finally 
be useful therefore to summarize additionally a few more specific areas in 
which the present work can be seen to point to further study with prospects 
of more rapid results:
5: In the capsule serotyping, two strains of P. multocida were found non reactive
with five different specific capsular antisera in the indirect haemagglutination 
test and their serotype could not be determined. It would be very valuable to 
select one of these strains or to seek further non reactive ones and attempt to 
raise antisera in the same manner as for the other serotypes. As previously 
observed, 5 recognisable capsule serotype seems extraordinarily low for such 
a widespread and common parasitic bacterium.
6: The present study could not identify the capsular substance of serotype D. It
is possible that the type D substance is a another kind of Alcian blue positive 
polysaccharide distinct from hyaluronic acid and chondroitin sulphate. This 
provides stimulus for a clearly needed biochemical analysis of type D capsule 
substance.
7: It has been observed that hypothermia rather than hyperthermia is the
characteristic thermal response to P. multocida endotoxin in mice. With this 
finding , the development of hypothermia in mice at the late phase of infection 
cycle with virulent P. multocida raises the possibility of an important role of 
pathogenic endotoxin in disease. There is scanty information in the 
literature about the effect of hypothermia specifically in mice. This 
observation needs to be substantiated more fully on a large group of animals 
and if possible in the natural host species. This will help to understand the 
pathogenesis of virulent P. multocida infections. The hypothermia is so 
striking, that one is tempted to think it may be an important immediate cause
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of death in the infected mouse. This could be tested by maintaining infected 
mice in a warmed chamber at 37°C throughout, with some arrangement for 
periodic monitoring of rectal temperature without undue cooling, and 
observing whether survival was prolonged by ameliorating the hypothermia.
8: Virulent P. multocida are efficient for a number of reasons and some of the
attributes associated with virulence were recognised. The constructive isogenic 
pairs, would have been useful in determining the relative importance of these 
attributes. Alternatively, it should be possible to restore the deficiencies of 
some of the avirulent strains using transposons insertion mutagenesis and to 
assess the effect on virulence.
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8. APPENDICES
Appendix I
Sample standard curve of neuraminic acid (thiobarbituric acid method)
0.3
0.2
r -  0 .9 9 6 0
0.1
605030 4020
ug/m l
Sample standard curve of protein
0.5
0.4
0.3
r -  0 .9 9 5 7
0.2
0.1
0 5 10 20 25 30
ug/m l
256
<am
 
o 
i-xi « 
c 
o 
e 
w** 
cooo 
c 
E
Appendix H
Sample standard curve of hyaluronic acid (turbidometric method)
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Appendix m
Approximating P. multocida serotype A cfu/ml by measuring optical density
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Approximating P. multocida serotype D cfu/ml by measuring optical density
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Approximating P. multocida serotype E cfu/ml by measuring optical density
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